notes to the consolidated financial · pdf filethe consolidated financial statements have been...

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

263

1. GENERAL INFORMATION PiramalEnterprisesLimited(PEL),(theCompany),alongwithitssubsidiaries(collectivelyreferredtoastheGroup)isoneofIndia’slargediversified

Group,withapresenceinHealthcare,HealthcareInformationManagementandFinancialServicesInHealthcare,PELisoneoftheleadingplayersgloballyinCRAMS(customresearchandmanufacturingservices)aswellasinthecriticalcaresegmentofinhalationandinjectableanaesthetics.ItalsohasastrongpresenceintheOTCsegmentinIndia.PEL’sHealthcareInformationManagementbusiness,DecisionResourcesGroup,isamongstthetop20USmarketresearchorganizationswhichprovideinformationservicestothehealthcareindustry. InFinancialServices,PELprovidescomprehensivefinancingsolutionstorealestatecompanies.StructuredFinanceGroup(SFG)alsoprovidesseniorandmezzaninegrowthcapitaltovariousbusinessesacrossvariedsectorsthatareintegralpartofIndia’sgrowthstory.TheCompanyalsohasstrategicallianceswithtopglobalfundssuchasCPPIBCreditInvestmentInc.,APGAssetManagementandBainCapitalCredit.PELalsohaslongtermequityinvestmentsinShriramGroup,aleadingfinancialconglomerateinIndia.

PELislistedontheBSELimitedandtheNationalStockExchangeofIndiaLimitedinIndia.

2a. SIGNIFICANT ACCOUNTING POLICIES i) Basis of preparation Compliance with Ind AS TheConsolidatedfinancialstatementscomplyinallmaterialaspectswithIndianAccountingStandards(IndAS)notifiedunderSection133of

theCompaniesAct,2013(theAct)[Companies(IndianAccountingStandards)Rules,2015]andotherrelevantprovisionsoftheAct.

ThefinancialstatementsuptoyearendedMarch31,2016werepreparedinaccordancewiththeaccountingstandardsnotifiedunderCompanies(AccountingStandard)Rules,2006 (asamended)andother relevantprovisionsof theAct.Thesefinancial statementsare thefirstfinancialstatementsoftheCompanyunderIndAS.ReferNote56forthedetailsoffirst-timeadoptionexemptionsavailedbytheGroup.

TheSeparatefinancialstatementsarepresentedinadditiontotheconsolidatedfinancialstatementspresentedbytheGroup.

Historical Cost convention TheConsolidatedfinancialstatementshavebeenpreparedonthehistoricalcostbasisexceptforthefollowing:

a) certainfinancialinstrumentsandcontingentconsideration-measuredatfairvalue b) assetsclassifiedasheldforsale-measuredatfairvaluelesscosttosell c) cashsettledstockappreciationrights-measuredatfairvalue d) planassetsofdefinedbenefitplans,whicharemeasuredatfairvalue

ii) Principles of consolidation and equity accounting a) Subsidiaries: Subsidiariesareallentities(includingStructuredentities)overwhichthegrouphascontrol.ControlisachievedwhentheGrouphaspower

overtheinvestee,isexposed,orhasrights,tovariablereturnsfromitsinvolvementwiththeinvesteeandhastheabilitytouseitspowertoaffectitsreturns.Subsidiariesarefullyconsolidatedfromthedateonwhichcontrolistransferredtothegroup.Theyaredeconsolidatedfromthedatethatcontrolceases.

Theacquisitionmethodofaccountingisusedtoaccountforbusinesscombinationsbythegroup.

Thegroupcombinesthefinancialstatementsoftheparentanditssubsidiarieslinebylineaddingtogetherlikeitemsofassets,liabilities,equity,incomeandexpenses.Intercompanytransactions,balancesandunrealisedgainsontransactionsbetweengroupcompaniesareeliminated.Unrealisedlossesarealsoeliminatedunlessthetransactionprovidesevidenceofanimpairmentofthetransferredasset.Accountingpoliciesofsubsidiarieshavebeenchangedwherenecessarytoensureconsistencywiththepoliciesadoptedbythegroup.

Non-controlling interests in the resultsandequityof subsidiariesareshownseparately in theconsolidatedstatementofprofitand loss,consolidatedstatementofchangesinequityandbalancesheetrespectively.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTSfortheyearendedMarch31,2017

Piramal Enterprises Limited Annual Report 2016-17264

CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTD.) for the year ended March 31, 2017

b) Associates: AnassociateisanentityoverwhichtheGrouphassignificantinfluence.Significantinfluenceisthepowertoparticipateinthefinancialand

operatingpolicydecisionsoftheinvesteebutisnotcontrolorjointcontroloverthosepolicies.Investmentsinassociatesareaccountedforusingtheequitymethodofaccounting(see(d)below),afterinitiallybeingrecognisedatcost.

c) Joint Arrangements: Under IndAS111 JointArrangements, investments in joint arrangements are classifiedas either jointoperationsor joint ventures. The

classificationdependsonthecontractualrightsandobligationsofeachinvestor,ratherthanthelegalstructureofthejointarrangement.TheGrouphasbothjointoperationsandjointventures.

Ajointoperationisajointarrangementwherebythepartiesthathavejointcontrolofthearrangementhaverightstotheassetsandobligationsfortheliabilitiesrelatingtothearrangement.

Ajointventureisajointarrangementwherebythepartiesthathavejointcontrolofthearrangementhaverightstothenetassetsofthejointarrangement.Jointcontrolisthecontractuallyagreedsharingofcontrolofanarrangement,whichexistsonlywhendecisionsabouttherelevantactivitiesrequireunanimousconsentofthepartiessharingcontrol.

TheGrouprecognisesitsdirectrighttotheassets,liabilities,revenuesandexpensesofjointoperationsanditsshareofanyjointlyheldorincurredassets,liabilities,revenuesandexpenses.Thesehavebeenincorporatedinthefinancialstatementsundertheappropriateheadings.

Interestsinjointventuresareaccountedforusingtheequitymethod(see(d)below),afterinitiallybeingrecognisedatcostintheconsolidatedbalance sheet.

d) Equity method: Undertheequitymethodofaccounting,theinvestmentsareinitiallyrecognisedatcostandadjustedthereaftertorecognisetheGroup’s

shareofpostacquisitionprofitsor lossesoftheinvesteeinprofitandloss,andthegroup’sshareofothercomprehensiveincomeoftheinvesteeinothercomprehensiveincome.Dividendsreceivedorreceivablefromassociatesorjointventuresarerecognisedasareductioninthecarryingamountoftheinvestment.

Unrealisedgainsontransactionsbetweenthegroupanditsassociatesandjointventuresareeliminatedtotheextentofthegroup’sinterestintheseentities.Unrealisedlossesarealsoeliminatedunlessthetransactionprovidesevidenceofanimpairmentoftheassettransferred.

ThecarryingamountofequityaccountedinvestmentsaretestedforimpairmentinaccordancewiththepolicymentionedinNote2a(vi)below.

e) Changes in ownership interests Thegrouptreatstransactionswithnon-controllingintereststhatdonotresultinlossofcontrolastransactionswithequityownersofthe

group.Achangeintheownership interestresults inanadjustmentbetweenthecarryingamountsofthecontrollingandnon-controllingintereststoreflecttheirrelativeinterestsinthesubsidiary.Anydifferencebetweentheamountoftheadjustmenttononcontrollinginterestsandanyconsiderationpaidorreceivedisrecognisedwithinequity.

iii) Business Combinations Theacquisitionmethodofaccountingisusedtoaccountforallbusinesscombinations,regardlessofwhetherequityinstrumentsorother

assetsareacquired.Theconsiderationtransferredfortheacquisitionofasubsidiarycomprisesthe:

-fairvaluesoftheassetstransferred; -liabilitiesincurredtotheformerownersoftheacquiredbusiness; -equityinterestsissuedbythegroup;and -fairvalueofanyassetorliabilityresultingfromacontingentconsiderationarrangement. Identifiableassetsacquiredandliabilitiesandcontingentliabilitiesassumedinabusinesscombinationare,withlimitedexceptions,measured

initiallyattheirfairvaluesattheacquisitiondate.Thegrouprecognisesanynon-controllinginterestintheacquiredentityonanacquisition-by-acquisitionbasisatthenon-controllinginterest’sproportionateshareoftheacquiredentity’snetidentifiableassets.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

265


Acquisition-relatedcostsareexpensedasincurred.

Theexcessofthe -considerationtransferred; -amountofanynon-controllinginterestintheacquiredentity,and -acquisition-datefairvalueofanypreviousequityinterestintheacquiredentity overthefairvalueofthenetidentifiableassetsacquiredisrecordedasgoodwill. Ifthoseamountsarelessthanthefairvalueofthenet

identifiableassetsofthebusinessacquired,thedifferenceisrecognisedinothercomprehensiveincomeandaccumulatedinequityascapitalreserveprovidedthereisclearevidenceoftheunderlyingreasonsforclassifyingthebusinesscombinationasabargainpurchase.Inothercases,thebargainpurchasegainisrecogniseddirectlyinequityascapitalreserve.

Wheresettlementofanypartofcashconsiderationisdeferred,theamountspayableinthefuturearediscountedtotheirpresentvalueasatthedateofexchange.Thediscountrateusedistheentity’sincrementalborrowingrate,beingtherateatwhichasimilarborrowingcouldbeobtainedfromanindependentfinancierundercomparabletermsandconditions.

Contingent consideration is classified either as equity or a financial liability. Amounts classified as a financial liability are subsequentlyremeasuredtofairvaluewithchangesinfairvaluerecognisedinprofitorloss.

Ifthebusinesscombinationisachievedinstages,theacquisitiondatecarryingvalueoftheacquirer’spreviouslyheldequityinterestintheacquireeisremeasuredtofairvalueattheacquisitiondate.Anygainsorlossesarisingfromsuchremeasurementarerecognisedinprofitorlossorothercomprehensiveincome,asappropriate.

Common control transactions Businesscombinationsinvolvingentitiesthatarecontrolledbythegroupareaccountedforusingthepoolingofinterestsmethodasfollows:

1) Theassetsandliabilitiesofthecombiningentitiesarereflectedattheircarryingamounts.

2) Noadjustmentsaremadetoreflectfairvalues,orrecogniseanynewassetsor liabilities.Adjustmentsareonlymadetoharmoniseaccountingpolicies.

3) Thebalanceof the retainedearningsappearing in thefinancial statementsof the transferor is aggregatedwith the correspondingbalanceappearinginthefinancialstatementsofthetransfereeorisadjustedagainstgeneralreserve.

4) Theidentityofthereservesarepreservedandthereservesofthetransferorbecomethereservesofthetransferee.

5) Thedifference,ifany,betweentheamountsrecordedassharecapitalissuedplusanyadditionalconsiderationintheformofcashorotherassetsandtheamountofsharecapitalofthetransferoristransferredtocapitalreserveandispresentedseparatelyfromothercapitalreserves.

6) Thefinancialinformationinthefinancialstatementsinrespectofpriorperiodsisrestatedasifthebusinesscombinationhadoccurredfromthebeginningoftheprecedingperiodinthefinancialstatements,irrespectiveoftheactualdateofcombination.However,wherethebusinesscombinationhadoccuredafterthatdate,thepriorperiodinformationisrestatedonlyfromthatdate.

iv) (a) Property, Plant and Equipment Freehold Land is carried at historical cost. All other items of Property Plant & Equipments are stated at cost of acquisition, less

accumulateddepreciationandaccumulatedimpairmentlosses,ifany.Directcostsarecapitaliseduntiltheassetsarereadyforuseandincludesfreight,duties,taxesandexpensesincidentaltoacquisitionandinstallationThecarryingamountofanycomponentaccountedforasaseparateassetisderecognisedwhenreplacedAllotherrepairsandmaintenancearechargedtoprofitorlossduringthereportingperiodinwhichtheyareincurred.SubsequentexpendituresrelatedtoanitemofPropertyPlant&EquipmentareaddedtoitscarryingvalueonlywhenitisprobablethatthefutureeconomicbenefitsfromtheassetwillflowtotheGroup&costcanbereliablymeasured. Lossesarisingfromtheretirementof,andgainsorlossesarisingfromdisposalofProperty,PlantandEquipmentarerecognisedintheConsolidatedStatementofProfitandLoss.




Depreciation Depreciation isprovidedonapro-ratabasison the straight linemethod (‘SLM’)over theestimateduseful livesof theassets specified in

Schedule II of the Companies Act, 2013 / estimated useful lives as determined by themanagement of respective subsidiaries based ontechnicalevaluation.Theassets’residualvaluesandusefullivesarereviewed,andadjustedifappropriate,attheendofeachreportingperiod.

OntransitiontoIndAS,thegrouphaselectedtocontinuewiththecarryingvalueofallofitsproperty,plantandequipmentrecognisedasat1April2015measuredasper thepreviousGAAPanduse that carryingvalueas thedeemedcostof theproperty,plantandequipment.

TheestimatedusefullivesofProperty,Plant&Equipmentareasstatedbelow:

Asset Class The Useful lifeBuildings 10years-60yearsCarpetedRoads 10yearsPlant&Machinery 3-20yearsContinuousProcessPlant 25yearsOfficeEquipment 3years-15yearsVehicles 4-8yearsHelicopter 20yearsShips/Yachts 13years/28YearsFurniture&fixtures 5-10years

(iv) (b) Non current assets held for sale Noncurrentassetsareclassifiedasheldforsaleiftheircarryingamountwillberecoveredprincipallythroughasaletransactionrather

thanthroughcontinuinguseandasaleisconsideredhighlyprobable.Theyaremeasuredattheloweroftheircarryingamountandfairvalueslesscosttosell,exceptforassetssuchasdeferredtaxassets,assetsarisingfromemployeebenefitsandfinancialassetswhicharespecificallyexemptfromthisrequirement.

(v) (a) Intangible Assets Intangible assets are stated at acquisition cost, net of accumulated amortisation and accumulated impairment losses, if any.

GainsorlossesarisingfromtheretirementordisposalofanintangibleassetaredeterminedasthedifferencebetweenthedisposalproceedsandthecarryingamountoftheassetandarerecognisedasincomeorexpenseintheConsolidatedStatementofProfitandLoss.

Theresearchanddevelopment(R&D)costisaccountedinaccordancewithIndAS-38‘Intangibles’.

ResearchResearch costs, including patent filing charges, technical know-how fees, testing charges on animal and expenses incurred ondevelopmentofamoleculetillthestageofPre-clinicalstudiesandtillthereceiptofregulatoryapprovalforcommencingphaseItrialsaretreatedasrevenueexpensesandchargedofftotheStatementofProfitandLossofrespectiveyear.

DevelopmentDevelopmentcostsrelatingtodesignandtestingofnewor improvedmaterials,productsorprocessesarerecognizedas intangibleassetsandarecarriedforwardunderIntangibleAssetsunderDevelopmentuntilthecompletionoftheprojectwhentheyarecapitalisedasIntangibleassets,ifthefollowingconditionsaresatisfied:

itistechnicallyfeasibletocompletetheassetsothatitwillbeavailableforuse; managementintendstocompletetheassetanduseorsellit; thereisanabilitytouseorselltheasset; itcanbedemonstratedhowtheassetwillgenerateprobablefutureeconomicbenefits; adequatetechnical,financialandotherresourcestocompletethedevelopmentandtouseorselltheassetareavailable;and theexpenditureattributabletotheassetduringitsdevelopmentcanbereliablymeasured.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

267


OntransitiontoIndAS,theGrouphaselectedtocontinuewiththecarryingvalueofallofitsIntangibleAssetsrecognisedasat1April2015measuredasperthepreviousGAAPandusethatcarryingvalueasthedeemedcostoftheIntangibleAssets.

IntangibleAssetswithfiniteusefullivesareamortizedonastraightlinebasisoverthefollowingperiod:

BrandsandTrademarks 10-15yearsCopyrights,Know-how(includingqualifyingProductDevelopmentCost)andIntellectualpropertyrights 4-15yearsComputerSoftware 3-6yearsCustomerrelationships 8-14yearsTechnology 7years

Theassets’residualvaluesandusefullivesarereviewed,andadjustedifappropriate,attheendofeachreportingperiod.TrademarksareassessedasIntangibleAssetswithindefiniteusefullives.

(v) (b) Goodwill Goodwillonacquisitionofsubsidiaries is includedin intangibleassets.Goodwillandintangibleassetsthathavean indefiniteuseful

lifearenotsubjecttoamortisationandaretestedannuallyforimpairment,ormorefrequentlyifeventsorchangesincircumstancesindicatethattheymightbeimpaired.Goodwilliscarriedatcostlessaccumulatedimpairmentlosses.

vi) Impairment of Assets TheGroupassessesateachBalanceSheetdatewhetherthereisanyindicationthatanassetmaybeimpaired.Forthepurposesofassessing

impairment,thesmallestidentifiablegroupofassetsthatgeneratescashinflowsfromcontinuingusethatarelargelyindependentofthecashinflowsfromotherassetsorgroupsofassets, isconsideredasacashgeneratingunit. Ifanysuchindicationexists,theGroupestimatestherecoverableamountoftheasset.Therecoverableamountisthehigherofanasset’sfairvaluelesscostsofdisposalandvalueinuse.Ifsuchrecoverableamountoftheassetortherecoverableamountofthecashgeneratingunit towhichtheassetbelongs is lessthan itscarryingamount,thecarryingamountisreducedtoitsrecoverableamount.ThereductionistreatedasanimpairmentlossandisrecognisedintheConsolidatedStatementofProfitandLoss.IfattheBalanceSheetdatethereisanindicationthatifapreviouslyassessedimpairmentlossnolongerexistsormayhavedecreased,therecoverableamountisreassessedandtheassetisreflectedattherecoverableamount.

vii) Financial instruments FinancialassetsandfinancialliabilitiesarerecognisedwhenaGroupentitybecomesapartytothecontractualprovisionsoftheinstruments.

Financialassetsandfinancialliabilitiesareinitiallymeasuredatfairvalue.Transactioncoststhataredirectlyattributabletotheacquisitionorissueoffinancialassetsandfinancialliabilities(otherthanfinancialassetsandfinancialliabilitiesatfairvaluethroughprofitorloss)areaddedtoordeductedfromthefairvalueofthefinancialassetsorfinancialliabilities,asappropriate,oninitialrecognition.Transactioncostsdirectlyattributabletotheacquisitionoffinancialassetsorfinancialliabilitiesatfairvaluethroughprofitorlossarerecognisedimmediatelyinprofitorloss.

Investments and Other Financial assets Classification: TheGroupclassifiesitsfinancialassetsinthefollowingmeasurementcategories:

thosetobemeasuredsubsequentlyatfairvalue(eitherthroughothercomprehensiveincome,orthroughprofitorloss),and thosemeasuredatamortisedcost.

Theclassificationdependsontheentity’sbusinessmodelformanagingthefinancialassetsandthecontractualtermsofthecashflows. Forassetsmeasuredatfairvalue,gainsandlosseswilleitherberecordedinprofitorlossorothercomprehensiveincome.Forinvestments

indebtinstruments,thiswilldependonthebusinessmodelinwhichtheinvestmentisheld.Forinvestmentsinequityinstruments,thiswilldependonwhethertheGrouphasmadeanirrevocableelectionatthetimeofinitialrecognitiontoaccountfortheequityinvestmentatfairvaluethroughothercomprehensiveincome.

TheGroupreclassifiesdebtinvestmentswhenandonlywhenitsbusinessmodelformanagingthoseassetschanges.




Measurement Atinitialrecognition,theGroupmeasuresafinancialassetatitsfairvalueplus,inthecaseofafinancialassetnotatfairvaluethroughprofit

orloss,transactioncoststhataredirectlyattributabletotheacquisitionofthefinancialasset.Transactioncostsoffinancialassetscarriedatfairvaluethroughprofitorlossareexpensedinprofitorloss.

Financialassetswithembeddedderivativesareconsideredintheirentiretywhendeterminingwhethertheircashflowsaresolelypaymentofprincipalandinterest.

Debtinstruments SubsequentmeasurementofdebtinstrumentsdependsontheGroup’sbusinessmodelformanagingtheassetandthecashflowcharacteristics

oftheasset.Therearethreemeasurementcategoriesintowhichthegroupclassifiesitsdebtinstruments:

Amortised cost: Assetsthatareheldforcollectionofcontractualcashflowswherethosecashflowsrepresentsolelypaymentsofprincipalandinterestare

measuredatamortisedcost.Againorlossonadebtinvestmentthatissubsequentlymeasuredatamortisedcostandisnotpartofahedgingrelationshipisrecognisedinprofitorlosswhentheassetisderecognisedorimpaired.Interestincomefromthesefinancialassetsisincludedinfinanceincomeusingtheeffectiveinterestratemethod.

Fair value through other comprehensive income (FVTOCI): Assetsthatareheldforcollectionofcontractualcashflowsandforsellingthefinancialassets,wheretheassets’cashflowsrepresentsolely

paymentsofprincipalandinterest,aremeasuredatfairvaluethroughothercomprehensiveincome(FVTOCI).MovementsinthecarryingamountaretakenthroughOCI,exceptfortherecognitionofimpairmentgainsorlosses,interestrevenueandforeignexchangegainsandlosseswhicharerecognisedinprofitandloss.Whenthefinancialassetisderecognised,thecumulativegainorlosspreviouslyrecognisedinOCIisreclassifiedfromequitytoprofitorlossandrecognisedinothergains/(losses).Interestincomefromthesefinancialassetsisincludedinotherincomeusingtheeffectiveinterestratemethod.

Fair value through profit or loss: AssetsthatdonotmeetthecriteriaforamortisedcostorFVTOCIaremeasuredatfairvaluethroughprofitorloss.Againorlossonadebt

investmentthatissubsequentlymeasuredatfairvaluethroughprofitorlossandisnotpartofahedgingrelationshipisrecognisedinprofitorlossandpresentednetinthestatementofprofitandlosswithinothergains/(losses)intheperiodinwhichitarises.Interestincomefromthesefinancialassetsisincludedinotherincome.

Equityinstruments TheGroupsubsequentlymeasuresallequity investmentsatfairvalue.WheretheGroup’smanagementhaselectedtopresentfairvalue

gainsandlossesonequityinvestmentsinothercomprehensiveincome,thereisnosubsequentreclassificationoffairvaluegainsandlossestoprofitorloss.DividendsfromsuchinvestmentsarerecognisedinprofitorlosswhentheGroup’srighttoreceivepaymentsisestablished.

Changesinthefairvalueoffinancialassetsatfairvaluethroughprofitorlossarerecognisedintheconsolidatedstatementofprofitandloss.

Impairmentoffinancialassets TheGroupapplies theexpected credit lossmodel for recognising impairment lossonfinancial assetsmeasuredat amortised cost, loan

commitments,tradereceivablesandothercontractualrightstoreceivecashorotherfinancialasset.

For trade receivables or any contractual right to receive cash or another financial asset that result from transactions that are withinthe scope of Ind AS 18, the Group always measures the loss allowance at an amount equal to lifetime expected credit losses. Further,forthepurposeofmeasuringlifetimeexpectedcreditloss(“ECL”)allowancefortradereceivables,theGrouphasusedapracticalexpedientaspermittedunder IndAS109.Thisexpectedcredit lossallowance iscomputedbasedonaprovisionmatrixwhichtakes intoaccounthistoricalcreditlossexperienceandadjustedforforward-lookinginformation.

Theexpectedcreditlossisaproductofexposureatdefault,probabilityofdefaultandlossgivendefault.TheGrouphasdevisedaninternalmodeltoevaluatetheprobabilityofdefaultandlossgivendefaultbasedontheparameterssetoutinIndAS109.Accordingly,thefinancial

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

269


instrumentsareclassifiedintoStage1–StandardAssetswithzerotothirtydayspastdue(DPD),Stage2–SignificantCreditDeteriorationoroverduebetween31to90daysandStage3–DefaultAssetswithoverdueformorethan90days.TheGroupalsotakesintoaccountthebelowqualitativeparametersindeterminingtheincreaseincreditriskforthefinancialassets:

1) Significantnegativedeviationinthebusinessplanofthedeveloper 2) Internalratingdowngradefortheborrowerortheproject 3) Currentandexpectedfinancialperformanceofthedeveloper 4) Needforrefinanceofloanduetochangeincashflowoftheproject 5) Significantdecreaseinthevalueofcollateral 6) Changeinmarketconditionsandindustrytrends

Forrecognitionofimpairmentlossonotherfinancialassetsandriskexposure,theGroupdeterminesthatwhethertherehasbeenasignificantincreaseinthecreditrisksinceinitialrecognition.Ifcreditriskhasnotincreasedsignificantly,12-monthECLisusedtoprovideforimpairmentloss.However,ifcreditriskhasincreasedsignificantly,lifetimeECLisused.If,inasubsequentperiod,creditqualityoftheinstrumentimprovessuchthatthereisnolongerasignificantincreaseincreditrisksinceinitialrecognition,thentheentityrevertstorecognisingimpairmentlossallowancebasedon12-monthECL.LifetimeECLaretheexpectedcreditlossesresultingfromallpossibledefaulteventsovertheexpectedlifeofafinancialinstrument.The12-monthECLisaportionofthelifetimeECLwhichresultsfromdefaulteventsthatarepossiblewithin12monthsafterthereportingdate.

DefaultAssetswhereinthemanagementdoesnotexpectanyrealisticprospectofrecoveryarewrittenofftotheStatementofProfitandLoss.

Derecognitionoffinancialassets Afinancialassetisderecognisedonlywhen: TheGrouphastransferredtherightstoreceivecashflowsfromthefinancialassetor retainsthecontractualrightstoreceivethecashflowsofthefinancialasset,butassumesacontractualobligationtopaythecash

flowstooneormorerecipients.

Wheretheentityhastransferredanasset,theGroupevaluateswhetherithastransferredsubstantiallyallrisksandrewardsofownershipofthefinancialasset.Insuchcases,thefinancialassetisderecognised.Wheretheentityhasnottransferredsubstantiallyallrisksandrewardsofownershipofthefinancialasset,thefinancialassetisnotderecognised.

Foreignexchangegainsandlosses Thefairvalueoffinancialassetsdenominatedinaforeigncurrencyisdeterminedinthatforeigncurrencyandtranslatedatthespotrateat

theendofeachreportingperiod.ForforeigncurrencydenominatedfinancialassetsmeasuredatamortisedcostandFVTPL,theexchangedifferencesarerecognisedinprofitorlossexceptforthosewhicharedesignatedashedginginstrumentsinahedgingrelationship.

Financial liabilities and equity instruments Classificationasdebtorequity DebtandequityinstrumentsissuedbyaGroupentityareclassifiedaseitherfinancialliabilitiesorasequityinaccordancewiththesubstance

ofthecontractualarrangementsandthedefinitionsofafinancialliabilityandanequityinstrument.

EquityInstrument Anequityinstrumentisanycontractthatevidencesaresidualinterestintheassetsofanentityafterdeductingallofitsliabilities.Equity

instrumentsissuedarerecognisedattheproceedsreceived,netofdirectissuecosts.

Financialliabilities AllfinancialliabilitiesaresubsequentlymeasuredatamortisedcostusingtheeffectiveinterestmethodoratFVTPL.

Financial liabilitiesareclassifiedasatFVTPLwhenthefinancial liability iseithercontingentconsiderationrecognisedbytheGroupasanacquirerinabusinesscombinationtowhichIndAS103appliesorisheldfortradingoritisdesignatedasatFVTPL.




Financialliabilitiesthatarenotheld-for-tradingandarenotdesignatedasatFVTPLaremeasuredatamortisedcostattheendofsubsequentaccountingperiods.Thecarryingamountsoffinancialliabilitiesthataresubsequentlymeasuredatamortisedcostaredeterminedbasedontheeffectiveinterestmethod.

Theeffectiveinterestmethodisamethodofcalculatingtheamortisedcostofafinancial liabilityandofallocatinginterestexpenseovertherelevantperiod.Theeffectiveinterestrateistheratethatexactlydiscountsestimatedfuturecashpayments(includingallfeespaidorreceivedthatformanintegralpartoftheeffectiveinterestrate,transactioncostsandotherpremiumsordiscounts)throughtheexpectedlifeofthefinancialliability,or(whereappropriate)ashorterperiod,totheamortisedcostofafinancialliability.

BorrowingsareclassifiedascurrentliabilitiesunlesstheGrouphasanunconditionalrighttodefersettlementoftheliabilityforatleast12monthsafterthereportingperiod.Wherethereisabreachofamaterialprovisionofalong-termloanarrangementonorbeforetheendofthereportingperiodwiththeeffectthatthe liabilitybecomespayableondemandonthereportingdate,theGroupdoesnotclassifytheliabilityascurrent,ifthelenderagreed,afterthereportingperiodandbeforetheapprovalofthefinancialstatementsforissue,nottodemandpaymentasaconsequenceofthebreach.

Foreignexchangegainsandlosses Forfinancialliabilitiesthataredenominatedinaforeigncurrencyandaremeasuredatamortisedcostattheendofeachreportingperiod,

theforeignexchangegainsandlossesaredeterminedbasedontheamortisedcostoftheinstruments.

FinancialGuaranteeContracts Afinancialguaranteecontractisacontractthatrequirestheissuertomakespecifiedpaymentstoreimbursetheholderforalossitincurs

becauseaspecifieddebtorfailstomakepaymentswhendueinaccordancewiththetermsofadebtinstrument.

FinancialguaranteecontractsissuedbytheGroupareinitiallymeasuredattheirfairvaluesandaresubsequentlymeasuredatthehigherof: theamountofthelossallowancedeterminedinaccordancewithIndAS109;and theamountinitiallyrecognisedless,whereappropriate,cumulativeamortisationrecognisedinaccordancewiththerevenuerecognition

policies.

Derecognitionoffinancialliabilities TheGroupderecognisesfinancial liabilitieswhen,andonlywhen, theGroup’sobligationsaredischarged, cancelledorhaveexpired.An

exchangebetweenwithalenderofdebtinstrumentswithsubstantiallydifferenttermsisaccountedforasanextinguishmentoftheoriginalfinancialliabilityandtherecognitionofanewfinancialliability.

Derivatives and hedging activities Derivativesareinitiallyrecognisedatfairvalueonthedateaderivativecontractisenteredintoandaresubsequentlyre-measuredtotheir

fairvalueattheendofeachreportingperiod.Theaccountingforsubsequentchangesinfairvaluedependsonwhetherthederivativeisdesignatedasahedginginstrument,andifso,thenatureoftheitembeinghedgedandthetypeofhedgerelationshipdesignated.

Thefullfairvalueofahedgingderivativeisclassifiedasanon-currentassetorliabilitywhentheremainingmaturityofthehedgeditemismorethan12months;itisclassifiedasacurrentassetorliabilitywhentheremainingmaturityofthehedgeditemislessthan12months.Tradingderivativesareclassifiedasacurrentassetorliability.

(i) Cashflowhedgesthatqualifyforhedgeaccounting: Theeffectiveportionofchangesinthefairvalueofderivativesthataredesignatedandqualifyascashflowhedgesisrecognisedin

theother comprehensive income in cashflowhedging reservewithinequity, limited to the cumulative change in fair valueof thehedgeditemonapresentvaluebasisfromtheinceptionofthehedge.Thegainorlossrelatingtotheineffectiveportionisrecognisedimmediatelyinprofitorloss,withinothergains/(losses).

(ii) Derivativesthatarenotdesignatedashedges: Thegroupentersintocertainderivativecontractstohedgeriskswhicharenotdesignatedashedges.Suchcontractsareaccountedforatfairvaluethroughprofitorloss.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

271


Embeddedderivatives DerivativesembeddedinahostcontractthatisanassetwithinthescopeofIndAS109arenotseparated.Financialassetswithembedded

derivativesareconsideredintheirentiretywhendeterminingwhethertheircashflowsaresolelypaymentofprincipalandinterest.

Derivativesembeddedinallotherhostcontractareseparatedonlyiftheeconomiccharacteristicsandrisksoftheembeddedderivativearenotcloselyrelatedtotheeconomiccharacteristicsandrisksofthehostandaremeasuredatfairvaluethroughprofitorloss.Embeddedderivativescloselyrelatedtothehostcontractsarenotseparated.

Offsetting Financial Instruments FinancialAssetsandLiabilitiesareoffsetand thenetamount is reflected in thebalancesheetwhere there isa legallyenforceable right

tooffsettherecognisedamountsandthereisanintentiontosettletheliabilitysimultaneously.Thelegallyenforceablerightmustnotbecontingentonfutureeventsandmustbeenforceableinthenormalcourseofbusinessandintheeventofdefault,insolvencyorbankruptcyoftheGrouporcounterparty.

viii) Trade Receivables Tradereceivablesarerecognisedinitiallyatfairvalueandsubsequentlymeasuredatamortisedcostusingtheeffectiveinterestmethod,less

provisionforimpairment.

ix) Inventories Inventories comprise of Raw and Packing Materials, Work in Progress, Finished Goods (Manufactured and Traded) and Engineering

Stores. Inventoriesarevaluedatthe lowerofcostandthenetrealisablevalueafterprovidingforobsolescenceandother losses,whereconsidered necessary. Cost is determined onWeighted Average basis. Cost includes all charges in bringing the goods to their presentlocation and condition, including octroi and other levies, transit insurance and receiving charges. The cost of Work-in-progress andFinishedGoodscomprisesofmaterials,direct labour,otherdirectcostsandrelatedproductionoverheadsandExcisedutyasapplicable. Netrealizablevalueistheestimatedsellingpriceintheordinarycourseofbusinesslesstheestimatedcostsofcompletionandtheestimatedcostsnecessarytomakethesale.

x) Employee Benefits (i) Short-term obligations Liabilitiesforwagesandsalaries,includingnon-monetarybenefitsthatareexpectedtobesettledwhollywithin12monthsaftertheend

oftheperiodinwhichtheemployeesrendertherelatedservicearerecognisedinrespectofemployees’servicesuptotheendofthereportingperiodandaremeasuredattheamountsexpectedtobepaidwhentheliabilitiesaresettled.Theliabilitiesarepresentedascurrentemployeebenefitobligationsinthebalancesheet.

(ii) Other long-term employee benefit obligations Theliabilitiesforearnedleavearenotexpectedtobesettledwhollywithin12monthsaftertheendoftheperiodinwhichtheemployees

rendertherelatedservice.Theyarethereforemeasuredasthepresentvalueofexpectedfuturepaymentstobemadeinrespectofservicesprovidedbyemployeesuptotheendofthereportingperiodusingtheprojectedunitcreditmethod.Thebenefitsarediscountedusingthemarketyieldsattheendofthereportingperiodthathavetermsapproximatingtothetermsoftherelatedobligation.Remeasurementsasaresultofexperienceadjustmentsandchangesinactuarialassumptionsarerecognisedinprofitorloss.

The obligations are presented as current liabilities in the balance sheet if the entity does not have an unconditional right to defersettlement for at least twelve months after the reporting period, regardless of when the actual settlement is expected to occur. LongTermServiceAwardsarerecognisedasaliabilityatthepresentvalueofthedefinedbenefitobligationasatthebalancesheetdate.

(iii) Post-employment obligations TheGroupoperatesthefollowingpost-employmentschemes: -DefinedContributionplanssuchasprovidentfund,superannuation,pension,employeestateinsuranceschemeandothersocial

securityschemesinoverseasjurisdictions -DefinedBenefitplanssuchasprovidentfundandGratuity,Pensionfund(incaseofasubsidiary)




IncaseofProvidentfund,contributionsaremadetoaTrustadministeredbytheGroup,exceptincaseofcertainemployees,wheretheContributionsaremadetotheRegionalProvidentFundOffice.

Defined Contribution Plans TheGroup’scontributiontoprovidentfund(incaseofcontributionstotheRegionalProvidentFundoffice),pensionandemployeestate

insuranceschemeandothersocialsecurityschemesinoverseasjurisdictionsareconsideredasdefinedcontributionplans,astheGroupdoesnotcarryanyfurtherobligationsapartfromthecontributionsmadeonamonthlybasisandarechargedasanexpensebasedontheamountofcontributionrequiredtobemade.Incaseof401(k)contributionplan(incaseofUSsubsidiaries),contributionbytheGroupisdiscretionary.AnycontributionmadeischargedtotheStatementofProfitandLoss.

Defined Benefit Plan Theliabilityorassetrecognisedinthebalancesheetinrespectofdefinedbenefitprovidentandgratuityplansisthepresentvalueofthe

definedbenefitobligationattheendofthereportingperiodlessthefairvalueofplanassets.Thedefinedbenefitobligationiscalculatedannuallybyactuariesusingtheprojectedunitcreditmethod.

Exceptincaseofanoverseassubsidiary,thepresentvalueofthedefinedbenefitobligationdenominatedinINRisdeterminedbydiscountingtheestimatedfuturecashoutflowsbyreferencetomarketyieldsattheendofthereportingperiodongovernmentbondsthathavetermsapproximatingtothetermsoftherelatedobligation.

Thenetinterestcostiscalculatedbyapplyingthediscountratetothenetbalanceofthedefinedbenefitobligationandthefairvalueofplanassets.Thiscostisincludedinemployeebenefitexpenseinthestatementofprofitandloss.Incaseofanoverseassubsidiary,wherepensionisclassifiedasaDefinedBenefitScheme,assetsaremeasuredusingmarketvaluesandliabilitiesaremeasuredusingaProjectedUnitCreditmethodanddiscountedusingmarketyieldsdeterminedbyreferencetohigh-qualitycorporatebondsthataredenominatedinthecurrencyinwhichbenefitswillbepaid,andthathavetermsapproximatingtothetermsoftherelatedobligation.Shortfall,ifany,isprovidedforinthefinancialstatements.

Remeasurementgainsandlossesarisingfromexperienceadjustments,changesinactuarialassumptionsandreturnonplanassets(excludinginterestincome)arerecognisedintheperiodinwhichtheyoccur,directlyinothercomprehensiveincome.Theyareincludedinretainedearnings in thestatementofchanges inequityand in thebalancesheet.Changes in thepresentvalueof thedefinedbenefitobligationresultingfromplanamendmentsorcurtailmentsarerecognisedimmediatelyinprofitorlossaspastservicecost.

BonusPlans-TheGrouprecognisesaliabilityandanexpenseforbonuses.Thegrouprecognisesaprovisionwherecontractuallyobligedorwherethereisapastpracticethathascreatedaconstructiveobligation.

xi) Provisions and Contingent Liabilities Provisionsarerecognisedwhenthereisapresentobligation(legalorconstructive)asaresultofapastevent,itisprobablethatanoutflow

ofresourcesembodyingeconomicbenefitswillberequiredtosettletheobligationandthereisareliableestimateoftheamountoftheobligation.Whenaprovisionismeasuredusingthecashflowsestimatedtosettlethepresentobligation,itscarryingamountisthepresentvalueofthosecashflows(whentheeffectofthetimevalueofmoneyismaterial).Thediscountrateusedtodeterminethepresentvalueisapre-taxratethatreflectscurrentmarketassessmentsofthetimevalueofmoneyandtherisksspecifictotheliability.Theincreaseintheprovisionduetothepassageoftimeisrecognisedasinterestexpense.

Contingentliabilitiesaredisclosedwhenthereisapossibleobligationarisingfrompastevents,theexistenceofwhichwillbeconfirmedonlybytheoccurrenceornonoccurenceofoneormoreuncertainfutureeventsnotwhollywithinthecontroloftheGrouporapresentobligationthatarisesfrompasteventswhereitiseithernotprobablethatanoutflowofresourceswillberequiredtosettletheobligationorareliableestimateoftheamountcannotbemade.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

273


xii) Revenue recognition Revenueismeasuredatthefairvalueoftheconsiderationreceivedorreceivable.

Sale of goods:Revenuefromthesaleofgoodsisrecognisedwhenthesignificantrisksandrewardsofownershipofthegoodshavepassedtothebuyer,basedontheapplicableincoterms.Amountsdisclosedasrevenueareinclusiveofexcisedutyandnetofreturns,tradeallowances,rebates,valueaddedtaxesandamountscollectedonbehalfofthirdparties.TheGrouprecognisesrevenuewhentheamountofrevenuecanbereliablymeasured,itisprobablethatfutureeconomicbenefitswillflowtotheGroupandtherevenuerecognitioncriteriahavebeencomplied.

Sale of Services: In contracts involving the rendering of services/development contracts, revenue ismeasured using the proportionatecompletionmethodand is recognisednetof service tax (provided that it isprobable that theeconomicbenefitswillflow to theGroupandtheamountofincomecanbemeasuredreliably).AdvisoryfeesareaccountedonanaccrualbasisinaccordancewiththeInvestmentManagementAgreementandAdvisoryServicesAgreement.

Interest: InterestincomefromafinancialassetisrecognisedwhenitisprobablethattheeconomicbenefitswillflowtotheGroupandtheamountofincomecanbemeasuredreliably.Interestincomeisaccruedonatimebasis,byreferencetotheamortisedcostandattheeffectiveinterestrateapplicable.

Dividend:Dividendincomefrominvestmentsisrecognisedwhentheshareholder’srighttoreceivepaymenthasbeenestablished(providedthatitisprobablethattheeconomicbenefitswillflowtotheGroupandtheamountofincomecanbemeasuredreliably).

xiii) Foreign Currency Transactions InpreparingthefinancialstatementsofeachindividualCompanyentity,transactionsincurrenciesotherthantheentity’sfunctionalcurrency

(foreigncurrencies)arerecognisedattheratesofexchangeprevailingatthedatesofthetransactions.Attheendofeachreportingperiod,monetaryitemsdenominatedinforeigncurrenciesareretranslatedattheratesprevailingatthatdate.Non-monetaryitemscarriedatfairvaluethataredenominatedinforeigncurrenciesareretranslatedattheratesprevailingatthedatewhenthefairvaluewasdetermined.Non-monetaryitemsthataremeasuredintermsofhistoricalcostinaforeigncurrencyarenotretranslated.

Exchangedifferencesonmonetaryitemsarerecognisedinprofitorlossintheperiodinwhichtheyarise.

Forthepurposeofpresentingconsolidatedfinancialstatements,theassetsandliabilitiesoftheCompany’sforeignoperationsthathaveafunctionalcurrencyotherthanpresentationcurrencyi.e.IndianRupeesaretranslatedusingexchangeratesprevailingatthereportingdate.Incomeandexpenseitemsaretranslatedattheaverageexchangeratesfortheperiod.Exchangedifferencesarising,ifany,arerecognizedinothercomprehensiveincomeandheldinforeigncurrencytranslationreserve(FCTR),acomponentofequity,excepttotheextentthatthetranslationdifferenceisallocatedtonon-controllinginterest.Whenaforeignoperationisdisposedoff,therelevantamountrecognizedinFCTRistransferredtothestatementofincomeaspartoftheprofitorlossondisposal.Goodwillandfairvalueadjustmentsarisingontheacquisitionofaforeignoperationaretreatedasassetsandliabilitiesoftheforeignoperationandtranslatedattheexchangerateprevailingatthereportingdate.

Foreigncurrencydifferencesarisingfromtranslationofintercompanyreceivablesorpayablesrelatingtoforeignoperations,thesettlementofwhichisneitherplannednorlikelyintheforeseeablefuture,areconsideredtoformpartofnetinvestmentinforeignoperationandarerecognizedinFCTR.

xiv) Exceptional Items Whenitemsofincomeandexpensewithinprofitorlossfromordinaryactivitiesareofsuchsize,natureorincidencethattheirdisclosure

is relevant toexplain theperformanceof theenterprise for theperiod, thenatureandamountof such items isdisclosed separatelyasExceptionalitems.

xv) Excise Duty Theexcisedutyinrespectofclosinginventoryoffinishedgoodsisincludedaspartofinventory.ThematerialconsumedisnetofCentral

ValueAddedTax(CENVAT)credits.ThedifferencebetweentheExcisedutyonopeningstockandclosingstockischargedtotheConsolidatedStatementofProfitandLoss.




xvi) Government Grants Grantsfromthegovernmentarerecognisedattheirfairvaluewherethereisareasonableassurancethatthegrantwillbereceivedandthe

groupwillcomplywithallattachedconditions.

Governmentgrantsrelatingtoincomearedeferredandrecognisedintheprofitorlossovertheperiodnecessarytomatchthemwiththecoststhattheyareintendedtocompensateandpresentedwithinotherincome.

Governmentgrantsrelatingtopurchaseofproperty,plantandequipmentareincludedinnon-currentliabilitiesasdeferredincomeandarecreditedtoprofitorlossonastraightlinebasisovertheexpectedlivesoftherelatedassetsandpresentedwithinotherincome.

xvii) Leases Operating Leases Leases inwhich a significant portionof the risks and rewardsof ownership arenot transferred to theGroup as lessee are classified as

operatingleases.

Intheeventthatleaseincentivesarereceivedtoenterintooperatingleases,suchincentivesarerecognisedasaliability.Paymentsmadeunderoperatingleases(netofanyincentivesreceivedfromthelessor)arechargedtoprofitorlossonastraight-linebasisovertheperiodoftheleaseunlessthepaymentsarestructuredtoincreaseinlinewithexpectedgeneralinflationtocompensateforthelessor’sexpectedinflationarycostincreases.

xviii) Taxes on Income Taxexpensefortheperiod,comprisingcurrenttaxanddeferredtax,areincludedinthedeterminationofthenetprofitorlossfortheperiod.

Current tax ismeasuredat theamountexpectedtobepaid tothetaxauthorities inaccordancewiththetaxation lawsprevailing in therespectivejurisdictions.

Deferredtaxisrecognisedontemporarydifferencesbetweenthecarryingamountsofassetsandliabilitiesintheseparatefinancialstatementsandthecorrespondingtaxbasesusedinthecomputationoftaxableprofit.Deferredtaxliabilitiesaregenerallyrecognisedforalltaxabletemporarydifferences.Deferredtaxassetsaregenerallyrecognisedforalldeductibletemporarydifferencestotheextentthatitisprobablethat taxableprofitswill beavailableagainstwhich thosedeductible temporarydifferences canbeutilised. Suchdeferred taxassetsandliabilitiesarenotrecognisedifthetemporarydifferencearisesfromtheinitialrecognition(otherthaninabusinesscombination)ofassetsandliabilitiesinatransactionthataffectsneitherthetaxableprofitnortheaccountingprofit.Inaddition,deferredtaxliabilitiesarenotrecognisedifthetemporarydifferencearisesfromtheinitialrecognitionofgoodwill.

Thecarryingamountofdeferredtaxassetsisreviewedattheendofeachreportingperiodandreducedtotheextentthatitisnolongerprobablethatsufficienttaxableprofitswillbeavailabletoallowallorpartoftheassettoberecovered.

Deferredtaxliabilitiesandassetsaremeasuredatthetaxratesthatareexpectedtoapplyintheperiodinwhichtheliabilityissettledortheassetrealised,basedontaxrates(andtaxlaws)thathavebeenenactedorsubstantivelyenactedbytheendofthereportingperiod.

Currentanddeferredtaxarerecognisedinprofitorloss,exceptwhentheyrelatetoitemsthatarerecognisedinothercomprehensiveincomeordirectly inequity, inwhichcase,thecurrentanddeferredtaxarealsorecognisedinothercomprehensiveincomeordirectly inequityrespectively.Wherecurrenttaxordeferredtaxarisesfromtheinitialaccountingforabusinesscombination,thetaxeffectisincludedintheaccountingforthebusinesscombination.

Currenttaxassetsandcurrenttaxliabilitiesareoffsetwhenthereisalegallyenforceablerighttosetofftherecognisedamountsandthereisanintentiontosettletheassetandtheliabilityonanetbasis.Deferredtaxassetsanddeferredtaxliabilitiesareoffsetwhenthereisalegallyenforceablerighttosetoffassetsagainstliabilitiesrepresentingcurrenttaxandwherethedeferredtaxassetsandthedeferredtaxliabilitiesrelatetotaxesonincomeleviedbythesamegoverningtaxationlaws.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

275


Deferredtaxliabilitiesarenotrecognisedfortemporarydifferencesbetweenthecarryingamountandtaxbasesofinvestmentsinsubsidiaries,associatesandinterestinjointarrangementswherethegroupisabletocontrolthetimingofthereversalofthetemporarydifferencesanditisprobablethatthedifferenceswillnotreverseintheforeseeablefuture.

Deferredtaxassetsarenotrecognisedfortemporarydifferencesbetweenthecarryingamountandtaxbasesofinvestmentsinsubsidiaries,associatesandinterestinjointarrangementswhereitisnotprobablethatthedifferenceswillreverseintheforeseeablefutureandtaxableprofitwillnotbeavailableagainstwhichthetemporarydifferencecanbeutilised.

xix) Cash and Cash Equivalents Inthecashflowstatement,cashandcashequivalentsincludescashonhand,demanddepositswithbanks,othershort-termhighlyliquid

investmentswithoriginalmaturitiesofthreemonthsorlessthatarereadilyconvertibletoknownamountsofcashandwhicharesubjecttoaninsignificantriskofchangesinvalue,andbankoverdrafts.Bankoverdraftsareshownwithinborrowingsincurrentliabilitiesinthebalancesheet.

xx) Borrowing Costs Generaland specificborrowingcostsdirectlyattributable toacquisitionor constructionofqualifyingassets (i.e. thoseProperty,Plant&

Equipmentswhichnecessarilytakeasubstantialperiodoftimetogetreadyfortheirintendeduse)arecapitalised.Otherborrowingcostsarerecognisedasanexpenseintheperiodinwhichtheyareincurred.

xxi) Deferred Revenue and Unbilled Revenue Amountsreceivedfromcustomersorbilledtocustomers,inadvanceofservicesperformedarerecordedasdeferredrevenueunderOther

CurrentLiabilities.UnbilledrevenueincludedinOtherFinancialAssets,representsamountsrecognisedinrespectofservicesperformedinaccordancewithcontractterms,notyetbilledtocustomersasattheyearend.

xxii) Segment Reporting The Chairman has been identified as the Chief Operating Decision Maker (CODM) as defined by Ind AS 108, “Operating Segments.”

Operating segments are reported in amanner consistent with the internal reporting provided to the chief operating decisionmakers. TheaccountingpoliciesadoptedforsegmentreportingareinconformitywiththeaccountingpoliciesadoptedfortheGroup.Revenueandexpenseshavebeenidentifiedtosegmentsonthebasisoftheirrelationshiptotheoperatingactivitiesofthesegment.Income/CostswhichrelatetotheGroupasawholeandarenotallocabletosegmentsonareasonablebasis,havebeenincludedunderUnallocatedIncome/Costs.Interestincomeandexpensearenotallocatedtorespectivesegments(exceptincaseofFinancialServicessegment).

xxiii) Dividends Provisionismadefortheamountofanydividenddeclared,beingappropriatelyauthorisedandnolongeratthediscretionoftheentity,onor

beforetheendofthereportingperiodbutnotdistributedattheendofthereportingperiod.

xxiv) Share appreciation rights Liabilitiesforthegroup’sshareappreciationrightsarerecognisedasemployeebenefitexpenseovertherelevantserviceperiod.Theliabilities

areremeasuredtofairvalueateachreportingdateandarepresentedasemployeebenefitobligationsinthebalancesheet.

xxv) Rounding of amounts AllamountsdisclosedinthefinancialstatementsandnoteshavebeenroundedofftothenearestcroresaspertherequirementofSchedule

III,unlessotherwisestated.

xxvi) Standards issued but not yet effective InMarch2017,theMinistryofCorporateAffairsissuedtheCompanies(IndianAccountingStandards)(Amendments)Rules,2017,notifying

amendmentstoIndAS7,‘Statementofcashflows’andIndAS102,‘Share-basedpayment.’TheseamendmentsareinaccordancewiththerecentamendmentsmadebyInternationalAccountingStandardsBoard(IASB)toIAS7,‘Statementofcashflows’andIFRS2,‘Share-basedpayment,’respectively.TheamendmentsareapplicabletotheGroupfromApril1,2017.




Amendment to Ind AS 7: Theamendmentto IndAS7requirestheentitiestoprovidedisclosuresthatenableusersoffinancialstatementstoevaluatechanges in

liabilitiesarisingfromfinancingactivities,includingbothchangesarisingfromcashflowsandnon-cashchanges,suggestinginclusionofareconciliationbetweentheopeningandclosingbalances in thebalancesheet for liabilitiesarising fromfinancingactivities, tomeet thedisclosurerequirement.

TheGroupisevaluatingtherequirementsoftheamendmentanditseffectontheconsolidatedfinancialstatements.

Amendment to Ind AS 102: TheamendmenttoIndAS102providesspecificguidancetomeasurementofcash-settledawards,modificationofcash-settledawardsand

awardsthatincludeanetsettlementfeatureinrespectofwithholdingtaxes.Itclarifiesthatthefairvalueofcash-settledawardsisdeterminedonabasisconsistentwiththatusedforequity-settledawards.Market-basedperformanceconditionsandnon-vestingconditionsarereflectedinthe‘fairvalues’,butnon-marketperformanceconditionsandservicevestingconditionsarereflectedintheestimateofthenumberofawardsexpectedtovest.Also,theamendmentclarifiesthatifthetermsandconditionsofacash-settledshare-basedpaymenttransactionaremodifiedwiththeresultthatitbecomesanequity-settledshare-basedpaymenttransaction,thetransactionisaccountedforassuchfromthedateofthemodification.Further,theamendmentrequirestheawardthatincludeanetsettlementfeatureinrespectofwithholdingtaxestobetreatedasequity-settledinitsentirety.Thecashpaymenttothetaxauthorityistreatedasifitwaspartofanequitysettlement.

TheGroupisevaluatingtherequirementsoftheamendmentandtheimpactontheconsolidatedfinancialstatementsisbeingevaluated.

2b. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTIES Fair Valuation: SomeoftheGroup’sassetsandliabilitiesaremeasuredatfairvalueforfinancialreportingpurposes.Inestimatingthefairvalueofanasset

andliability,theGroupusesmarketobservabledatatotheextentitisavailable.WhenLevel1inputsarenotavailable,theGroupengagesthirdpartyqualifiedexternalvaluerstoestablishtheappropriatevaluationtechniquesandinputstothevaluationmodel.

InformationaboutthevaluationtechniquesandinputsusedindeterminingthefairvalueofvariousassetsandliabilitiesaredisclosedinNote57.

Impairment of Goodwill (Refer Note 41) Determiningwhethergoodwillisimpairedrequiresanestimationofthevalueinuseofthecash-generatingunitstowhichgoodwillhasbeen

allocated.ThevalueinusecalculationrequirestheGrouptoestimatethefuturecashflowsexpectedtoarisefromthecash-generatingunitandasuitablediscountrateinordertocalculatethepresentvalue.Wheretheactualfuturecashflowsarelessthanexpected,amaterialimpairmentlossmayarise.

Expected Credit Loss: When determiningwhether the risk of default on a financial instrument has increased significantly since initial recognition, the Group

considersreasonableandsupportableinformationthatisrelevantandavailablewithoutunduecostoreffort.Thisincludesbothquantitativeandqualitativeinformationandanalysis,basedontheGroup’shistoricalexperienceandcreditassessmentandincludingforward-lookinginformation.

TheinputsusedandprocessfollowedbytheGroupindeterminingtheincreaseincreditriskhavebeendetailedinNote50(f).

Useful life of Assets: Property,plantandequipmentandIntangibleAssetsrepresentasignificantproportionoftheassetsoftheGroup.Depreciationisderived

afterdetermininganestimateofanasset’sexpectedusefullifeandtheexpectedresidualvalueattheendofitslife.TheusefullivesandresidualvaluesofGroup’sassetsaredeterminedbymanagementatthetimetheassetisacquiredandreviewedperiodically,includingateachfinancialyearend.Thelivesarebasedonhistoricalexperiencewithsimilarassetsaswellasanticipationoffutureevents,whichmayimpacttheirlife,suchaschangesintechnology.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

277


Deferred Taxes Deferredtaxisrecordedontemporarydifferencesbetweenthetaxbasesofassetsandliabilitiesandtheircarryingamounts,attherates

thathavebeenenactedorsubstantivelyenactedatthereportingdate.Theultimaterealizationofdeferredtaxassetsisdependentuponthegenerationoffuturetaxableprofitsduringtheperiodsinwhichthosetemporarydifferencesandtaxlosscarry-forwardsbecomedeductible.TheGroupconsiderstheexpectedreversalofdeferredtaxliabilitiesandprojectedfuturetaxable incomeinmakingthisassessment.Theamountofthedeferredtaxassetsconsideredrealizable,however,couldbereducedintheneartermifestimatesoffuturetaxableincomeduringthecarry-forwardperiodarereduced.

Defined benefit plans: Thecostof thedefinedbenefitplansandthepresentvalueof thedefinedbenefitobligationarebasedonactuarialvaluationusing the

projectedunitcreditmethod.Anactuarialvaluationinvolvesmakingvariousassumptionsthatmaydifferfromactualdevelopmentsinthefuture.Theseincludethedeterminationofthediscountrate,futuresalaryincreasesandmortalityrates.Duetothecomplexitiesinvolvedinthevaluationanditslong-termnature,adefinedbenefitobligationishighlysensitivetochangesintheseassumptions.Allassumptionsarereviewedateachreportingdate.

Contingent Consideration (Refer Note 40) Inaccountingforbusinesscombinations,judgmentisrequiredindeterminingcontingentconsideration.Contingentconsiderationispayable

incaseofachievementofcertainmilestones. It iscalculatedbyapplyinganappropriatediscountratetotheprobabilityadjustedsales/margins.

Functional Currency (Refer Note 50(d)) FunctionalcurrencyisthecurrencyoftheprimaryeconomicenvironmentinwhichtheCompanyanditssubsidiariesoperate.TheGroup

assessesthefactorsasperINDAS21indeterminingthefunctionalcurrencyoftheCompanyanditssubsidiaries.Ifthereisanychangeinunderlyingtransactions,eventsandconditionsintheCompanyoritssubsidiary,theGroupreassessesthefunctionalcurrency.

Assessment of Significant influence (Refer Note 39 (c)) Irrespectiveofthevotingrightsinanentity,iftheGrouphasarighttoappointDirectorsorparticipatesinallsignificantfinancialandoperating

decisionsofaninvestee,thereisanexistenceofsignificantinfluenceandtheinvestmentisconsideredasanAssociate.

Assessment of Joint control (Refer Note 39 (b)) Irrespectiveofthevotingrightsinanentity,ifacontractualarrangementrequiresunanimousconsentfromallthepartiesfortherelevant

activitiesandifthereisaseparationofthelegalformofthestructure,thearrangementisaccountedasaJointventure.




3.

PRO

PERT

Y, P

LAN

T &

EQ

UIP

MEN

T A

ND

OTH

ER IN

TAN

GIB

LE A

SSET

S

(` inCrores)

Par

ticul

ars

GRO

SS C

ARRY

ING

AM

OU

NT

ACC

UM

ULA

TED

DEPR

ECIA

TIO

N /

AM

ORT

ISAT

ION

N

ET C

ARRY

ING

AM

OU

NT

Ope

ning

A

s at

April

1,

2016

Acq

uisi

tion

Add

ition

s D

educ

tions

/

Adju

stm

ents

Exc

hang

e

Diffe

renc

e

As a

t M

arch

31,

20

17 (A

)

Ope

ning

A

s at

Apr

il 1,

20

16

Acq

uisi

tion

For

the

Yea

r #

Ded

uctio

ns

/ A

djus

tmen

ts

Exc

hang

e Di

ffere

nce

Impa

irmen

t A

s at

Mar

ch 3

1,

2017

(B)

As a

t M

arch

31

, 201

7 (A

-B)

As a

t M

arch

31,

20

16

Tang

ible

Ass

ets

Land

Freeh

old

100

.35

8.03

0.16

- (1

1.78

) 9

6.76

0.15

- -

- -

- 0

.15

96.

61

100

.20

Build

ings

255

.93

38.63

17.01

4

.22

(4.04)

303

.31

17.28

-

18.86

4.07

(0.45)

- 3

1.62

2

71.6

9 238

.65

Road

s1.05

- 0.23

- (0

.07)

1.2

1 0.16

- 0.28

- -

- 0

.44

0.7

7 0.89

Plan

t&Equ

ipmen

t1,066

.90

76.60

226

.95

40.41

(3

8.91

) 1

,291

.13

127

.09

- 171

.49

31.78

(7

.71)

- 2

59.0

9 1

,032

.04

939

.81

Furnitu

re&fixtures

41.95

0.56

11.

64

0.01

(1.00)

53.

14

8.69

- 9.35

- 0.18

- 1

8.22

3

4.92

3

3.26

OfficeEqu

ipmen

t10.39

1.06

10.68

0.83

(0.38)

20.

92

2.10

- 4.48

0.75

(0.13)

- 5

.70

15.

22

8.29

Ship

s1.04

- -

0.16

- 0

.88

0.10

- 0.09

0.02

- -

0.1

7 0

.71

0.94

Helicop

ter^

9.60

- -

- -

9.6

0 0.54

- 0.54

- -

- 1

.08

8.5

2 9.06

MotorVeh

icles

5.5

4 -

0.77

0.28

- 6

.03

0.79

- 0.84

0.17

- -

1.4

6 4

.57

4.75

Tota

l ( I

) 1,492

.75

124

.88

267

.44

45.91

(5

6.18

) 1

,782

.98

156

.90

- 205

.93

36.79

(8

.11)

- 3

17.9

3 1

,465

.05

1,335

.85

Inta

ngib

le A

sset

s ( A

cqui

red

)Cu

stom

erre

latio

ns93.03

4

5.46

-

- (3

.46)

135

.03

5.04

- 1

5.42

-

(0.62)

- 1

9.84

1

15.1

9 87.99

Favourab

lelease

1.3

5 -

- -

(0.03)

1.3

2 -

- 0.51

- -

- 0

.51

0.8

1 1

.35

Tech

nolo

gy2.67

- -

- (0

.06)

2.6

1 0.03

- 0.37

- -

- 0

.40

2.2

1 2

.64

Bran

dsand

Trade

marks*+

584

.24

2,263

.21

124

.68

- (9

4.17

) 2

,877

.96

57.77

-

92.32

-

(6.45)

- 1

43.6

4 2

,734

.32

526

.47

Copyrig

hts,Kn

owho

w

and

Intellectua

lprope

rtyrig

hts

21.27

86.74

-

- (2

.94)

105

.07

9.57

- 7.21

- (0

.20)

- 1

6.58

8

8.49

11.70

Compu

terS

oftware

96.79

0.49

130

.70

3.59

(6.45)

217

.94

25.02

-

59.75

1.82

(2.51)

- 8

0.44

1

37.5

0 71.77

In

tang

ible

Ass

ets

(Inte

rnal

ly G

ener

ated

)Prod

uctK

now-how

2.3

2 -

- -

- 2

.32

0.19

- 0.19

- -

- 0

.38

1.9

4 2

.13

Tota

l ( II

)801

.67

2,395

.90

255

.38

3.59

(107

.11)

3,3

42.2

5 97.62

-

175

.77

1.82

(9.78)

- 2

61.7

9 3

,080

.46

704

.05

Gra

nd T

otal

( I +

II )

2,294

.42

2,520

.78

522

.82

49.50

(1

63.29)

5,1

25.2

3 2

54.5

2 -

381

.70

38.61

(1

7.89

) -

579

.72

4,5

45.5

1 2,039

.90

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

279


3.

PRO

PERT

Y, P

LAN

T &

EQ

UIP

MEN

T A

ND

OTH

ER IN

TAN

GIB

LE A

SSET

S

(` inCrores)

Par

ticul

ars

GRO

SS C

ARRY

ING

AM

OU

NT

ACC

UM

ULA

TED

DEPR

ECIA

TIO

N /

AM

ORT

ISAT

ION

N

ET C

ARRY

ING

AM

OU

NT

Dee

med

Co

st A

s at

April

1,

2015

Acq

uisi

tion

Add

ition

s D

educ

tions

/

Adju

stm

ents

E

xcha

nge

Diffe

renc

e A

s at

Mar

ch 3

1,

2016

(A)

Ope

ning

A

s at

Apr

il 1,

20

15

Acq

uisi

tion

For

the

Yea

r #

Ded

uctio

ns /

Ad

just

men

ts

Exc

hang

e Di

ffere

nce

Impa

irmen

t @

@

As a

t M

arch

31,

20

16 (B

)

As a

t M

arch

31

, 201

6 (A

-B)

As a

t Ap

ril 1

, 20

15

Tang

ible

Ass

ets

Land

Freeh

old

105

.12

- -

7.41

2.6

4 100

.35

- -

0.13

- 0.02

- 0.15

100

.20

105

.12

Build

ings

228

.37

0.67

26.

52

4.83

5.20

255

.93

- -

16.82

0.36

0.82

- 17.28

238

.65

228

.37

Road

s1.05

- -

- -

1.05

- -

0.16

- -

- 0.16

0.89

1.05

Plan

t&Equ

ipmen

t752

.68

0.92

325

.39

33.

13

21.04

1,066

.90

- -

139

.29

17.44

4

.32

0.92

127

.09

939

.81

752

.68

Furnitu

re&fixtures

33.81

0.21

8.76

1.93

1.10

41.95

-

- 8.09

0.14

0.74

- 8.69

33.

26

33.81

OfficeEqu

ipmen

t 4

.53

- 6

.14

0.38

0.10

10.39

-

- 2

.32

0.22

- -

2.10

8.29

4.5

3 Sh

ips

1.04

- -

- -

1.04

- -

0.10

- -

- 0.10

0.94

1.04

Helicop

ter^

9.60

- -

- -

9.60

- -

0.54

- -

- 0.54

9.06

9.60

MotorVeh

icles

2.86

- 2.76

0.08

- 5

.54

- -

0.79

- -

- 0.79

4.75

2.86

Tota

l ( I

) 1,139

.06

1.80

369

.57

47.76

30.08

1,49

2.75

-

- 168

.24

18.16

5.90

0.92

156

.90

1,335

.85

1,139

.06

Inta

ngib

le A

sset

s (Ac

quire

d)

Custom

erre

latio

ns -

91.84

-

- 1.19

93.03

-

- 5.04

- -

- 5.04

87.99

-

Favourab

lelease

- 1.30

- -

0.05

1.3

5 -

- -

- -

- -

1.3

5 -

Tech

nolo

gy -

2.76

- -

(0.09)

2.67

- -

0.03

- -

- 0.03

2.6

4 -

Bran

dsand

Trade

marks*+

373

.24

23.90

176

.26

14.59

2

5.43

584

.24

- -

46.71

8.46

5.3

5 14.17

57.77

526

.47

373

.24

Copyrig

hts,Kn

owho

w

and

Intellectua

lprope

rtyrig

hts

20.54

-

0.53

- 0.20

21.27

-

- 9.55

- 0.02

- 9.57

11.70

20.54

Compu

terS

oftware

21.

66

0.40

74.23

1

.34

1.84

96.79

-

- 25.69

1

.15

0.48

- 25.02

71.77

2

1.66

In

tang

ible

Ass

ets

(Inte

rnal

ly G

ener

ated

)Prod

uctK

now-how

2.3

2 -

- -

- 2

.32

- -

0.19

- -

- 0.19

2.1

3 2

.32

Tota

l ( II

)417

.76

120

.20

251

.02

15.93

28.62

801

.67

- -

87.21

9.61

5.85

14.17

97.62

704

.05

417

.76

Gra

nd T

otal

( I +

II )

1,556

.82

122

.00

620

.59

63.69

58.70

2,294

.42

--

255

.45

27.77

11.75

15.09

2

54.5

2 2,039

.90

1,556

.82

*MaterialIntan

gibleAssetsaso

nMarch31,201

7:

Asse

t Cla

ssAs

set D

escr

iptio

nCa

rryi

ng V

alue

as a

t M

arch

31,

201

7Ca

rryi

ng V

alue

as a

t M

arch

31,

201

6Ca

rryi

ng V

alue

as a

t Ap

ril 1

, 201

5Re

mai

ning

use

ful l

ife a

s on

Mar

ch 3

1, 2

017

Bran

ds&Trade

marks

Registered

trad

emarks

323

.32

224

.60

64.37

7yearsto15

yea

rsBran

ds&Trade

marks

Internallydevelop

edbrand

200

.22

227

.24

234

.57

7years

Bran

ds&Trade

marks

Purcha

sedBran

ds(R

efer$and

Note40

A.(ii))

2,1

26.7

1 -

- 15

yea

rsCopyri

ghts

,Knowhow

andIntellectua

lprope

rtyrig

hts

Purcha

sedMan

ufacturin

gKn

ow-How

(Re

fer$

) 7

9.98

-

- 10

yea

rs

#De

preciatio

nforthe

yea

rinclude

sdep

reciati

onamou

nting

to`

9.34Crores(P

reviou

sYea

r` 5

.51Crores)o

nassetsusedforR

esea

rchan

dDe

velopm

ent.

+Ce

rtainBran

dsarein

theprocesso

fbeing

registered

inth

ena

meofth

eCo

mpa

ny,forwhichth

ene

cessaryap

plicati

onhasbee

nmad

ewith

trad

emarkregistry.

^Th

eCo

mpa

nyhasa25%

shareinjo

into

wne

rshipofHelicop

ter

@@Losso

nim

pairm

ento

fassetsinPiramalCriti

calC

areIta

liaSPA

-ReferNote37

(c).

ReferN

ote44

forthe

assetsm

ortgaged

ass

ecurity

againstborrowings.

ReferN

ote28

Bfo

rthe

con

tractualcap

italcom

mitm

entsfo

rpurchaseofPrope

rty,Plan

t&Equ

ipmen

t

$ Ac

quis

ition

of I

ntan

gibl

es fr

om Ja

nsse

n Ph

arm

aceu

tica

NV

OnOctob

er10,201

6,th

eGrou

pthroug

hitssu

bsidairy,P

iramalCriti

calC

areLimite

d,hasacquiredfivean

esthesiaand

painman

agem

entinjectableprod

uctsfrom

JanssenPh

armaceu

ticaNVfor`

1,069

.92crores(U

.S.$16

1.16

million)(inclusiveoftransactio

ncosts).T

heacquisiti

onis

expectedtostren

gthe

ntheCo

mpa

ny’spresen

cein

the

ane

sthe

siaand

painman

agem

entinjectab

leprodu

ctsform

ingpa

rtoftheCo

mpa

ny’sPh

armaceu

tical

man

ufacturin

gan

dservicesbusiness.

TheCo

mpa

nyre

corded

theacqu

isitio

nofth

esebran

dsand

technicalkno

whow

asp

rodu

ctin

tang

ibles.The

Com

panyestimated

thatth

eusefullifeofthe

sebrand

sis1

5yearsa

ndth

atoftechn

icalkno

whow

is10years.The

carrying

value

ofthe

seintang

iblesa

sonMarch31,201

7is`

1,011

.62crores.

Anearno

utcon

siderati

onuptoUSD

20Million(`

133

.10Crores)ispa

yableiftheprod

uctp

ortfo

lioachievescertainagreed

fina

ncialm

ileston

esoverthe

next3

0mon

ths.Thiswillberecorded

whe

nthepa

ymen

tisprob

able

infu

ture.




4 (A) INVESTMENTS ACCOUNTED FOR USING THE EQUITY METHOD

Particulars As at March 31, 2017 As at March 31, 2016 As at April 1, 2015 Quantity (` in crores) Quantity (` in crores) Quantity (` in cro res)

Investments in Equity Instruments:A. In Joint Ventures (Unquoted) - At Cost:i. ConvergenceChemicalsPrivateLimited

InterestasatApril1 35,705,100 35.06 30,605,100 30.30 30,605,100 30.30Add-Additionalcapitalcontributionduringtheperiod - 5,100,000 5.10 - Add-Shareofprofit/(loss)fortheperiod (0.32) (0.34) -

34.74 35.06 30.30ii. ShrilekhaBusinessConsultancyPrivateLimited(ReferNoteAbelow)

InterestasatJanuary9,2017 62,234,605 2,540.42 - - Add-Shareofprofit/(loss)fortheperiod 17.00 - -

2,557.42 - - TOTAL (A) 2,592.16 35.06 30.30

B. In Associates :I Quoted - At Cost:

PiramalPhytocareLimitedInterestasatApril1 4,550,000 0.87 4,550,000 1.45 4,550,000 1.45 Add-Shareofprofit/(loss)fortheperiod 0.01 (0.58) -

TOTAL ( B (I) ) 0.88 0.87 1.45 II Unquoted - At Cost:a. AllerganIndiaPrivateLimited

InterestasatApril1 3,920,000 97.57 3,920,000 61.76 3,920,000 61.76Add-Shareofprofit/(loss)fortheperiod 28.11 35.81 - Add-Shareofothercomprehensiveincomefortheperiod (0.08) - - Less-Dividendreceived (19.60) - -

106.00 97.57 61.76b. ShriramCapitalLimited(ReferNoteAbelow)

InterestasatApril1 161,077,548 2,419.38 161,077,548 2,302.18 161,077,548 2,302.18Add-Shareofprofit/(loss)fortheperiod 129.00 153.26 - Less-Dividendreceived (8.30) (36.06) - Less: Impact of conversion from partnership firm to private limited company

(161,076,548) (2,540.07)

1,000 0.01 2,419.38 2,302.18c. BluebirdAeroSystemsLimited

InterestasatApril1 67,137 44.30 67,137 35.32 67,137 35.32 Add-Shareofprofit/(loss)fortheperiod (2.80) 6.06 - Add-Currencytranslationdifferences (3.12) 2.92 -

38.38 44.30 35.32 d. ContextMatters,Inc.

Costofinvestment 11,943,822 16.21 - - Add-Shareofprofit/(loss)fortheperiod (1.10) - -

15.11 - - TOTAL ( B(II) ) 159.50 2,561.25 2,399.26

Total equity accounted investments ( A+B(I)+B(II) ) 2,752.54 2,597.18 2,431.01Aggregate market value of quoted investments 37.65 32.21 15.81Aggregate carrying value of unquoted investments 2,751.66 2,596.31 2,429.56Aggregate amount of impairment in value of investments - - -

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

281


Note AInvestment in Partnership firm - Shrilekha Financial Services

Name of Partners Share in profits (%)PiramalEnterprisesLimited 74.95ShriramOwnershipTrustanditsNominees 25.05Totalcapitalofthepartnershipfirm ` 8.30crores

TheGrouphas a 74.95% interest in a joint operation called Shrilekha Financial Serviceswhichwas set up as a partnership togetherwith ShriramOwnershipTrusttoinvestinShriramCapitalLimited.ShrilekhaFinancialServicesholds26.68%inShriramCapitalLimited,therebygivingtheGroupaneffectiveinterestof20%.

TheprincipalplaceofbusinessofthejointoperationisinIndia.

ShrilekhaFinancialServiceshasbeenconvertedintoaprivatelimitedcompany,ShrilekhaBusinessConsultancyPrivateLimitedfromJanuary9,2017.Hence,witheffectfromJanuary9,2017,theinvestmentinShrilekhaBusinessConsultancyPrivateLimitedisconsideredasinvestmentinJointVenture.

ShrilekhaFinancialServiceswasapartnershipfirmtillJanuary8,2017andwasaccountedasaJointoperation.Accordingly,theGrouprecogniseditsshareofinvestmentinShriramCapitalLimited,whichwasshownunderInvestmentinAssociates.AfterconversionofShrilekhaFinancialServicesintoaprivatelimitedcompany,ithasbecomeajointventure.Accordingly,investmentinShrilekhaBusinessConsultancyPrivateLimitedhasbeenshownundertheheadInvestmentinJointVenture,unlikeasdisclosedinearlieryears.

4 (B) INVESTMENTS Non-Current Investments:

Particulars As at March 31, 2017 As at March 31, 2016 As at April 1, 2015 Quantity (` in crores) Quantity (` in crores) Quantity (` in crores)

Investments in Equity Instruments (fully paid-up)Other Body CorporatesQuoted-AtFVTOCI:i. ShriramCityUnionFinanceLimited 6,579,840 1,552.64 6,579,840 988.46 6,579,840 1,292.94ii. ShriramTransportFinanceCompanyLimited 22,600,000 2,436.28 22,600,000 2,154.11 22,600,000 2,542.27

3,988.92 3,142.57 3,835.21Unquoted-AtFVTPL:i. SearchlightHealthPrivateLimited - - 230,858 1.07 - - ii. NavayugaRoadProjectsPrivateLimited 4,114 * 4,114 * 4,114 *iii. PiramalGlassLimited - - 2,021,395 28.30 2,021,395 28.30iv. ShriramFinancialVenturesChennaiPrivateLimited - - 74,970 0.06 74,970 0.06

- 29.43 28.36Investments in Preference Shares (fully paid-up)Other Body CorporatesUnquoted-AtFVTPL:i. Procured,Inc. 354,108 1.70 135,296 0.66 135,296 0.63

1.70 0.66 0.63

*AmountsarebelowtheroundingoffnormadoptedbytheCompany





Investment in Debentures:Other Body Corporates (Refer Note 44):Quoted:RedeemableNon-ConvertibleDebentures-AtAmortisedCost:VGNDevelopersPrivateLimited 21,011 136.71 24,580 193.47 22,870 225.03HaamidRealEstatesPrivateLimited - - 5,500 20.30 5,500 47.46HaamidRealEstatesPrivateLimited-SR-II - - 1,700 12.07 - - InternationalLandDevelopersPrivateLimited - - - - 2,436 24.36 SPRConstructionPrivateLimited 11,600 43.48 1,170 94.82 1,000 100.16ThreeCGreenDevelopersPrivateLimited 6,168 20.71 8,812 86.92 22,500 199.26CenturyJointDevelopersPrivateLimited 19,000 172.27 - - ACMECleantechSolutionsPrivateLimited 216 220.02 - - - - RedeemableNon-ConvertibleDebentures-AtFVTPLGMRHoldingsPrivateLimited 4,500 577.11 4,500 487.05 - - Unquoted:RedeemableOptionallyConvertibleDebentures-AtAmortisedCost:NavayugaRoadProjectsPrivateLimitedSR-I - - 4,250 718.05 4,250 601.95ChitraHoldingsPrivateLimited - - 1,268 3.45 2,000 10.66AnilineConstructionCompanyPrivateLimited-II - - - - 2,500 22.46 RegenInfrastructurePrivateLimited 1,905 165.58 2,000 191.48 - - RedeemableNon-ConvertibleDebentures-AtFVTPL:OzoneUrbanaInfraDevelopersPrivateLimited-SR-II - - 1,500 184.04 - - EsselGreenEnergyLimited 15,000 171.48 75 75.92 - - SmaaashEntertainmentPrivateLimited 1,200,000 125.25 - - - - OzoneInfraDevelopersPrivateLimited 8,500 93.93 - - - - SPRConstructionPrivateLimited 600 6.59 - - - - RedeemableNon-ConvertibleDebentures-AtAmortisedCost:KeystoneRealtorsPrivateLimited - - - - 2 2.86OmkarCityDevelopmentPrivateLimited 769 764.31 750 742.22 - - OmkarRealtors&DevelopersPrivateLimited-I - - - - 2,910 24.42 BaashyaamConstructionsPrivateLimited-SR-I 300 2.99 7,110 43.13 7,000 60.38BaashyaamConstructionsPrivateLimited-SR-II 5,000 49.98 3,900 37.16 - - TrueValueHomes(India)PrivateLimited - - - - 2,000 152.65 OzoneDevelopersBangalorePrivateLimited - - - - 10,000 78.52DarodeJogRealitiesPrivateLimited - - - - 1,600,000 68.78CenturyJointDevelopmentsPrivateLimited-I - - - - 8,500 51.29CenturyJointDevelopmentsPrivateLimited-II - - 210 206.28 - - LandcraftDevelopersPrivateLimited-II - - 3,150 82.76 5,000 59.51LandcraftDevelopersPrivateLimited-I - - 10,450 6.18 6,200 31.07OzoneHomesPrivateLimited - - - - 3,800 19.17SkylarkArcadiaPrivateLimited - - - - 5,000 24.31 VijayGroupHousingPrivateLimited-I - - - - 6,000 27.52VijayGroupHousingPrivateLimited-II 13,440 99.39 10,560 113.65 - - UrbanizeDevelopers(India)PrivateLimited - - - - 2,000 15.26 AcmeHousingIndiaPrivateLimited - - 7,600 37.51 8,300 65.47KrishnaECampusPrivateLimited - - 520 46.87 450 39.68HaldharDevelopersPrivateLimited - - 1,000 99.04 1,000 98.60RajeshEstateandNirmanPrivateLimited-SR-I - - 10 3.98 20 8.75RajeshEstateandNirmanPrivateLimited-SR-II - - 80 39.07 120 59.23

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

283



VirgoPropertiesPrivateLimited - - - - 1,800 15.24 AdarshHavenPrivateLimited 1,240 131.15 951 46.67 1,070 93.20ArihantUnitechRealtyProjectLimited 3,358 26.12 4,827 43.53 2,500 22.32 NeelkanthMansionsAndInfrastructurePrivateLimited - - 13,763 121.86 13,800 136.26 NeelkanthVinayakRealtorsPrivateLimited 4,200 17.54 3,500 20.66 2,700 26.66 BestechIndiaPrivateLimited-I 8,250 45.11 8,250 80.03 7,500 72.47BestechIndiaPrivateLimited-II 18,700 182.60 17,329 156.54 - - BhaveshwarPropertiesPrivateLimited 2,460 13.76 2,300 20.17 1,000 9.69TridhaatuConstructionPrivateLimitedSR-I&II - - - - 1,500 74.99KothariAutoPartsManufacturersPrivateLimited-SR-A 200 103.24 159 95.76 - - KothariAutoPartsManufacturersPrivateLimited-SR-B 212 99.06 192 102.35 - - KothariAutoPartsManufacturersPrivateLimited-SR-C 290 142.16 280 28.00 - - OzoneUrbanaInfraDevelopersPrivateLimited-SR-I - - 4,250 426.90 - - EssemInfraPrivateLimited 19,230,000 131.06 22,500,000 192.09 - - WadhwaGroupHoldingsPrivateLimited 2,390 355.00 2,390 229.67 - - EktaHousingPrivateLimited 709 45.88 835 72.26 - - EktaParksvilleHomesPrivateLimited 1,171 76.27 1,376 119.34 - - LogixCityDevelopersPrivateLimited 12,500 77.11 11,850 116.77 - - ForumHomesPrivateLimited 106 60.44 60 58.72 - - WadhwaConstructions&InfrastructurePrivateLimited 2,000 106.59 1,550 146.26 - - NirmalLifestyleLimited 165 109.97 172 152.61 - - PhoenixHoduDevelopersPrivateLimited 9,500 66.88 9,500 93.63 - - NilkanthTechParkPrivateLimitedFacility1 13,069 98.30 7,800 77.06 - - NilkanthTechParkPrivateLimitedFacility2 5,876 43.22 6,000 59.65 - - ATSHomesPrivateLimited 34,175 311.22 32,175 322.52 - - RaghuleelaLeasingandConstructionsPrivateLimited 175 163.85 175 173.36 - - NirajKumarAssociatesPrivateLimited 6,061 59.61 3,200 30.41 - - GuardianPromoters&DevelopersPrivateLimited - - 6,900 65.58 - - ArunExcelloHomesPrivateLimited 2,394 215.11 1,995 193.47 - - ArunExcelloRealtyPrivateLimited 1,700 159.14 990 97.27 - - BoulevardProjectsPrivateLimited 22,500 206.69 22,500 211.03 - - FlagshipInfrastructurePrivateLimited 8,727 81.67 10,000 99.24 - - AmbeTradeCorpPrivateLimited - - 6,969 62.44 - - ParanjapeSchemesConstructionLimited 81,760 76.20 31,800 312.21 - - Emami Realty Limited 100 79.66 100 99.51 - - AkarshakRealtyPrivateLimited 15,000 147.11 15,000 146.86 - - MarvelMegaRealtorsPrivateLimited 1,244,200 121.53 100,000 102.22 - - KumarAgroProductsPrivateLimited 33,983,000 305.57 30,531,013 301.75 - - IdealRealEstatePrivateLimited 7,000 29.33 580 49.59 - - KanakiaKingStyleConstructionsPrivateLimited 8,604 86.02 7,400 74.03 - - OzoneInfraDevelopersPrivateLimited - - 8,500 84.66 - - EvieRealEstatePrivateLimited 12,530 120.02 21,000 190.91 - - KeystoneRealtorsPrivateLimited-I 79 59.85 63 62.97 - - KeystoneRealtorsPrivateLimited-II 173 141.84 160 159.99 - - VatikaInfraconPrivateLimited 25,862 268.36 16,673 166.98 - - ATSHeightsPrivateLimited 20,985 214.05 19,000 190.50 - - ValdelRealEstatePrivateLimited 28 27.96 70 64.73 - - NCLIndustriesLimited 22,000 219.94 400,000 40.00 - - SanghiIndustriesLimited 2,564,800 253.84 2,564,829 256.46 - -





CenturyRealEstateHoldingsPrivateLimitedSeries2 4,200 39.75 - - - - AlekhyaPropertyDevelopomentsPrivateLimited 163 160.79 - - - - LodhaDevelopersPrivateLimited 10,200 250.00 - - - - ShreeniwasCottonMillsPrivateLimited 8,950 895.00 - - - - VatikaOneonOnePrivateLimited 100 10.00 - - - - ATSRealEstateBuildersPrivateLimited 2,930 29.30 - - - - NobilityEstatesPrivateLimited 11,000 110.00 - - - - KingsCanyonPrivateLimitedLtd 2,095 204.38 - - - - LodhaDevelopersPrivateLimited 6,250 555.00 - - - - CenturyRealEstateHoldingsPrivateLimited 4,000 39.24 - - - - RustomjeeConstructionsPrivateLimited - - - - 2.85 28.57AkarshResidencyPrivateLimited 78 77.27 - - - - AksharSpacePrivateLimited 760 67.35 - - - - AkshayaPrivateLimited 9,220 74.74 - - - - AlekhyaPropertyDevelopmentsPrivateLimited 108 107.02 - - - - AtriaBrindavanPowerPrivateLimited 15,250 152.50 - - - - ATSRealEstateBuildersPrivateLimited 18,500 185.00 - - - - CenturyRealEstateHoldingsPrivateLimited 16,000 159.17 - - - - CenturyRealEstateHoldingsPrivateLimited 17,900 198.03 - - - - DostiRealtyLimited 9,650 95.66 - - - - GoldenHomesPrivateLimited 6,750 56.19 - - - - GoodEarthEcoDevelopmentPrivateLimited 7,000 66.18 - - - - JaykaliDevelopersPrivateLimited 6,000 58.44 - - - - KanakiaSpacesRealtyPrivateLimited 58 58.00 - - - - KanakiaSpacesRealtyPrivateLimited 70 10.80 - - - - ManjeeraRetailHoldingsPrivateLimited 15,671 142.66 - - - - ParanjapeSchemesConstructionLimited 21,223 207.34 - - - - Reliance Big Limited 15,899 146.75 - - - - SecurityandIntelligenceServices(India)Limited 80 64.63 - - - - WadhwaGroupHoldingsPrivateLimited 2,500 142.84 - - - - MantriDevelopersPrivateLimited 17,551 174.58 - - - - NorthTownEstatePrivateLimited 4,420 43.36 - - - - OmkarRealtors&DevelopersPrivateLimited-II 365 233.12 400 361.26 - - OmkarRealtorsandDevelopersPrivateLimited-III 1,527 145.17 - - - - OmkarRealtorsandDevelopersPrivateLimited-IV 22,69 225.15 - - - - OrnateSpacesPrivateLimited 18,910 194.02 - - - - PhoenixEmbassyTechZonePrivateLimited 5,267 51.11 - - - - PrateekInfraprojectsIndiaPrivateLimited 10,000 98.80 - - - - RDBuildtech&Developers(Karnataka)PrivateLimited 110 107.04 - - - - RunwalHomesPrivateLimited 12,126 108.00 - - - - SarvavasaBuildtechandFarmsPrivateLimited 9,318 92.16 - - - - SarvavasaBuildtechandFarmsPrivateLimited 21,270 210.85 - - - - ShreeniwasCottonMillsPrivateLimited 3,250 335.68 - - - - SiddhiRajHousingProjectsPrivateLimited 200 19.43 - - - - TridhaatuMumbaiStructurePrivateLimited 150 14.97 - - - - TridhaatuMumbaiStructurePrivateLimited 301 29.56 - - - - WisemoreAdvisoryPrivateLimited 209,800 209.89 - - - - VatikaOneOnOnePrivateLimited 1,950 195.00 - - - - ReliableExports(India)PrivateLimited 23,000 230.00 - - - -

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

285



BaashyaamConstructionsPrivateLimited 3,300 29.05 - - - - Less:ProvisionforImpairmentbasedonExpectedcreditlossmodel 283.72 207.07 61.55

14,757.08 9,698.83 2,536.66Investments in Alternative Investment Funds/Venture Capital FundsIn Others (Unquoted) - At FVTPL:ClassAUnitsofFaeringCapitalIndiaEvolvingFundII 250,000 25.00 150,000 15.00 - - ClassCunitsofIndiareitFundSchemeIV 1,401 27.57 1,975 32.94 2,293 35.26 ClassDunitsofIndiareitFundSchemeIV 18 0.02 24 0.02 28 0.03ClassA3unitsofIndiareitMumbaiRedevelopmentFund 2,025 23.80 2,775 33.45 2,625 32.41 ClassBunitsofIndiareitMumbaiRedevelopmentFund 12 0.01 37 0.04 50 0.05ClassCunitsofIndiareitFundSchemeV 4,957 61.76 5,625 53.35 2,813 27.82ClassDunitsofIndiareitFundSchemeV 25 0.03 50 0.05 50 0.05ClassAunitsofIIFLIncomeOpportunitiesFundSeries-SpecialSituations 50,000,000 48.27 50,000,000 55.75 27,500,000 28.44ClassCunitsofIIFLIncomeOpportunitiesFundSeries-SpecialSituations 4,500 - 7,500 0.01 7,500 0.01ClassAunitsofIndiareitApartmentFund 1,769 22.61 1,313 15.74 906 10.98ClassCunitsofIndiareitApartmentFund 60 - 100 0.00 - - ClassAunitsofLICHFLUrbanDevelopmentFund 7,287 7.29 7,848 7.21 - - ClassBunitsofredeemableparticipatingsharesIndiareitOffshoreFund 1,000,000 0.06 1,000,000 0.07 1,000,000 0.06ManagementsharesofIndiareitOffshoreFund 100 0.00 100 - 100 - ManagementsharesofIOF-IIIPte.Ltd. - - - - 1,000 0.01

216.42 213.63 135.12 TOTAL NON CURRENT INVESTMENTS 18,964.12 13,085.12 6,535.98

4 (B) INVESTMENTS Current Investments:


Investment in Debentures:In Other Body Corporates (Refer Note 44):Quoted :RedeemableNon-ConvertibleDebentures-AtAmortisedCost:VGNDevelopersPrivateLimited 21,011 81.00 24,580 49.87 - - InternationalLandDevelopersPrivateLimited - - - - 2,436 1.22 HaamidRealEstatesPrivateLimited - - 5,500 27.51 5,500 6.88HaamidRealEstatesPrivateLimited-SR-II - - 1,700 7.04 - - SPRConstructionPrivateLimited 11,600 72.50 1,170 20.97 - - ThreeCGreenDevelopersPrivateLimited 6,168 44.06 - - 22,500 22.50CenturyJointDevelopersPrivateLimited 19,000 15.00 - - - - RedeemableNon-ConvertibleDebentures-AtFVTPL:GMRHoldingsPrivateLimited - 13.50 - 11.24 - -

226.06 116.63 30.60Unquoted:RedeemableOptionallyConvertibleDebentures-AtAmortisedCostChitraHoldingsPrivateLimited - - 1,268 7.33 2,000 7.32AnilineConstructionCompanyPrivateLimited-I - - - - 7,700 46.09AnilineConstructionCompanyPrivateLimited-II - - - - 2,500 1.60AshviDevelopersPrivateLimited - - - - 13,591 135.91KohinoorPlanetConstructionsPrivateLimited - - 680 23.93 680 41.52





RegenInfrastructurePrivateLimited 1,905 26.72 2,000 10.08 - - NavayugaRoadProjectsPrivateLimitedSR-I 4,250 823.16 - - - - RedeemableNon-ConvertibleDebentures-AtFVTPLEsselGreenEnergyLimited - - - 0.19 - - RedeemableNon-ConvertibleDebentures-AtAmortisedCostOmkarRealtors&DevelopersPrivateLimited-I - - 320 32.60 2,910 261.08OmkarRealtors&DevelopersPrivateLimited-II 365 130.00 400 35.00 - - KothariAutopartManufacturersPrivateLimitedFacility2 - - - 0.03 - - VijayCitispacePrivateLimited - - - - 3,830 14.46 BaashyaamConstructionsPrivateLimited-SR-I - - 7,110 15.11 7,000 8.10BaashyaamConstructionsPrivateLimited-SR-II 3,300 3.67 - - - - TrueValueHomes(India)PrivateLimited - - - - 2,000 26.07OzoneDevelopersBangalorePrivateLimited - - - - 10,000 17.38DarodeJogRealitiesPrivateLimited - - 704,000 70.15 1,600,000 89.30CenturyJointDevelopmentsPrivateLimited-I - - - - 8,500 31.88CenturyJointDevelopmentsPrivateLimited-II - - 210 4.73 - - LandcraftDevelopersPrivateLimited-I - - 3,150 25.00 5,000 16.97LandcraftDevelopersPrivateLimited-II - - 10,450 19.70 - - OzoneHomesPrivateLimited - - - - 3,800 18.50SkylarkArcadiaPrivateLimited - - - - 5,000 25.00VijayGroupHousingPrivateLimited-I - - - - 6,000 23.00VijayGroupHousingPrivateLimited-II 13,440 43.20 10,560 3.40 - - UrbanizeDevelopers(India)PrivateLimited - - - - 2,000 5.18AcmeHousingIndiaPrivateLimited - - 7,600 38.00 8,300 16.60KrishnaECampusPrivateLimited - - 520 9.19 450 4.15 AdarshHavenPrivateLimited - - 951 47.47 1,070 11.89VirgoPropertiesPrivateLimited - - - - 1,800 2.25 BestechIndiaPrivateLimited-I 8,250 23.57 - - - - ArihantUnitechRealtyProjectLimited 3,358 5.58 4,827 3.76 - - NeelkanthMansionsAndInfrastructurePrivateLimited - - 13,763 29.51 - - NeelkanthVinayakRealtorsPrivateLimited 4,200 24.00 3,500 6.17 - - BhaveshwarPropertiesPrivateLimited 2,460 10.80 2,300 6.48 - - OzoneUrbanaInfraDevelopersPrivateLimited-SR-I - - 4,250 21.89 - - EssemInfraPrivateLimited 19,230,000 60.23 22,500,000 29.96 - - EktaHousingPrivateLimited 709 23.57 835 10.38 - - EktaParksvilleHomesPrivateLimited 1,171 38.44 1,376 16.93 - - NirmalLifestyleLimited 165 53.64 145 17.21 - - BoulevardProjectsPrivateLimited 22,500 57.32 22,500 8.44 - - AmbeTradeCorpPrivateLimited - - 6,969 6.69 - - IdealRealEstatePrivateLimited 7,000 40.00 5,800 7.25 - - EvieRealEstatePrivateLimited 12,530 8.03 21,000 19.10 - - KeystoneRealtorsPrivateLimited-I 79 17.62 63 0.06 - - ArunExcelloHomesPrivateLimited 2,394 26.39 - 1.65 - - ArunExcelloRealtyPrivateLimited 1,700 10.97 - 0.83 - - LogixCityDevelopersPrivateLimited 12,500 46.88 - - - - OzoneInfraDevelopersPrivateLimited - - - 1.78 - - ValdelRealEstatePrivateLimited - - 70 5.42 - - ParanjapeSchemesConstructionLimited 8,176 5.02 - - - - LodhaDevelopersPrivateLimited 10,200 794.87 - - - -

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

287



ShreeniwasCottonMillsPrivateLimited 8,950 26.48 - - - - KingsCanyonSEZPrivateLimited 2,095 3.94 - - - - CenturyRealEstateHoldingsPrivateLimited - 0.01 - - - - LodhaDevelopersPrivateLimited 6,250 70.00 - - - - MindSpaceRealtyPrivateLimited - - - - 850 8.50KeystoneRealtorsPrivateLimited - - - - 2 11.35 AksharSpacePrivateLimited 760 7.60 - - - - AkshayaPrivateLimited 9,220 16.20 - - - - ATSHomesPrivateLimited 15,000 41.75 - - - - BestechIndiaPrivateLimited 18,700 2.83 - - - - EmamiRealtyPrivateLimited 100 20.00 - - - - FlagshipInfrastructurePrivateLimited 8,727 5.03 - - - - ForumHomesPrivateLimited 106 44.94 - - - - GoldenHomesPrivateLimited 6,750 10.66 - - - - GoodEarthEcoDevelopmentPrivateLimited 7,000 4.00 - - - - HaldharDevelopersPrivateLimited 675 65.69 - - - - KanakiaSpacesRealtyPrivateLimited 70 58.00 - - - - KeystoneRealtorsPrivateLimited-I 173 28.75 - - - - KumarAgroProductsPrivateLimited 33,983,000 31.37 - - - - ManjeeraRetailHoldingsPrivateLimited 15,671 14.09 - - - - MarvelMegaRealtorsPrivateLimited 1,244,200 1.40 - - - - NilkanthTechParkPrivateLimited 13,069 30.92 - - - - NilkanthTechParkPrivateLimited 5,876 15.56 - - - - ParanjapeSchemesConstructionLimited 21,223 3.42 - - - - PheonixHoduDevelopersPrivateLimited 9,500 27.14 - - - - RaghuleelaLeasingandConstructionPrivateLimited 175 10.00 - - - - RajeshEstateandNirmanPrivateLimited 54 26.57 - - - - RajeshEstateandNirmanPrivateLimited 80 39.57 - - - - Reliance Big Limited 15,899 20.66 - - - - RunwalHomesPrivateLimited 12,126 13.26 - - - - SecurityandIntelligenceServices(India)Limited 80 13.33 - - - - TridhaatuMumbaiStructurePrivateLimited 18 1.82 - - - - WadhwaConstructions&InfrastructurePrivateLimited 2,000 93.33 - - - - WadhwaGroupHoldingsPrivateLimited 2,500 100.00 - - - - Less:ProvisionforImpairmentbasedonExpectedcreditlossmodel 75.67 23.88 24.14

3,272.39 628.17 830.56InvestmentinMutualFunds(Unquoted)-AtFVTPL:BirlaSunLifeCashPlus-DailyDividend-DirectPlan-Reinvest - - - - 1,996,993 20.01HDFC CashManagement Fund - Saving Plan - Direct Plan - Daily DividendReinvestment - Reinvestment

- - - - 14,106,891 15.00

ICICIPrudentialLiquid-DirectPlan-DailyDividend-Reinvestment - - - - 2,499,375 25.01RelianceLiquidFund-TreasuryPlan-DirectDailyDividendOption-Reinvest 98,139.76 15.00 - - 196,310 30.01

UTI-LiquidCashPlan-Institutional-DirectPlan-DailyDividend-Reinvestment - - - - 98,125 10.00

DSPBlackRockLiquidityFund-DirectPlan-DailyDividend-Reinvestment 249,841.78 25.00 - - - - FranklinIndiaTreasuryManagementAccount-SuperInstitutionalPlan-Direct- Daily Dividend Reinvestment

299,504.83 30.01 - - - -





ICICI Prudential Money Market Fund - Direct Plan - Daily Dividend -Reinvestment

2,996,274.53 30.01 - - - -

KotakLiquidDirectPlanDailyDividend-Reinvestment 204,447.13 25.00 - - - - TataMoneyMarketFundDirectPlan-DailyDividend-Reinvestment 299,597.72 30.01 - - - - AxisLiquidFund-DailyDividendReinvestment 2,123.38 0.21 2,026 0.20 50,145 5.02DSPBlackRockLiquidityFund-InstitutionalPlan-DailyDividend 2,496.33 0.25 2,383 0.24 20,798 2.08L&TLiquidFund-RegularDailyDividendReinvestmentPlan 2,106.63 0.21 2,010 0.20 45,224 4.58RelianceLiquidFund-TreasuryPlan-DirectDaily 35,499.83 5.42 33,868 5.17 23,675 3.63 ReligareInvescoLiquidFund-DailyDividend - - - - 120,890 12.10HDFCLiquidFund-Dividend-DailyReinvestment 4,339 0.44 4,141 0.42 - - SBIPremierLiquidFundRegularPlanGrowth 19,646.46 5.00 - - - - TataMoneyMarketFundRegularPlan-Growth 19,583.84 5.00 - - - - RelianceLiquidFundTreasuryPlan-GrowthPlan-GrowthOption 12,649.27 5.00 - - - - BirlaSunlifeCashPlus-Growth 191,982.58 5.00 - - - - DSPBlackrockUltraShortTermFund-RegularPlan-Growth 4,229,152.39 5.00 - - - - KotakTreasuryAdvantageFund-Growth(RegularPlan) 1,920,034.41 5.00 - - - -

191.56 6.23 127.44Total Current Investments 3,463.95 634.40 958.00Aggregate market value of quoted investments -Non-Current 5,159.22 4,037.20 4,431.48-Current 226.06 116.63 30.60Aggregate carrying value of unquoted investments -Non-Current 14,088.62 9,254.99 2,166.05-Current 3,313.56 541.65 951.54Aggregate amount of impairment in value of investments 359.39 230.95 85.69ReferNote44forInvestmentsmortgagedassecurityagainstborrowings.

Details of Total Investments: (ii) Financialassetscarriedatfairvaluethroughprofitorloss(FVTPL)

MandatorilymeasuredatFVTPLEquity - 29.43 28.36PreferenceShares 1.70 0.66 0.63Mutual Funds 191.56 6.23 127.44Debentures 987.86 758.44 - AlternativeInvestmentFund/VentureCapitalFunds 216.42 213.63 135.12

1,397.54 1,008.39 291.55(iii) Financialassetscarriedatamortisedcost

Debentures 17,041.61 9,568.56 3,367.22 17,041.61 9,568.56 3,367.22

(iv) FinancialassetsmeasuredatFVTOCIEquityinstruments-EquityShares 3,988.92 3,142.57 3,835.21

3,988.92 3,142.57 3,835.21TOTAL 22,428.07 13,719.52 7,493.98

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

289


5. LOANS - NON-CURRENT

As at March 31, 2017

` in Crores


` in Crores

As at April 1, 2015 ` in Crores

Loans (Secured and Considered Good) - at Amortised Cost TermLoans(Refernote44) 5,865.52 631.13 436.94Less:Provisionforexpectedcreditloss 110.00 25.41 3.70

5,755.52 605.72 433.24 InterCorporateDeposits(Refernote44) 43.78 1,487.56 581.91Less:Provisionforexpectedcreditloss 0.73 33.04 13.84

43.05 1,454.52 568.07 Loans (Secured and Considered Doubtful) - at Amortised Cost TermLoans 60.47 24.09 57.46Less:Provisionforexpectedcreditloss 23.89 10.55 35.57

36.58 13.54 21.89 TOTAL 5,835.15 2,073.78 1,023.20

6. OTHER FINANCIAL ASSETS - NON-CURRENT

Bankdepositswithmorethan12monthsmaturity(ReferNote44) - 20.00 - Advancesrecoverable 1.00 1.71 - Claims Receivable - 0.18 - SecurityDeposits 38.10 39.87 33.68RestrictedDeposit-EscrowAccount(Refernotebelow) 12.80 45.99 -

TOTAL 51.90 107.75 33.68Note:AmountslyinginEscrowdepositrepresenttheamountstobeinvestedinSearchlightHealthPrivateLimited(formerlyknownasHealthSuperHiwayPrivateLimited),pendingfulfilmentofConditionsprecedentforeachtrancheofinvestment.

7. DEFERRED TAX ASSETS (NET)

(a) Deferred Tax Assets on account of temporary differences -Measurementoffinancialassetsatamortisedcost/fairvalue 82.46 53.07 51.78- Provision for expected credit loss on financial assets (includingcommitments)

177.91 129.96 26.34

-OtherProvisions 7.41 4.77 15.15 -UnusedTaxCredit/losses 459.46 236.30 103.41-Amortisationofexpenseswhichareallowedincurrentyear 2.56 3.67 5.12 -Expensesthatareallowedonpaymentbasis 39.93 34.62 25.69-Effectofrecognitionofleaserentexpenseonstraightlinebasis 2.50 2.74 - -Unrealisedprofitmarginoninventory 40.32 - - -Othertemporarydifferences 4.60 0.27 0.90

817.15 465.40 228.39(b) Deferred Tax Liabilities on account of temporary differences

-Property,PlantandEquipmentandIntangibleassets (167.42) (140.11) (132.09)-Measurementoffinancialliabilitiesatamortisedcost (18.65) (4.29) (1.47)-Fairvaluemeasurementofderivativecontracts (2.41) (3.07) (2.99)-Othertemporarydifferences (3.46) - -

(191.94) (147.47) (136.55) TOTAL 625.21 317.93 91.84

DeferredTaxAssetsandDeferredTaxLiabilitiesoftherespectiveentityhavebeenoffsetastheyrelatetothesamegoverningtaxationlaws.ReferNote54formovementsduringtheyear.




8. OTHER NON-CURRENT ASSETS


` in Crores


` in Crores

As at April 1, 2015

` in Crores Advance Tax [Net of Provision of ` 4,615.44 Crores at March 31, 2017, ` 4,426.35CroresasatMarch31,2016and` 3,883.24CroresasatApril1,2015]

282.02 295.71 235.06

Advancesrecoverable 87.89 92.62 60.02Unamortizeddistributionfees 10.81 17.60 26.87Prepayments 6.38 6.57 6.92Capital Advances 6.06 7.00 10.60PensionAssets(ReferNote42) 5.89 5.33 3.84BalancewithGovernmentAuthorities 0.09 - -

TOTAL 399.14 424.83 343.31

9. INVENTORIES

RawandPackingMaterials[includesinTransitof` 7.40CroresasonMarch31,2017,` 4.79CroresasonMarch31,2016,` 6.98CroresasatApril1,2015]

243.53 254.82 248.53

Work-in-Progress 270.53 256.54 221.02FinishedGoods 115.40 148.19 129.48Stock-in-trade[includesinTransitofNILasonMarch31,2017,` 2.77CroresasonMarch31,2016,` 4.49CroresasatApril1,2015]

48.08 18.79 6.35

StoresandSpares 45.53 45.43 50.67 TOTAL 723.07 723.77 656.05

1.ReferNote44fortheinventorieshypothecatedassecurityagainstborrowings. 2.Thecostofinventoriesrecognisedasanexpenseduringtheyearwas` 1,530.94crores(Previousyear` 1,423.30Crores). 3.Thecostofinventoriesrecognisedasanexpenseincludesareversalof` 0.26Crores(Previousyearchargeof` 1.17Crores)inrespectofwritedownsofinventorytonetrealisablevalueand` 9.19crores(Previousyear` 5.42Crores)inrespectofprovisionsforslowmoving/nonmoving/expired/nearexpiryproducts.

10. TRADE RECEIVABLES

Secured-ConsideredGood 0.20 0.20 0.20Unsecured-ConsideredGood 1,109.32 973.17 822.99Unsecured-ConsideredDoubtful 38.34 31.53 22.40Less:ExpectedCreditLossonTradeReceivables (40.12) 1,107.74 (34.09) 970.81 (26.30) 819.29

TOTAL 1,107.74 970.81 819.29

InthePharmaceuticalsManufacturingandServicesbusiness,thecreditperiodonsaleofgoodsrangesfrom7to150days;intheInformationManagementbusiness,theaveragecreditperiodallowedtocustomersis42days.

TheGrouphasadocumentedCreditRiskManagementPolicyforitsPharmaceuticalsManufacturingandServicesbusiness.Foreverynewcustomer(exceptestablishedlargepharmacompanies),thegroupperformsacreditratingcheckusinganexternalcreditagency.Ifacustomerclearsthecreditrating check, the credit limit for that customer is derivedusing internally documented scoring systems. The credit limits for all the customers arereviewedonanongoingbasis.

IntheInformationManagementbusiness,thecustomerbaseismainlycomprisedofthetopbio-techcompanieswithnohistoryoffailingtopayforproductsorderedorservicesrendered.Intheeventthatnewinformationarisesaboutacustomer’sfinancialconditionwhichwouldimpacttheirabilitytopayandmanagementbelievesthatthereisanexposure,aprovisionisestablishedforthesepotentialcreditlosses.Todate,theselosseshavebeenwithinmanagement’sexpectations.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

291


TheGrouphasusedapracticalexpedientbycomputingtheexpectedcreditlossallowanceforExternalTradeReceivablesbasedonaprovisionmatrix.Theprovisionmatrixtakesintoaccounthistoricalcreditlossexperienceandadjustedforforward-lookinginformation.Theexpectedcreditlossallowanceisbasedontheageingofthedaysthereceivablesaredueandtheratesasgivenintheprovisionmatrix.Theprovisionmatrixattheendofthereportingperiodisasfollows:

Ageing - Pharmaceuticals Manufacturing and Services business Expected credit loss (%) - For external customers

Lessthan150days 0.30% 151 days to 365 days 0.30%Morethan365days 100.00%

Ageing - Information Management business Expected credit loss (%) - For external customers

Less than 42 days - Morethan42days 1.00%

ìncroresAgeing Expectedcreditloss

March 31, 2017 March 31, 2016 April 1, 2015Within due date 1.89 1.84 1.65 AfterDuedate 38.23 32.25 24.65

ìncrores Ageing of receivables

March 31, 2017 March 31, 2016 April 1, 2015 Less than 365 days 1,103.00 968.79 805.56Morethan365days 44.86 36.11 40.03

TOTAL 1,147.86 1,004.90 845.59

Ifthetradereceivables(discounted)arenotpaidatmaturity,thebankhasrighttorequesttheGrouptopaytheunsettledbalance.AstheGrouphasnottransferredtherisksandrewardsrelatingtothesecustomers,itcontinuestorecognizethefullcarryingamountofthereceivablesandhasrecognizedthecashreceivedonthetransferasasecuredborrowing(ReferNote23).

Attheendofthereportingperiod,thecarryingamountofthetradereceivablesthathavebeentransferredbuthavenotbeende-recognizedamountedto ` 20.59Crores(Previousyear` 66.30Crores)andthecarryingvalueofassociatedliabilityis` 20.59Crores(Previousyear` 66.30Crores)(ReferNote23).

ìncrores Movement in Expected Credit Loss Allowance: Year ended

March 31, 2017 Year ended

March 31, 2016

Balanceatthebeginningoftheyear 34.09 26.30Add:Expectedcreditlossacquiredonbusinesscombination 0.39 0.37Add:Movementinexpectedcreditlossallowanceontradereceivablescalculatedatlifetimeexpectedcreditlosses 7.87 8.65Less:Baddebtswrittenoff (3.30) (1.23)Add:Effectoftranslationdifferences 1.07 - Balanceattheendoftheyear 40.12 34.09ReferNote44forthereceivableshypothecatedassecurityagainstborrowings.




11. CASH AND CASH EQUIVALENTS


` in Crores


` in Crores


Cash and Cash equivalents i. BalancewithBanks

-CurrentAccounts 264.52 290.82 27.18-DepositAccount(lessthan3monthsoriginalmaturity) 1,225.44 1,489.96 - 290.82 - 278.08

ii. Cash on Hand 0.48 7.16 0.63 TOTAL 1,490.44 297.98 278.71

TherearenorepatriationrestrictionswithregardtoCashandCashEquivalentsasattheendofthereportingperiodandpriorperiods

12. OTHER BANK BALANCES

i. Earmarkedbalanceswithbanks- Unclaimed Dividend Account 15.94 19.46 13.05-Others 0.02 0.04 0.02

15.96 19.50 13.07 ii. MarginMoney 13.01 12.28 0.05iii. Deposit Account (more than 3 months original maturity but less

than 12 months) 21.49 36.18 131.86

TOTAL 50.46 67.96 144.98

13. LOANS - CURRENT

Loans Secured and Considered Good - at amortised cost: TermLoans 575.49 252.57 276.84Less:Allowanceforexpectedcreditloss 11.57 23.72 0.69

563.92 228.85 276.15InterCorporateDeposits - 377.07 54.80Less:Allowanceforexpectedcreditloss - 8.32 1.34

- 368.75 53.46 Loans Secured and Considered Doubtful - At Amortised Cost:

TermLoans 47.08 8.28 58.44Less:Allowanceforexpectedcreditloss 18.58 3.62 41.63

28.50 4.66 16.81

Loans to Related Parties Unsecured and Considered Good - At amortised Cost

27.79 7.19 -

Inter Corporate Deposits - Unsecured and Considered Good - - At amortised Cost

880.37 850.00 1,275.00

Inter Corporate Deposits Unsecured and Considered Doubtful - InterCorporateDeposits 8.30 8.30 8.30Less:Allowanceforexpectedcreditloss 8.30 - 8.30 - 8.30 -

TOTAL 1,500.58 1,459.45 1,621.42

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

293


14. OTHER FINANCIAL ASSETS - CURRENT


` in Crores


` in Crores

As at April 1, 2015

` in Crores SecurityDeposits 21.51 12.66 12.19Advancesrecoverable 14.33 6.91 6.01DerivativeFinancialAssets 14.69 11.47 12.77ConsiderationReceivable - 70.00 5.20OtherReceivablefromrelatedparties 0.28 - - Unbilledrevenues 99.13 25.20 20.07Bankdeposits(ReferNote44) 20.00 - - InterestAccrued 3.90 2.82 1.71Others 9.78 8.72 2.84

TOTAL 183.62 137.78 60.79

15. OTHER CURRENT ASSETS

Unsecured and Considered Good (Unless otherwise stated) Advances : UnsecuredandConsideredGood 92.29 109.37 153.90ConsideredDoubtful 0.08 0.08 0.08

92.37 109.45 153.98Less:ProvisionforDoubtfulAdvances 0.08 0.08 0.08

92.29 109.37 153.90Prepayments 55.02 14.75 11.56 Unamortizeddistributionfees 15.06 9.96 10.67BalancewithGovernmentAuthorities 43.91 54.14 44.20Claims Receivable 16.92 12.45 10.51

TOTAL 223.20 200.67 230.84

16. SHARE CAPITAL

Authorised Share Capital 250,000,000(250,000,000)EquitySharesof` 2/-each 50.00 50.00 50.003,000,000(3,000,000)PreferenceSharesof` 100/-each 30.00 30.00 30.0024,000,000(24,000,000)PreferenceSharesof` 10/-each 24.00 24.00 24.00105,000,000(105,000,000)UnclassifiedSharesof` 2/-each 21.00 21.00 21.00

TOTAL 125.00 125.00 125.00

Issued, Subscribed and paid up 172,563,100(172,563,100)EquitySharesof` 2/-each(fullypaidup) 34.51 34.51 34.51

TOTAL 34.51 34.51 34.51




Particulars As at March 31, 2017 As at March 31, 2016 As at April 1, 2015 No. of shares ` In Crores No. of shares ` In Crores No. of shares ` In Crores

(i) Movement in Equity Share Capital Atthebeginningoftheyear 172,563,100 34.51 172,563,100 34.51 172,563,100 34.51 Add:Issuedduringtheyear - - - - - - Less:Sharescancelledduringtheyear - - - - - - At the end of the year 172,563,100 34.51 172,563,100 34.51 172,563,100 34.51

(ii) Details of shareholders holding more than 5% shares in the Company

No. of shares ` In Crores No. of shares ` In Crores No. of shares ` In Crores TheSriKrishnaTrustthroughitsTrustees,Mr.AjayPiramalandDr.(Mrs.)SwatiA.Piramal(PreviouslyheldthroughitsCorporateTrustees,PiramalManagementServicesPrivateLimited)

75,458,452 43.73% 83,905,941 48.62% 84,120,694 48.75%

AberdeenGlobalIndianEquity(Mauritius)Limited 4,185,039 2.43% 7,600,000 4.40% 10,237,882 5.93%

(iii) Aggregate number of shares issued for consideration other than cash and shares bought back during the period of five years immediately preceding the current financial year:

Particulars Financial Year No. of shares i. EquitySharesallottedasfullypaid-uppursuanttomergerofPHLHoldingsPrivateLimitedintotheCompany 2013-14 84,092,879ii. EquitySharesallottedasfullypaid-uppursuanttodemergerofR&DNCEdivisionofPiramalPhytocareLimited

(PPL)(formerlyknownasPiramalLifeSciencesLimited)intotheCompany2011-12 5,352,585

iii. EquitysharesboughtbackbytheCompany 2011-12 705,529iv. EquitysharesboughtbackbytheCompany 2010-11 41,097,100

(iv) Terms and Rights attached to equity shares

Equity Shares: TheCompanyhasoneclassofequityshareshavingaparvalueof` 2/-pershare.Eachshareholderiseligibleforonevotepershareheld.ThedividendproposedbytheBoardofDirectorsissubjecttotheapprovaloftheshareholdersintheensuingAnnualGeneralMeeting,exceptincaseofinterimdividend. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the Company after distribution of allpreferentialamounts,inproportiontotheirshareholding.

17. OTHER EQUITY


` in Crores


` in Crores

As at April 1, 2015

` in Crores CapitalReserve 56.66 56.66 56.66 CapitalRedemptionReserve 61.73 61.73 61.73DebentureRedemptionReserve 655.79 524.00 85.42GeneralReserve 5,637.18 5,683.55 5,690.99ForeignCurrencyTranslationReserve (68.13) 97.78 - ReserveFundU/S45-IC(1)OfReserveBankOfIndiaAct,1934 85.32 38.95 31.51 FVTOCI-EquityInstruments 1,552.23 705.88 1,398.52CashFlowHedgingReserve 3.07 - - RetainedEarnings 6,864.21 5,745.29 6,066.14

TOTAL 14,848.06 12,913.84 13,390.97

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

295



` in Crores


` in Crores Capital Reserve Atthebeginningoftheyear 56.66 56.66

56.66 56.66 ThisreserveisoutcomeofpastBusinessCombinations.

Capital Redemption Reserve Atthebeginningoftheyear 61.73 61.73

61.73 61.73This reservewas created asper requirementsof CompaniesAct pursuant tobuybackof equity shares andredemptionofpreferenceshares.

Debenture Redemption Reserve Atthebeginningoftheyear 524.00 85.42Add:Transferduringtheyear 131.79 438.58

655.79 524.00TheDebentureredemptionreserveiscreatedaspertherequirementsofRule18(7)oftheCompanies(ShareCapitalandDebentures)Rules,2014.Theamountrepresents25%oftheamountpayableonredemptionofdebentures.DebentureredemptionreservehasnotbeencreatedinrespectofNBFCsubsidiarywhichhasprivatelyplaceddebenturesinaccordancewiththeCompanies(ShareCapitalandDebentures)Rules,2014.General Reserve Atthebeginningoftheyear 5,683.55 5,690.99Less:TransferredtoReserveFundu/s45-IC(1)oftheReserveBankofIndiaAct,1934 46.37 7.44

5,637.18 5,683.55Foreign Currency Translation Reserve Atthebeginningoftheyear 97.78 - Add:Othercomprehensiveincomefortheyear (217.48) 97.78Less:Incometaximpactontheabove 51.57 -

(68.13) 97.78Exchangedifferencesarisingontranslationofforeignoperationsarerecognisedinothercomprehensiveincomeandaccumulatedinaseparatereservewithinequity.Thecumulativeamountisreclassifiedtoprofitorlosswhenthenetinvestmentisdisposedoff.Reserve fund u/s 45-IC(1) of Reserve Bank of India �ct, 1934 Atthebeginningoftheyear 38.95 31.51 Add:AmounttransferredfromGeneralReserve 46.37 7.44

85.32 38.95ReserveFundisrequiredtobemaintainedu/s45-IC(1)oftheReserveBankofIndiaAct,1934forNonBankingFinancialCompanies.DuringthecurrentyearendedMarch31,2017,PHLFininvestPrivateLimitedandPiramalFinanceLimitedhavetransferredanamountof`7.71Crores(PreviousYear` Nil) and `38.66Crores(PreviousYear`7.44Crores)respectively,being20%ofProfitafterTaxdeterminedinaccordancewithStatutoryfinancialstatements.FVTOCI - Equity Instruments Atthebeginningoftheyear 705.88 1,398.52Add:ChangesinFairvalueofFVTOCIEquityinstruments 846.35 (692.64)

1,552.25 705.88TheGrouphaselectedtorecognisechangesinthefairvalueofcertaininvestmentsinequitysecuritiesinothercomprehensiveincome.ThesechangesareaccumulatedwithintheFVOCIequityinvestmentsreservewithinequity.TheGrouptransfersamountsfromthisreservetoretainedearningswhentherelevantequitysecuritiesarederecognised.Cash Flow Hedging Reserve Atthebeginningoftheyear - - Add:Transferduringtheyear 3.07 -

3.07 - TheGroupuseshedging instrumentsaspartof itsmanagementof foreigncurrency riskassociatedwith itsForeignCurrencyNon-repatriableloans.Totheextentthesehedgesareeffective,thechangeinthefairvalueofhedginginstrumentisrecognisedinthecashflowhedgingreserve.





` in Crores


` in Crores Retained Earnings Atthebeginningoftheyear 5,745.29 6,066.14Add:Profitfortheyear 1,252.04 904.74Less:RemeasurementofPostEmploymentBenefitObligations 1.62 8.15Less:DebentureRedemptionReserve 131.79 438.58Add:TransactionswithNonControllinginterest 0.29 - Less:Dividendspaid - 778.86

6,864.21 5,745.29 TOTAL 14,848.06 12,913.84

OnAugust17,2015,adividendof` 20pershare(totaldividend` 345.13Croresanddividenddistributiontaxof` 70.26crores)waspaidtoholdersoffullypaidequityshares.OnMarch21,2016,adividendof` 17.50pershare(totaldividendof` 301.99Croresanddividenddistributiontaxof` 61.48crores)waspaidtoholdersoffullypaidequityshares.

ADividendof` 21perequityshare(1050%ofthefacevalueof` 2/-each)amountingto`362.38Crores(DividendDistributionTaxthereonof`73.78Crores)hasbeenrecommendedbytheBoardofDirectorswhichissubjecttoapprovaloftheShareholders.

18. NON CURRENT BORROWINGS As at

March 31, 2017 ` in Crores


` in Crores


Secured - at amortized cost TermLoanFromBanksRupee Loans 5,532.19 1,593.40 458.10ForeignCurrencyNonRepatriableLoans 483.83 - - Others 856.06 907.59 1,002.34

6,872.08 2,500.99 1,460.44TermLoanfromOthers 1,743.33 - - RedeemableNonConvertibleDebentures 3,098.71 598.27 - TermLoanFromfinancialinstitutions 0.04 0.13 0.21

Unsecured - at amortized cost TermLoanFromBanks:Rupee Loans - 299.31 - ForeignCurrencyNonRepatriableLoans - 398.24 - Others 1,382.15 881.90 1,371.73

1,382.15 1,579.45 1,371.73RedeemableNonConvertibleDebentures 1,399.38 2,795.16 854.89

TOTAL 14,495.69 7,474.00 3,687.27

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

297


Terms of repayment, nature of security & rate of interest in case of Secured Loans:A. Secured Term Loans from Banks (Rupee Loans and Others)

(`inCrores) Nature of Security Terms of repayment Principal

Outstanding as at March 31,

2017

Principal Outstanding as

at March 31, 2016

Principal Outstanding as at April 1, 2015

First Charge on the present and future Property Plant &Equipmentsofthecompanywithaminimumsecuritycoverof1.15times.

Repaymentin10semiannualinstalments 174.99 244.99 303.33

FirstPariPassuChargeonallmovableandimmovablePropertyPlant & Equipments of the borrower for `100 crores with aminimumFinancialAssetCover(FACR)of1.15times.

Repayment in seven semi annual instalments 71.43 100.00 100.00

Hypothecationofreceivablesarisingoutof identifiedfinancialassets i.e.Borrower’s investment (a) IndebenturespertainingtoRealEstateSector&(b) Inter-corporatedepositspertainingtoRealEstateSectorwithaminimumassetcoverof1.10timesforoverallfacilities.

Repaymentin12equalquarterlyinstalments.1st instalment first day of the 27thmonth.Final Maturity 5 years from date of eachdrawdown.

- 500.00 -

Firstparipassuchargebywayofhypothecationof receivablesarising out of identified financial assets i.e. investment inDebentures&inter-corporatedepositspertainingtoRealEstateSectorwithaminimumassetcoverof1.10timesfortheoverallfacilities.

Repaymentin3equaltranchesattheendof24,30and36monthsfromthedateoffirstdisbursement

- 250.00 -

Hypothecation of allmovable properties of the Company i.e.plant andmachinery (excludingCurrentAssets and IntangibleAssets) both present and future at the below locations:(a)Pithampur, Madhya Pradesh (b) Ennore, Chennai (c ) DigwalVillage,Medak District, Andhra Pradesh (d) Mahad DistrictRaigad, Maharashtra and the Equitable Mortgage of all theimmovable properties, both LeaseHold and FreeHold of theCompany, both present and future .The charge will be onpari-passu basis with existing Term Lenders with a minimumFinancialAssetCover(FACR)of1.15times.

Repaymentin5HalfYearlyinstalmentsof` 40Croreseachcommencing24monthsafterthefirstdisbursement

200.00 200.00 -

Firstparipassuchargebywayofhypothecationorreceivablesarisingoutof identifiedfinancial assets (to the satisfactionofthe Lender) covered under loan agreements of the Borrowerwith a minimum asset cover of 1.10 times for the overallfacilities.Atanypointoftime,suchassetswillnotincludethoseassetswherein the scheduled repayment isoverdue formorethan120daysorsuchotherdaysofNPArecognitionaspertheRBIguidelines,whicheverislower.

Repayment in 14 unequal quarterlyinstalments. The first of such instalment ofrepayment shall fall dueon thefirstdayofthe 21st month from the date of the firstdrawdown.

- 250.00 -

Repayment in 14 unequal quarterlyinstalments after moratorium period of 18months

- 100.00 -

Firstparipassuchargebywayofhypothecationoverreceivablesof entire secured financial services investments of borrower(excluding investments in Shriram group) whether current orinfuturewithaminimumcoverof1.10xoftheprincipalandaccruedinterest.

Moratoriumof18monthsandrepaymentin2equalquarterlyinstalments

150.00 - -

Chargeonbrandsacquiredonexclusivebasis TotalTenorof30months fromdateoffirstdrawdown with 1 year moratorium andthereafterpayableinthreeequalhalfyearlyinstalments

175.00 - -

Chargeonbrandsacquiredonexclusivebasis Total Tenor of 30 months with 1 yearmoratoriumandthereafterpayableinthreeequalhalfyearlyinstalments

100.00 - -

Firstpari-passuchargeonthereceivablespresentandfuture Repayable quartely installments startingafter twelve months from inital drawdowndate

31.25 43.75 50.00




(`inCrores) Nature of Security Terms of repayment Principal

Outstanding as at March 31,

2017

Principal Outstanding as

at March 31, 2016

Principal Outstanding as at April 1, 2015

Firstpari-passuchargeonthereceivablespresentandfuture Repayable quartely installments startingafter twelve months from inital drawdowndate

20.00 20.00 70.00

Firstpari-passuchargeonthereceivablespresentandfuture Repayable in ten equal half yearlyinstallmentswithmoratoriumperiodofoneyearfromdrawdowndate

150.00 - -

Firstpari-passuchargeonthestandardmoveableassetincludingreceivablesandbookdebtspresentandfuture

RepayableinFifteenmonthsfromdrawdowndate

150.00 - -

Firstpari-passuchargeonthestandardmovableassetsincludingreceivablespresentandfuture.

Repayable in twelve equal quarterlyinstalmentscommencing from27monthofinitialdrawdowndate

250.00 - -

Firstpari-passuchargeonthestandardmovableassetsincludingreceivablesandbookdebtspresentandfuture

Repayable in four equal quarterlyinstalments commencing from 5th quarterfromdrawdowndate

250.00 - -


Repayable in twelve equal monthlyinstalmentsafter themoratoriumperiodof24monthfromthedateoffirstdisbursement

250.00 - -

Firstpari-passuchargeonthestandardassetsreceivables RepayableinFifteenmonthsfromdrawdowndate

2,000.00 - -

Firstpari-passuchargebywayofhypothecationonthestandardmoveableassetsincludingreceivablesandbookdebtspresentandfuture

Repayableintenequalquarterlyinstalmentscommencingfrom21stmonthfromdateofeachdrawdown

750.00 - -


Repayable in three years from drawdowndate

700.00 - -

Firstpari-passuchargebywayhypothecationonthestandardmovable assets including receivables and book debts presentandfuture

Repayableinfourequalquarterlyinstalmentscommencingafteroneyearfromthedateoffirstdisbursement

300.00 - -

Hypothecationofimmovableproperties,equipment,intellectualproperty,inventory,receivablesandothermovableproperty.

Repayable in 14 quarterly instalmentscommencingfromdateofdisbursement

- 77.09 99.24

Fixed and floating charges over the freehold and leaseholdpropertyandallotherassetsownedbythecompany.

Repayablein20quarterlyinstalmentsfromdateofdisbursement

69.82 92.97 92.35

FirstChargeonall tangibleand intangibleassetsbothpresentandfutureofasubsidiary

Repayable in 11 semi annual instalments fromdateofdisbursement

843.07 925.96 918.80

Collateralizedbyalltheassetsofthesubsidiary Repayablein16quarterlyequalinstalmentsfromdateofdisbursement

95.66 - -

Theeffectivecostsfortheaboveloansareintherangeof2.44%[GBPLIBOR+2.21%]to10.15%perannum(PreviousYear3.00%[USDLIBOR+2.65%]to10.75%perannum)Satisfactionofchargesinrespectofcertainrepaidloansarestillawaited.Creationofchargesinrespectofcertainloansareinprocess.ReferNote44forassetshypothecated/mortgagedassecuritiesagainsttheSecuredBorrowings

B. Foreign Currency Non Repatriable Loans:(`inCrores)

Nature of Security Terms of repayment Principal Outstanding as at

March 31, 2017

Principal Outstanding as at

March 31, 2016


April 1, 2015Firstpari-passuchargeonthemovableassets includingreceivablespresentandfuture

Repayable in two years from drawdowndate

250.00 - -

Firstpari-passuchargeonthestandardassets includingreceivablespresentandfuture

Repayable in two years from drawdowndate

250.00 - -

Theeffectivecostsfortheaboveloansareintherangeof9.60%to9.75%perannum

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

299


C. Term Loan from others:(`inCrores)


March 31, 2017


March 31, 2016


April 1, 2015Firstpari-passuchargeonhypothecationof receivablespresentandfuture

Repayable in five equal quarterlyinstalments commencing24Month fromthedateoffirstdisbursement

250.00 - -

Firstpari-passuchargeonhypothecationof receivablespresentandfuture

Repayable in 21 months from drawdowndate

1,500.00 - -

Theeffectivecostsfortheaboveloansareintherangeof9.65%to10%perannum

D. Secured Debentures:

(`inCrores)Particulars Nature of Security Terms of

Repayment Principal

Outstanding as at March 31, 2017


March 31, 2016


April 1, 2015 5000(payableannually)9.25% Secured RatedListed Redeemable Non Convertible Debenturesof` 1,000,000each

Secured by First Pari Passu non exclusivechargebyhypothecationoverthespecifiedidentified receivables and a first rankingpari passu mortgage over SpecificallyMortgagedPremisesorsuchotherpropertyasmaybeidentifiedbytheCompanyassetout in the Debenture Trust Deed and theDeedofHypothecation.

Series A - ` 250 Croresredeemable at par at theend of 730 days from thedateofallotmentandSeriesB - ` 250Croresredeemableatparattheendof762daysfromthedateofallotment

500.00 500.00 -

1000(payableannually)9.40% Secured RatedListed Redeemable Non Convertible Debenturesof` 1,000,000each

SecuredbyaFirstPariPassumortgageoverspecificallyMortgagedPremisesandafirstpari passuhypothecationoverportionsofspecificidentifiedReceivablesassetoutintheDebentureTrustDeedandtheDeedofHypothecation.

Option I - ` 50 Croresredeemableatparattheendof729daysfromthedateofallotment andOption II -` 50Croresredeemableatparattheendof1094daysfromthedateofallotment

100.00 100.00 -

400 (payable annually)9.383% Secured RatedListed Redeemable Non Convertible Debenturesof` 1,000,000each


The amount of ` 40 Croresredeemable at par at theend of 561 days from thedateofallotment

40.00 - -



The amount of ` 40 Croresredeemable at par at theendof 1093days from thedateofallotment

40.00 - -




25.00 - -




35.00 - -





Repayment Principal



March 31, 2016


April 1, 2015 1500(payableannually)9.45% Secured RatedListed Redeemable Non Convertible Debenturesof` 1,000,000each


Option I - ` 50 Croresredeemableatparattheendof 1092days from thedateofallotmentandOption II -` 100Croresredeemableatparattheendof1107daysfromthedateofallotment

150.00 - -



Theamountof` 10Croresredeemable at par at theendof 1826days from thedateofallotment

10.00 - -




5.00 - -



Series 1 - The amount of ` 150Croresredeemableatparattheendof1050daysfrom thedateof allotment.Series II -The amount of ` 150Croresredeemableatthe end of 1090 days fromthedateofallotment

300.00 - -



Theamountof` 200Croresredeemable at par at theendof 1095days from thedateofallotment

200.00 - -



The amount of `15 Croresredeemable at par at theendof 1109days from thedateofallotment

15.00 - -


SecuredthroughaFirstPariPassuchargeby hypothecation over specific identifiedReceivables and a first ranking pari passumortgage over specifically mortgagedpremisesorsuchotherpropertyasmaybeidentifiedbythecompanyassetoutintheDebentureTrustdeed

Theamountof` 100Croresredeemable at par at theend of 728 days from thedateofallotment

100.00 - -


SecuredthroughaFirstPariPassuchargeby hypothecation over specific identifiedReceivables and a first ranking pari passumortgage over specifically mortgagedpremises or such other property as maybe identified by the company as set outin theDebenture Trust deed andDeed ofHypothecation

Theamountof` 100Croresredeemable at par at theend of 970 days from thedateofallotment

100.00 - -

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

301



Repayment Principal



March 31, 2016


April 1, 2015 100 (payable annually)9.267% Secured RatedListed Redeemable Non Convertible Debenturesof`1,000,000each


The amount of ` 10 Croresredeemable at par at theend of 963 days from thedateofallotment

10.00 - -

200 (payable annually)9.267% SecuredRatedListed Redeemable Non Convertible Debenturesof`1,000,000each


The amount of `20 Croresredeemable at par at theend of 962 days from thedateofallotment

20.00 - -

500 (payable annually)8.95 % Secured RatedListed Redeemable Non Convertible Debenturesof`1,000,000each


The amount of `50 Croresredeemable at par at theend of 646 days from thedateofallotment

50.00 - -

10,000Secured ,Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalueof`1,000,000

First pari-passu charge by hypothecationoverthemovableassetsandafirstrankingpari passu mortgage over SpecificallyMortgagedProperty

Repayable after 1093 daysfrom thedateof allotment.;withputoption

1,000.00 - -

250 Secured , Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalueof`1,000,000


Repayable after 1093 daysfromthedateofallotment.

25.00 - -

3,000 Secured Rated,Unlisted, RedeemableNon ConvertibleDebentures (NCD’s)each having face valueof`1,000,000



300.00 - -

3,500 Secured , Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalueof`1,000,000



350.00 - -

50 Secured Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalueof`1,000,000



5.00 - -

2,000 Secured Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalueof`1,000,000


Repayable after 1152 daysfromthedateofallotment

200.00 - -





Repayment Principal



March 31, 2016


April 1, 2015 1,500 Secured Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalue of ` 1,000,000 ;with50%partlypaidandissued


Repayable after 1093 daysfromthedateofallotment;withaputoption

750.00 - -

3,000 Secured Rated,Listed,RedeemableNonConvertible Debentures(NCD’s)eachhavingfacevalueof`1,000,000


Repayable after 549 daysfromthedateofallotment

300.00 - -

Theeffectivecostsfortheaboveloansareintherangeof7.75%to9.57%perannum(Previousyear9.25-9.40%) Creationofchargesinrespectofcertaindebenturesareinprocess. ReferNote44forassetshypothecated/mortgagedassecuritiesagainsttheSecuredBorrowings

E. Term loans from financial institutions(`inCrores)


March 31, 2017


March 31, 2016


April 1, 2015Firstparipassuchargeonmotorcarsofasubsidiary. Repayable in 48 equal monthly

instalments commencing from October10, 2014. Interest to be paid@ 10.23%p.a.

0.12 0.21 0.27

Terms of repayment & rate of interest in case of Unsecured Loans:A. Unsecured Term Loans

(` inCrores)Particulars Payment Terms As at

March 31, 2017As at

March 31, 2016As at

April 1, 2015Long term Unsecured loans frombanks

Repaymentfromthedateofdisbursementrepaymentattheendof15thmonthfor` 75Crores,attheendof16thmonthfor` 75Croresandattheendof17thmonthfor` 100Crores

- 250.00 -

RepaymentonSeptember4,2017foranamountof` 100Crores 100.00 100.00 - RepaymentonApril10,2017foranamountof` 200Crores - 200.00 - Repayablein6semiannualinstalmentsfromdateofdrawdown 43.45 132.65 208.39Repayablein7semiannualinstalmentsfromdateofdrawdown 20.34 71.58 115.45 Repayablein6semiannualinstalmentsfromdateofdrawdown## 118.74 193.98 201.37RepaymentonOctober11,2017 1040.87 - - RepaymentonFebruary26,2018 291.83 - - Repayablein8halfyearlyinstalmentsfromdateofdrawdown - 1,093.27 1,343.86Repayablein6monthlyequalinstalmentsfromdateofdrawdown - - 41.71

Long term Unsecured foreigncurrency Non Repatriable loansfrombanks

RepaymentonJune30,2017foranamountof` 250Crores 249.47 249.47 - RepaymentonAugust21,2017foranamountof` 150Crores - 149.46 -

Theeffectivecostsfortheaboveloansareintherangeof3.48%[GBPLIBOR+2.63%]to10%perannum(PreviousYear3.45%[GBPLIBOR+2.63%]to10%perannum) ##Subsequenttotheyearend,thisloanhasbeenrepaidvoluntarilyaheadofthescheduledrepaymentdates.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

303


Unsecured DebenturesParticulars Terms of Repayment As at

March 31, 2017As at

March 31, 2016As at

April 1, 20153,500 9.66% (payable annually) UnsecuredRedeemable Non Convertible Debentures of ` 1,000,000each

Redeemable at par at the end of 5th year from theallotment date. The same has been redeemed on February8,2016

- - 350.00

5,000 9.43% Unsecured Redeemable NonConvertibleDebenturesof` 1,000,000each*

SeriesA-` 350Croresredeemableatparattheendof731daysfromthedateofallotmentandSeriesB-` 100Croresredeemableatparattheendof1095daysfromthedateofallotment,SeriesC-` 50Croresredeemableatparattheendof1095daysfromthedateofallotment

150.00 500.00 500.00

4,000 9.15% (payable annually) UnsecuredRedeemable Non Convertible Debentures ` 1,000,000each

SeriesA-`150Croresredeemableatparattheendof711daysfromthedateofallotmentandSeriesB-` 150Croresredeemableatparattheendof746daysfromthedateofallotmentandSeriesC-` 100Croresredeemableatparattheendof767daysfromthedateofallotment

400.00 400.00 -


SeriesD-` 100Croresredeemableatparattheendof1096daysfromthedateofallotment

100.00 100.00 -


SeriesA-`235Croresredeemableatparattheendof731daysfromthedateofallotment

235.00 235.00 -


SeriesB-`100Croresredeemableatparattheendof1092daysfromthedateofallotmentandSeriesC-`285Croresredeemableatparattheendof1096daysfromthedateofallotment

385.00 385.00 -


Series I -`75Crores redeemableatparat theendof532days fromthedateofallotmentandSeries II -`15Croresredeemableatparattheendof644daysfromthedateofallotmentandSeriesIII-`65Croresredeemableatparattheendof731daysfromthedateofallotment

80.00 155.00 -

2,500 9.27% (payable annually) UnsecuredRedeemable Non Convertible Debentures of ` 1,000,000each

SeriesI-`250Croresredeemableatparattheendof581daysfromthedateofallotment

- 250.00 -

2,450 9.27% (payable annually) UnsecuredRedeemable Non Convertible Debentures of`1,000,000each

SeriesIV-`21Croresredeemableatparattheendof974daysfromthedateofallotmentandSeriesV-`224Croresredeemableatparattheendof1112daysfromthedateofallotment

245.00 245.00 -


SeriesII-`200Croresredeemableatparattheendof731daysfromthedateofallotment

200.00 200.00 -

2,000 9.40% (payable annually) UnsecuredRedeemable Non Convertible Debentures`1,000,000each

SeriesIII-`200Croresredeemableatparattheendof1092daysfromthedateofallotment

200.00 200.00 -

7,000 9.40% (payable monthly) UnsecuredRedeemable Non Convertible Debentures`1,000,000each

OptionI-`400Croresredeemableatparattheendof1103daysfromthedateofallotmentandOptionII-`300Croresredeemableatparattheendof 1132daysfromthedateofallotment

- 700.00 -

1,000 9.33% (payable annually) UnsecuredRedeemable Non Convertible Debentures`1,000,000each

Theamountof`100Croresredeemableatparattheendof517daysfromthedateofallotment

100.00 100.00 -

5,000 Unsecured, Subordinated, Tier II,Rated, Listed, Redeemable Non ConvertibleDebentures (NCDs) each having face value of `1,000,000

The NCDs are repayable after 10 years from the date ofallotment

500.00 - -

500 Unsecured, Unlisted, Redeemable NonConvertible Debentures (NCDs) each havingfacevalueof`1,000,000

TheNCDsarerepayableon12March2016. - - 50.00

Theeffectivecostsfortheaboveloansareintherangeof9.13%to10.65%perannum *InterestonSeriesA&Bispayableannually.InterestonSeriesCispayableatmaturity




19. OTHER FINANCIAL LIABILITIES - NON-CURRENT


` in Crores


` in Crores

As at April 1, 2015

` in Crores DerivativeFinancialLiabilities - 4.03 - LeaseEqualisationLiability 5.79 7.15 0.25Employeerelatedliabilities - - 0.64Contingentconsideration 141.79 35.98 - Deposits Received 2.90 - 1.64

TOTAL 150.48 47.16 2.53

20. NON-CURRENT PROVISIONS

Provisionforemployeebenefits(ReferNote42) 34.95 23.11 19.92Provisionforgrants-committed* 4.91 15.58 24.29ProvisionforOnerouscontracts* 4.25 10.08 1.06Provisionforincentive* 29.48 22.60 - Others - - 3.73

TOTAL 73.59 71.37 49.00*ReferNote51formovementsduringtheyear

21. DEFERRED TAX LIABILITIES (NET)

(a) Deferred Tax Liabilities on account of temporary differences -FairValuationofInvestment 15.43 8.21 7.28-UnamortisedDistributionExpenses 6.70 9.54 12.83-Shareofundistributedearningsofassociates 11.60 10.75 6.70-Others 0.85 6.18 9.62

34.58 34.68 36.43 (b) Deferred Tax Asset on account of temporary differences

-Unusedtaxcredits/losses - - (0.39)-Property,PlantandEquipmentandIntangibleassets (0.97) (0.65) (0.31)-Expensesthatareallowedonpaymentbasis (1.68) (3.77) (1.92)-Others (1.18) - -

(3.83) (4.42) (2.62) TOTAL 30.75 30.26 33.81

22. OTHER NON-CURRENT LIABILITIES

DeferredGovernmentgrantrelatedtoassets 4.06 5.03 3.50Othergrantsrelatedtoassets 28.30 22.98 - DeferredRevenue 2.87 0.29 0.92

TOTAL 35.23 28.30 4.42

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

305


23. CURRENT BORROWINGS


` in Crores


` in Crores

As at April 1, 2015

` in Crores Secured - at amortised cost

Loansfrombanks-WorkingcapitalDemandLoan 35.05 134.60 121.61 -Overdraftwithbanks 175.70 131.93 89.92-CollaterizedDebtObligations(ReferNote10) 20.59 66.30 -

231.34 332.83 211.53 Unsecured - at amortised cost

LoansfrombanksRupee Loans

- Repayable on demand 1,147.06 526.38 537.01-Others 1.01 13.42 8.38

ForeignCurrencyNonrepatriableLoans 146.29 - - Others 1,039.12 - -

CommercialPapers 9,514.66 5,951.30 2,039.62Loansfromrelatedparties(ReferNote43) - 5.00 -

11,848.14 6,496.10 2,585.01 TOTAL 12,079.48 6,828.93 2,796.54

Note:

Description of loan Terms of repayment Rate of Interest Secured Loans: WorkingcapitalDemandLoan At Call 10.45%paOverdraftwithbanks At Call 4.25%to13%paCollaterizedDebtObligations Attheendofcreditperiod(maximum60daysfromthedateofsale) 0.80%to1.50%paUnsecured Loans: CommercialPapers Repayablewithin365daysfromdateofdisbursement 7.45%to9.25%paLoansfromrelatedparties At Call 8.76%paRupee Loans At Call 8.10%to9.00%paForeignCurrencyLoans Repayablewithin365daysfromdateofdisbursement 9.40%to9.80%paOthers(LoansfromBanks) Repayablewithin365daysfromdateofdisbursement 2.13%to4.41%paOthers(PCFC) At Call 0.80%to1.50%pa

ReferNote44forassetshypothecated/mortgagedassecuritiesagainsttheSecuredBorrowings




24. OTHER FINANCIAL LIABILITIES - CURRENT


` in Crores


` in Crores

As at April 1, 2015

` in Crores Currentmaturitiesoflong-termdebt(ReferNote18) 3,875.81 1,975.86 702.53DeferredConsideration(ReferNote40) 998.72 73.55 - UnpaidDividend(ReferNotebelow) 15.94 19.46 13.05LeaseEqualisation 1.46 0.82 - Employeerelatedliabilities 142.84 161.36 87.25CapitalCreditors 42.74 8.49 5.91Retentionmoney - 1.50 - SecurityDepositsReceived 1.44 4.21 1.25 DerivativeFinancialLiabilities 30.73 - - Otherpayables 2.93 1.97 5.32

TOTAL 5,112.61 2,247.22 815.31

TherearenoamountsdueandoutstandingtobecreditedtoInvestorEducationandProtectionFundasattheyearend.

25. OTHER CURRENT LIABILITIES

AdvanceFromCustomers 124.78 47.43 45.42 Incomereceivedinadvance - 1.65 - DeferredRevenue 273.92 366.73 300.18DeferredGovernmentgrantrelatedtoassets 0.20 - - Deferredrent 6.95 4.80 - StatutoryDues 44.66 38.31 52.64

TOTAL 450.51 458.92 398.24

26. CURRENT PROVISIONS

Provisionforemployeebenefits(ReferNote42) 85.32 44.76 18.44ProvisionforExpectedCreditLossonLoanCommitments(ReferNote50(f)) 6.36 39.93 25.34 ProvisionforWealthTax 0.21 0.21 0.21ProvisionforOnerouscontracts* 5.11 7.11 35.49Provisionforgrants-committed* 12.97 13.25 - ProvisionforLitigations&Disputes* 3.50 13.39 26.42

TOTAL 113.47 118.65 105.90*ReferNote51formovementsduringtheyear

27. CURRENT TAX LIABILITIES (NET)

Provision for Income Tax [Net of Advance Tax of ` 404.44 Crores as on March31,2017,`162.12CroresasonMarch31,2016and` 442.25CroresasonApril1,2015]

37.48 23.87 15.91

TOTAL 37.48 23.87 15.91

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

307


28 CONTINGENT LIABILITIES AND COMMITMENTS As at



` in Crores

As at April 1, 2015

` in Crores A Contingent liabilities 1 ClaimsagainsttheCompanynotacknowledgedasdebts:

-DemanddatedJune5,1984theGovernmenthasaskedforpaymenttothecreditoftheDrugsPricesEqualisationAccount,thedifferencebetweenthecommonsalepriceandtheretentionpriceonproductionofVitamin‘A’Palmitate(OilyForm)fromJanuary28,1981toMarch31,1985notacceptedbytheCompany.TheCompanyhas been legally advised that the demand is untenable.

0.61 0.61 0.61

2 Guaranteesissued(OtherthanFinancialGuarantees) 7.69 9.06 5.54 3 LetterofComfortissuedbyasubsidiary 14.00 - - 4 Others

i. Appealsfiledinrespectofdisputeddemands: IncomeTax -wheretheCompanyisinappeal 683.86 732.45 744.39 -wheretheDepartmentisinappeal 142.23 144.25 144.25 SalesTax 17.66 14.43 15.41 Central/StateExcise 22.08 10.36 18.29 LabourMatters 0.16 0.39 0.42 Stamp Duty 4.05 4.05 4.05 Legal Cases 8.50 8.50 8.50ii. UnexpiredLettersofCredit 8.07 12.61 10.58

5 DividendpayableonCompulsorilyConvertiblePreferenceSharesandtaxthereon 9.76 - - Note:Futurecashoutflowsinrespectof1and4(i)abovearedeterminableonlyonreceiptofjudgments/decisionspendingwithvariousforums/authorities.

B Commitments a. Estimatedamountofcontractsremainingtobeexecutedoncapitalaccount

andnotprovidedfor 210.10 57.85 63.08

b. OtherCommitments CommitmenttoInvestinNonConvertibleDebentures 106.45 1,257.45 798.94 Loan Commitments 230.40 115.50 110.00 CommitmenttoinvestinInterCompanyDeposits - 439.95 60.00 CommitmenttoinvestinOptionallyConvertibleDebentures - - 100.00 CommitmenttoinvestinAlternativeInvestmentFunds 75.00 85.00 - TheCompanyhasimportedrawmaterialsatconcessionalrates,underthe

Advance License Schemeof theGovernment of India, to fulfil conditionsrelatedtoquantifiedexportsinstipulatedperiod

9.38 15.44 21.64




29. REVENUE FROM OPERATIONS Year ended


Year ended March 31, 2016

` in Crores Saleofproducts(includingexciseduty) 3,473.84 3,062.28SaleofServices 1,813.85 1,643.27Incomeoffinancingactivities:Interestincomeoninstrumentsmeasuredatamortisedcost 2,929.41 1,498.91IncomeoninstrumentsmandatorilymeasuredatFVTPL 208.65 86.32DividendincomeoninstrumentsdesignatedatFVTOCI(referNotebelow) 32.47 32.80Others 22.91 33.22

8,481.13 6,356.80OtheroperatingrevenuesProcessingChargesReceived 2.88 2.89Miscellaneous Income 62.74 21.79

65.62 24.68 TOTAL 8,546.75 6,381.48

AlldividendsfromequityinvestmentsdesignatedasatFVTOCIrecognisedforboththeyearsrelatetoinvestmentsheldattheendofeachreportingperiod.Therewasnodividendincomerelatingtoinvestmentsderecognizedduringthereportingperiod.

30. OTHER INCOME (NET)

InterestIncomeonFinancialAssets-OnLoansandBankDeposits(atamortisedcosts) 99.80 104.49

Dividend Income-OncurrentinvestmentsatFVTPL 18.12 7.31

GainonsaleofinvestmentsmeasuredatFVTPL 24.23 1.94

OtherGains&Losses:-ExchangeGain(Net) 45.46 102.39 Rent Received 1.79 1.54 Miscellaneous income 44.35 33.99

TOTAL 233.75 251.66

31. COST OF MATERIALS CONSUMED

OpeningInventory 254.82 248.53Add:Inventoryacquiredonbusinesscombination(Refernote40) 17.06 - Add:Purchases 1,093.67 1,267.77Less:ClosingInventory 243.53 254.82

TOTAL 1,122.02 1,261.48

32. PURCHASES OF STOCK-IN-TRADE

TradedGoods 268.64 109.13TOTAL 268.64 109.13

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

309


33. CHANGES IN INVENTORIES OF FINISHED GOODS, WORK-IN-PROGRESS AND STOCK-IN-TRADE

Year Ended March 31, 2017

` in Crores

Year Ended March 31, 2016

` in CroresOpening Stocks :

Work-in-Progress 256.54 221.02FinishedGoods 148.19 129.48Stock-in-trade 18.79 6.35 Less:ExciseDuty 3.34 1.34

420.18 355.51 Add: Inventory Acquired on Business Combination (Refer Note 40)

Work-in-Progress 19.15 - FinishedGoods 2.01 - Less:ExciseDuty - -

21.16 -Closing Stocks :

Work-in-Progress 270.53 256.54 FinishedGoods 115.40 148.19Stock-in-trade 48.08 18.79Less:ExciseDuty 3.11 3.34

430.90 420.18TOTAL 10.44 (64.67)

34. EMPLOYEE BENEFITS EXPENSE

SalariesandWages 1,604.59 1,517.97ContributiontoProvidentandOtherFunds 81.54 68.76GratuityExpense 3.61 2.76StaffWelfare 104.13 93.56

TOTAL 1,793.87 1,683.05

35. FINANCE COSTS

FinanceChargeonfinancialliabilitiesmeasuredatamortisedcost 2,000.62 953.69InterestonIncomeTax - 0.02Otherborrowingcosts 30.36 5.36

TOTAL 2,030.98 959.07

Duringtheyear,theCompanyhascapitalizedborrowingcostsof` 14.26Crores(Previousyear` NIL)relatingtoprojects,includedinCapitalWorkinProgress.ThecapitalisationrateusedtodeterminetheamountofborrowingcoststobecapitalisedistheweightedaverageinterestrateapplicabletotheCompany’sgeneralborrowingsduringtheyear,inthiscase9.00%(PreviousyearNIL).




36. OTHER EXPENSES Year ended



` in Crores ProcessingCharges 35.76 8.87ConsumptionofStoresandSparesParts 86.74 77.39ConsumptionofLaboratorymaterials 27.03 28.36Power,FuelandWaterCharges 101.03 98.73RepairsandMaintenance

Buildings 30.54 28.52PlantandMachinery 64.34 61.90Others 25.58 17.18

120.46 107.60Rent

Premises 85.66 79.16Leasehold Land 0.13 0.07OtherAssets 20.27 21.06

106.06 100.29Rates&Taxes(includesexciseduty) 77.42 62.25 Insurance 27.87 27.20TravellingExpenses 107.46 93.60Directors’Commission 1.84 1.80Directors’SittingFees 0.92 0.87CapitalWorkinProgresswrittenoff - 4.72ExpectedCreditLossonTradeReceivables(ReferNoteno10) 7.87 8.65ExpectedCreditLossonFinancialAssets(includingCommitments)(ReferNoteno50(f)) 154.98 167.74LossonSaleofNonCurrentInvestments(Net) - 0.48Advanceswrittenoff 0.01 0.21Property,Plant&EquipmentsWrittenOff - 6.21 LossonSaleofPropertyPlant&Equipments(Net) 7.16 2.29AdvertisementandBusinessPromotionExpenses 179.62 149.30Donations 2.43 15.34 ExpendituretowardsCorporateSocialResponsibilityactivities 39.47 25.86ContributiontoElectoralTrust 24.60 - Freight 47.74 39.08Exportexpenses 3.70 3.85ClearingandForwardingExpenses 35.11 13.54 CommunicationandPostage 33.95 30.91PrintingandStationery 15.84 15.37Claims 3.79 3.87LegalCharges 14.71 11.72ProfessionalCharges 170.47 170.75RoyaltyExpense 31.19 34.82ServiceCharges 1.92 0.58InformationTechnologyCosts 68.73 51.08Marketresearch 104.67 113.14 R&DExpenses(Net) 100.75 144.62 Commissiononfundraising 14.47 15.01MiscellaneousExpenses 53.77 39.18

TOTAL 1,809.54 1,675.28

Note

DetailsinrespectofCorporateSocialResponsibilityExpenditure:Grossamountrequiredtobespentduringtheyear–` 10.81croresAmountspentduringtheyearonRevenueExpenditure–` 39.47croresAmountspentduringtheyearonCapitalExpenditure-` Nil

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

311


37. EXCEPTIONAL ITEMS INCOME /(EXPENSES) (NET) Year ended



` in Crores Gainonsaleofproperties(Refernote37(a)) - 70.23IncomeassociatedwithR&Dscaledown(Refernote47(a)) - 2.56 LossonSaleofPiramalClinicalResearchBusiness(Refernote37(b)) - (2.60)Lossonimpairmentofassets(Refernote37(c)) - (15.09)Onerouscontractexpenses(net)(Refernote37(d)) - (0.16)EmployeeSeverancecosts(Refernote37(e)) (9.95) (9.28)

TOTAL (9.95) 45.66

a) Duringthepreviousyear,theCompanyhadsoldcertainpropertieshavingawrittendownvalueof` 11.07croresfor`81.30croresresultinginagainof` 70.23crores.

b) Duringthepreviousyear,theCompanysolditsclinicalresearchbusinessknownasPCRbusiness.PropertyPlant&Equipmentsofthisdivisionalongwiththeemployeesweretransferredonaslumpsalebasisasapartofthetransactionforaconsiderationof`4.64crores,resultinginalossof`

2.60crores.

c) Losson impairmentof assets comprises impairmentof certain tangible assets andAltaselect brand inPiramalCritical Care Italia S.P.A in thepreviousyear.

d) Duringthepreviousyear,PiramalHealthcareCanadaLimitedsolditsbrandBSTCargeltoSmith&NephewOrthopaedicsAGforaconsiderationofUSD5Million(equivalent`33.13crores).Theresultantlossof`0.16Croreshasbeendisclosedunderexceptionalexpensesabove.

e) EmployeeSeverancecostsconsistsofamountspaidtoemployeesasapartofmanagementseparationprogramme.

38. OTHER COMPREHENSIVE INCOME/(EXPENSE)

OtherComprehensiveIncome/(Expense)relatedto:FairValuationofEquityinvestments 846.35 (692.64)Remeasurementofpost-employmentbenefitobligations (1.54) (8.15)Shareofothercomprehensiveincomeofassociatesaccountedforusingtheequitymethod (0.08) - Deferredgains/(losses)oncashflowhedges 3.07 - Exchangedifferencesontranslationofforeignoperations (165.91) 97.78

TOTAL 681.89 (603.01)




39 INTERESTS IN OTHER ENTITIES (a) Subsidiaries TheGroup'ssubsidiariesatMarch31,2017aresetoutbelow. Unlessotherwisestated,theyhavesharecapitalconsistingsolelyofequitysharesthatarehelddirectlybythegroup,andtheproportionof

ownershipinterestsheldequalsthevotingrightsheldbythegroup. Thecountryofincorporationorregistrationisalsotheirprincipalplaceofbusiness.

Sr. No.

Name of the Company Principal place of business / Country of

incorporation

Ownership interest held by

the group

Ownership interest held by non-controlling

interests

Principal Activity

% voting power held as at

March 31, 2017


March 31, 2017 1 PHLFininvestPrivateLimited India 100% - FinancialServices 2 SearchlightHealthPrivateLimited (w.e.f.December23,

2016) (formerly known as Health Superhiway PrivateLimited)

India 51% 49% InformationManagement

3 PiramalInternational Mauritius 100% - Holding Company 4 PiramalHoldings(Suisse)SA Switzerland 100% - Holding Company 5 PiramalImagingSA* Switzerland 98.34% 1.66% Pharmaceuticalmanufacturingandservices 6 PiramalImagingGmbH* Germany 100% - Pharmaceuticalmanufacturingandservices7 PiramalImagingLimited* U.K. 100% - Pharmaceuticalmanufacturingandservices8 PiramalCriticalCareItalia,S.P.A** Italy 100% - Pharmaceuticalmanufacturingandservices9 PiramalCriticalCareDeutschlandGmbH** Germany 100% - Pharmaceuticalmanufacturingandservices10 PiramalCriticalCareLimited** U.K. 100% - Pharmaceuticalmanufacturingandservices 11 PiramalHealthcare(Canada)Limited** Canada 100% - Pharmaceuticalmanufacturingandservices 12 PiramalHealthcareUKLimited** U.K. 100% - Pharmaceuticalmanufacturingandservices 13 PiramalHealthcarePensionTrusteesLimited** U.K. 100% - Pharmaceuticalmanufacturingandservices 14 Piramal Critical Care South Africa (Pty) Ltd ** (w.e.f.

November16,2016)SouthAfrica 100% - Pharmaceuticalmanufacturingandservices

15 PiramalDutchHoldingsN.V. Netherlands 100% - Holding Company 16 PiramalHealthcareInc.** U.S.A 100% - Holding Company17 PiramalCriticalCare,Inc.** U.S.A 100% - Pharmaceuticalmanufacturingandservices18 PiramalPharmaInc.** U.S.A 100% - Pharmaceutical manufacturing

andservices19 Piramal Pharma Solutions Inc. (formerly known as

ColdstreamLaboratoriesInc.)**U.S.A 100% - Pharmaceuticalmanufacturingandservices

20 PELPharmaInc.**(w.e.f.July26,2016) U.S.A 100% - Pharmaceuticalmanufacturingandservices 21 AshStevensLLC**(w.e.f.August31,2016) U.S.A 100% - Pharmaceuticalmanufacturingandservices 22 DRGHoldcoInc.$ U.S.A 100% - Holding Company 23 PiramalIPPHoldingsLLC$ U.S.A 100% - Holding Company 24 DecisionResourcesInc.$ U.S.A 100% - InformationManagement 25 DecisionResourcesInternational,Inc.$ U.S.A 100% - InformationManagement 26 DR/DecisionResources,LLC$ U.S.A 100% - InformationManagement27 DR/MRGHoldings,LLC# U.S.A 100% - InformationManagement28 MillenniumResearchGroupInc.$ Canada 100% - InformationManagement29 DecisionResourcesGroupAsiaLtd$ HongKong 100% - InformationManagement30 DRGUKHoldcoLimited$ U.K. 100% - Holding Company 31 DecisionResourcesGroupUKLimited$ U.K. 100% - Holding Company 32 SigmaticLimited$ U.K. 100% - InformationManagement 33 ActivateNetworksInc.$ U.S.A 100% - InformationManagement 34 DRGAnalytics&InsightsPrivateLimited$ India 100% - InformationManagement 35 DRGSingaporePteLtd$(w.e.f.July21,2016) Singapore 100% - InformationManagement 36 PiramalDutchIMHoldcoB.V. Netherlands 100% - InformationManagement37 PEL-DRGDutchHoldcoB.V.$ Netherlands 100% - InformationManagement38 PiramalFundManagementPrivateLimited India 100% - FinancialServices

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

313


Sr. No.

Name of the Company Principal place of business / Country of

incorporation

Ownership interest held by

the group

Ownership interest held by non-controlling

interests

Principal Activity


March 31, 2017


March 31, 201739 Piramal Finance Limited (formerly known as

PiramalFinancePrivateLimited)India 100% - FinancialServices

40 Piramal Housing Finance Private Limited ## (w.e.fFebruary10,2017)

India 100% - FinancialServices

41 PiramalInvestmentAdvisoryServicesPrivateLimited India 100% - FinancialServices 42 PiramalInvestmentOpportunitiesFund India 100% - FinancialServices 43 INDIAREITInvestmentManagementCo.$$ Mauritius 100% - FinancialServices 44 PiramalAssetManagementPrivateLimited$$ Singapore 100% - FinancialServices 45 PiramalSystems&TechnologiesPrivateLimited India 100% - Holding Company 46 PiramalTechnologiesSA@ Switzerland 100% - Holding Company47 PELFinholdPrivateLimited India 100% - Holding Company48 PELAssetResurgenceAdvisoryPrivateLimited India 100% - FinancialServices49 PiramalConsumerProductsPrivateLimited India 100% - Holding Company50 PiramalCapitalLimited(w.e.f.July26,2016) India 100% - Holding Company 51 PiramalAssetReconstructionPrivateLimited India 100% - FinancialServices 52 HealthcareBusinessInsightsLLC@@ U.S.A 100% - InformationManagement 53 Cost&QualityAcademy,LLC@@ U.S.A 100% - InformationManagement 54 InformationTechnologyAcademy,LLC@@ U.S.A 100% - InformationManagement 55 Labor&ProductivityAcademy,LLC@@ U.S.A 100% - InformationManagement 56 SupplyChainAcademy,LLC@@ U.S.A 100% - InformationManagement57 SolutionProviderAcademy,LLC@@ U.S.A 100% - InformationManagement58 RevenueCycleAcademy,LLC@@ U.S.A 100% - InformationManagement59 RevenueCycle360,LLC@@ U.S.A 100% - InformationManagement

*heldthroughPiramalHoldings(Suisse)SA**heldthroughPiramalDutchHoldingsN.V.@heldthroughPiramalSystems&TechnologiesPrivateLimited $heldthroughPiramalDutchIMHoldcoB.V. $$heldthroughPiramalFundManagementPrivateLimited #mergedintoDR/DecisionResources,LLCw.e.f.January17,2017 @@mergedintoDecisionResourcesIncw.e.f.October3,2016 ##heldthroughPiramalFinanceLimited

CSR(CorporateSocialResponsibilities)subsidiaries: PiramalUdgamDataManagementSolutions(Udgam)### PiramalFoundationforEducationalLeadership(PFEL)### PiramalSwasthyaManagementandResearchInstitute(formerlyknownas“HealthManagementandResearchInstitute”)(PSMRI) PiramalHealthcareFoundation###TheseCSRcompanies(###)incorporatedundersection25oftheCompaniesAct,1956(Section8oftheCompaniesAct,2013),beinglimitedbyguarantee(nothavingsharecapital)andPSMRI(beingasociety)areengagedinCorporateSocialResponsibilityactivities.Basedonthecontrolassessmentcarriedoutbythecompany,thesameisnotconsolidatedasperIndAS110.




TheGroup’ssubsidiariesatMarch31,2016andApril1,2015aresetoutbelow.

Sr. No.

Name of the Company Principal place of business / Country

of incorporation

Ownership interest held by the group

Ownership interest held by non-controlling interests

Principal Activity


March 31, 2016


April 1, 2015


March 31, 2016


April 1, 2015 1 PHLFininvestPrivateLimited India 100% 100% - - FinancialServices 2 PiramalInternational Mauritius 100% 100% - - Holding Company 3 PiramalHoldings(Suisse)SA Switzerland 100% 100% - - Holding Company 4 PiramalImagingSA* Switzerland 98.34% 98.34% 1.66% 1.66% Pharmaceutical manufacturing

andservices 5 PiramalImagingGmbH* Germany 100% 100% - - Pharmaceutical manufacturing

andservices 6 PiramalImagingLimited* U.K. 100% 100% - - Pharmaceutical manufacturing

andservices7 PiramalCriticalCareItalia,S.P.A* Italy 100% 100% - - Pharmaceutical manufacturing

andservices8 PiramalCriticalCareDeutschland

GmbH##Germany 100% 100% - - Pharmaceutical manufacturing

andservices9 Piramal Critical Care Limited

(formerly known as Piramal LifeSciences(UK)Limited)###

U.K. 100% 100% - - Pharmaceutical manufacturingandservices

10 Piramal Healthcare (Canada)Limited ##

Canada 100% 100% - - Pharmaceutical manufacturingandservices

11 PiramalHealthcare (UK) Limited##


12 Piramal Healthcare PensionTrusteesLimited##


13 PiramalDutchHoldingsN.V. Netherlands 100% 100% - - Holding Company 14 PiramalHealthcareInc.** U.S.A 100% 100% - - Holding Company 15 PiramalCriticalCare,Inc.** U.S.A 100% 100% - - Pharmaceutical manufacturing

andservices 16 PiramalPharmaInc.** U.S.A 100% 100% - - Pharmaceutical manufacturing

andservices17 ColdstreamLaboratoriesInc.** U.S.A 100% 100% - - Pharmaceutical manufacturing

andservices18 DRGHoldcoInc.**(w.e.fAugust

26,2015)U.S.A 100% - - - Holding Company

19 Piramal IPP Holdings LLC **(w.e.fNovember6,2015)

U.S.A 100% - - - Holding Company

20 DecisionResourcesInc.** U.S.A 100% 100% - - InformationManagement 21 DecisionResourcesInternational,

Inc.**U.S.A 100% 100% - - InformationManagement

22 DR/DecisionResources,LLC** U.S.A 100% 100% - - InformationManagement 23 DR/MRGHoldings,LLC** U.S.A 100% 100% - - InformationManagement 24 MillenniumResearchGroup Inc.

**Canada 100% 100% - - InformationManagement

25 Decision Resources Group AsiaLtd**

HongKong 100% 100% - - InformationManagement

26 DRGUKHoldcoLimited** U.K. 100% 100% - - Holding Company27 Decision Resources Group UK

Limited**U.K. 100% 100% - - Holding Company

28 SigmaticLimited** U.K. 100% 100% - - InformationManagement29 ActivateNetworksInc.** U.S.A 100% 100% - - InformationManagement30 Healthcare Business Insights

LLC**(w.e.f.May14,2015)U.S.A 100% - - - InformationManagement

31 DRGAnalytics& InsightsPrivateLimited**(w.e.fMay11,2015)

India 100% - - - InformationManagement

32 Piramal Dutch IMHoldco B.V.**(w.e.f.March7,2016)

Netherlands 100% - - - InformationManagement

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

315


Sr. No.

Name of the Company Principal place of business / Country

of incorporation

Ownership interest held by the group

Ownership interest held by non-controlling interests

Principal Activity


March 31, 2016


April 1, 2015


March 31, 2016


April 1, 2015 33 PEL-DRG Dutch Holdco B.V.**

(w.e.f.March7,2016)Netherlands 100% - - - InformationManagement

34 Piramal Fund ManagementPrivateLimited

India 100% 100% - - FinancialServices

35 PiramalFinancePrivateLimited India 100% 100% - - FinancialServices 36 Piramal Investment Advisory

ServicesPrivateLimitedIndia 100% 100% - - FinancialServices

37 INDIAREIT Investment ManagementCo.$$

Mauritius 100% 100% - - FinancialServices

38 Piramal Asset ManagementPrivateLimited$$

Singapore 100% 100% - - FinancialServices

39 Piramal Systems& TechnologiesPrivateLimited

India 100% 100% - - Holding Company

40 PiramalTechnologiesSA@ Switzerland 100% 100% - - Holding Company 41 Piramal Investment

OpportunitiesFundIndia 99.16% 99.71% 0.84% 0.29% FinancialServices

42 PELFinholdPrivateLimited India 100% 100% - - Holding Company 43 PEL Asset Resurgence Advisory

Private Limited (w.e.f. February22,2016)

India 100% - - - FinancialServices

44 Piramal Consumer ProductsPrivateLimited(w.e.f.March23,2016)

India 100% - - - Holding Company

45 Piramal Asset ReconstructionPrivate Limited (w.e.f. January29,2016)

India 100% - - - FinancialServices

46 Cost & Quality Academy, LLC**(w.e.f.May14,2015)

U.S.A 100% - - - InformationManagement

47 Information TechnologyAcademy, LLC** (w.e.f. May 14,2015)


48 Labor & Productivity Academy,LLC**(w.e.f.May14,2015)


49 Supply Chain Academy, LLC**(w.e.f.May14,2015)


50 Solution Provider Academy,LLC**(w.e.f.May14,2015)


51 Revenue Cycle Academy, LLC**(w.e.f.May14,2015)


52 RevenueCycle360,LLC**(w.e.f.May14,2015)


*heldthroughPiramalHoldings(Suisse)SA ##heldthroughPiramalHoldings(Suisse)SAtillMarch22,2016;AfterMarch22,2016,heldthroughPiramalDutchHoldingsN.V. ###heldthroughPiramalHoldings(Suisse)SAtillDecember1,2015;AfterDecember1,2015,heldthroughPiramalDutchHoldingsN.V. **heldthroughPiramalDutchHoldingsN.V. $$heldthroughPiramalFundManagementPrivateLimited @heldthroughPiramalSystems&TechnologiesPrivateLimited

CSR(CorporateSocialResponsibilities)subsidiaries: PiramalUdgamDataManagementSolutions(Udgam)### PiramalFoundationforEducationalLeadership(PFEL)### PiramalSwasthyaManagementandResearchInstitute(formerlyknownas“HealthManagementandResearchInstitute”)(PSMRI) PiramalHealthcareFoundation###




TheseCSRcompanies(###)incorporatedundersection25oftheCompaniesAct,1956(Section8oftheCompaniesAct,2013),beinglimitedbyguarantee(nothavingsharecapital)andPSMRI(beingasociety)areengagedinCorporateSocialResponsibilityactivities.Basedonthecontrolassessmentcarriedoutbythecompany,thesameisnotconsolidatedasperIndAS110.

TheGroupundertookthefollowingcommoncontroltransactions.Thesetransactionshavenoimpactontheconsolidatedfinancialstatements.

March 2017 (a)PiramalHealthcareIncsolditsinvestmentinPiramalPharmaSolutionsInc.(erstwhileColdstreamLaboratoriesInc.)toPELPharmaInc.(b)PiramalHoldings(Suisse)SAsolditsinvestmentinPiramalCriticalCareItaliaS.P.AtoPiramalDutchHoldingsN.V.(c)DRGUKHoldcoLimitedsolditsinvestmentinDecisionResourcesGroupUKLimitedtoPEL-DRGDutchHoldcoB.V.(d)DR/MRGHoldings,LLCsolditsinvestmentinMilleniumResearchGroupInctoPEL-DRGDutchHoldcoB.V.(e)PiramalDutchHoldingsN.V.solditsinvestmentinPEL-DRGDutchHoldcoB.V.toPiramalDutchIMHoldcoB.V.

March 2016 (a)PiramalHealthcareInc.distributeddividendsbywayoftransferofits90%holdinginDRGHoldcoInctoPiramalDutchHoldingsN.V.(b)PiramalHoldings(Suisse)SAsolditsinvestmentsinPiramalHealthcareUKLimited,PiramalHealthcare(Canada)LimitedandPiramalCriticalCareDeutschlandGmbHtoPiramalDutchHoldingsN.V. (c)PiramalHealthcare(Canada)LimitedsolditsinvestmentinPiramalCriticalCareLimited[formerlyknownasPiramalLifeSciences(UK)Limited]toPiramalDutchHoldingsN.V.

(b) Interest in Joint Ventures / Joint operations

Principal place of business

Carrying Amount (` In Crores) % of ownership interest Sr. No. Name of the Company March 31 2017 March 31 2016 April 1 2015

1 ConvergenceChemicalsPrivateLimited(Jointventure) India 34.74 35.06 30.30 51% 2 Shrilekha Business Consultancy Private Limited (Joint venture)

(incorporated on January 9, 2017) (was partneship firm ShrilekhaFinancialServicesuptoJanuary8,2017)

India 2,557.42 - - 74.95%

3 ShrilekhaFinancialServices(includesshareofassetsinShriramCapitalLimited)(Jointoperation)

India - 2,419.73 2,302.81 74.95%

Theabove investments in jointventuresareaccounted forusingEquityMethod.Theseare unlisted investmentsandhencequotedpricesarenotavailable.

Significant judgement: classification of joint venture Convergence Chemicals Private Limited ConvergenceChemicalsPrivateLimitedisajointventuresetuptodevelop,manufactureandsellspecialityfluorochemicals.TheCompanyhasnotcommencedmanufacturingactivitiesasobtainingrequisiteregulatoryapprovalsandlicensesisunderwayandislikelytobecompletedduringthenextfinancialyear. TheGroupowns51%equitysharesofConvergenceChemicalsPrivateLimited.ThecontractualarrangementstatesthatPELandtheothershareholdershallnominatetwodirectorseachtotheboardandforanymeetingoftheboardthequorumshallbetwodirectorsprovidedthatonedirectorfromeachpartyispresent.ThisgivesboththepartiesajointcontroloverConvergenceChemicalsPrivateLimited.ConvergenceChemicalsPrivateLimitedisaPrivateLimitedCompanywhoselegalformconfersseparationbetweenthepartiestothejointarrangementandtheCompanyitself.Accordingly,thelegalformofConvergenceChemicalsPrivateLimitedandthetermsofthecontractualarrangementindicatethatthearrangementisaJointVenture. Accordingly,siginificantfinancialinformationforConvergenceChemicalsPrivateLimitedhasbeenprovidedbelowfromthedatethejointarrangementisaccountedasaJointventure.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

317


Shrilekha Business Consultancy Private Limited (Earlier known as Shrilekha Financial Services) ThejointventureagreementinrelationtoShrilekhaFinancialServices(PartnershipFirm)requiredunanimousconsentfromallpartiesforallrelevantactivities.TheGrouphasa74.95%interestinajointoperationcalledShrilekhaFinancialServiceswhichwassetupasapartnershiptogetherwithShriramOwnershipTrusttoinvestinShriramCapitalLimited.ShrilekhaFinancialServicesholds26.68%inShriramCapitalLimited.ThiswasapartnershipfirmtillJanuary8,2017,wherethepartnershaddirectrightstotheassetsofthepartnershipandwerejointlyandseverallyliablefortheliabilitiesincurredbythepartnership.Accordingly,thisjointarrangementwastreatedasaJointOperation.TheGrouprecogniseditsshareofinvestmentinShriramCapitalLimited,whichwasshownunderInvestmentinAssociates.

Thispartnershipfirmwas converted intoaPrivate LimitedCompany,whereby theunanimous consentof theGroupand theother shareholder isrequiredforfundamental issues.Sincethereisseparationofthelegalformofthestructure,thejointarrangement isaccountedasaJointventure. InvestmentinShrilekhaBusinessConsultancyPrivateLimitedhasbeenshownundertheheadInvestmentinJointVenture,unlikeasdisclosedinearlieryears. SiginificantfinancialinformationforShrilekhaBusinessConsultancyPrivateLimitedhasbeenprovidedbelowfromthedatethejointarrangementisaccountedasaJointventure.Significant financial information for joint ventures Convergence Chemicals Private LimitedSummarised Balance sheet

(`inCrores)Particulars March 31, 2017 March 31, 2016 April 1, 2015Currentassets 13.92 0.51 0.72Non-currentassets 168.38 148.06 92.93Currentliabilities (33.69) (27.51) (2.24)Non-currentliabilities (80.49) (52.32) (32.00)Net Assets 68.12 68.74 59.41The above amounts of assets and liabilities include the following:Cashandcashequivalents 13.56 0.41 0.72Currentfinancialliabilities(excludingtradeandotherpayablesandprovisions) (25.64) (24.56) -Non-currentfinancialliabilities(excludingtradeandotherpayablesandprovisions) (80.46) (52.32) (32.00)

Summarised statement of profit and loss

(`inCrores)Particulars March 31, 2017 March 31, 2016Revenue - - Interestincome - - Depreciationandamortisation - - Interestexpense - - Incometaxexpense (0.01) - Profit for the year (0.62) (0.67)Othercomprehensiveincome - - Total comprehensive income (0.62) (0.67)Dividendsreceived - -




Reconciliation to carrying amounts(ìnCrores)

Particulars March 31, 2017 March 31, 2016Opening net assets 68.74 59.41Profitfortheyear (0.62) (0.67)Othercomprehensiveincome - - Dividends paid - - CapitalContribution - 10.00Closing net assets 68.12 68.74Group'ssharein% 51% 51%Proportion of the Group’s ownership interest 34.74 35.06Carryingamount 34.74 35.06

Commitments(ìnCrores)

Convergence Chemicals Private LimitedParticulars March 31, 2017 March 31, 2016 April 1, 2015Shareofjointventure'scommitments-Estimatedamountofcontractsremainingtobeexecutedoncapitalaccountandnotprovidedfor

0.01 - -

TOTAL COMMITMENTS 0.01 - -

Shrilekha Business Consultancy Private LimitedSummarised Balance sheet

(ìnCrores)Shrilekha Business Consultancy Private Limited

Particulars March 31, 2017Currentassets 8.12 Non-currentassets 2,661.29 Currentliabilities (0.06)Net Assets 2,669.35 The above amounts of assets and liabilities include the following:Cashandcashequivalents 0.11 Currentfinancialliabilities(excludingtradeandotherpayablesandprovisions) (0.06)

Summarised statement of profit and loss(ìnCrores)

Shrilekha Business Consultancy Private LimitedParticulars For the period January 9, 2017 to March 31, 2017Revenue - Interestincome - Depreciationandamortisation - Interestexpense - Incometaxexpense - Shareofprofitfromassociate 22.67 Profit for the year 22.67 Othercomprehensiveincome - Total comprehensive income 22.67 Dividendsreceived -

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

319


Reconciliation to carrying amounts(ìnCrores)

Shrilekha Business Consultancy Private LimitedParticulars March 31, 2017NetassetsasonMarch31,2017 2,669.35 Closing net assets 2,669.35 Group'ssharein% 74.95%ProportionoftheGroup’sownershipinterest 2,000.68 Goodwill 556.74 UnpaidDividendandDividenddistributiontaxthereon - Carrying amount 2,557.42

Shrilekha Financial Services (partnership firm accounted as a Joint operation) Summarised Balance sheet

(ìnCrores)Shrilekha Financial Services

Particulars March 31, 2016 April 1, 2015Currentassets 0.55 0.91Non-currentassets 2,485.18 2,328.80Currentliabilities (0.08) (0.06)Net Assets 2,485.65 2,329.65The above amounts of assets and liabilities include the following:Cashandcashequivalents 0.55 0.82Currentfinancialliabilities(excludingtradeandotherpayablesandprovisions) (0.08) (0.06)

Summarised statement of profit and loss(ìnCrores)

Shrilekha Financial ServicesParticulars Period April 1 2016

to January 8, 2017March 31, 2016

Revenue - - Interestincome - - Depreciationandamortisation - - Interestexpense - - Incometaxexpense - - Shareofprofitfromassociate 172.12 204.12Profit for the year 172.06 204.11Othercomprehensiveincome - - Total comprehensive income 172.06 204.11Dividendsreceived 8.30 36.06




(c) Interest in Associates

Principal place of business

Carrying Amount (` In Crores) % of ownership interest Sr. No. Name of the Company March 31 2017 March 31 2016 April 1 2015

1 AllerganIndiaPrivateLimited India 106.00 97.57 61.76 49%

AllerganIndiaPrivateLimitedismainlyengagedintradingofopthalmicproducts.

Allergan India Private Limited Significant judgement: classification of associate TheGroupowns49%equitysharesofAllerganIndiaPrivateLimited.AsperthetermsofthecontractualagreementwithAllerganPharmaceuticals(Ireland)Limited,thecompanybyvirtueofitsshareholdingneitherhasthepowertodirecttherelvantactivitiesofthecompany,norhastherighttoappointmajorityoftheDirectors.Thecompanyonlyhasarighttoparticipateinthepolicymakingprocesses.AccordinglyAllerganIndiaPrivateLimitedhasbeenconsideredasanAssociate.

Significant financial information for associateSummarised Balance sheet

(`inCrores)

Allergan India Private LimitedParticulars March 31, 2017 March 31, 2016 April 1, 2015Currentassets 225.83 228.86 146.97Non-currentassets 28.10 13.90 19.55Currentliabilities (46.01) (91.78) (40.48)Non-currentliabilities - - - Net Assets 207.92 150.98 126.04

Summarised statement of profit and loss

(`inCrores)

Allergan India Private LimitedParticulars March 31, 2017 March 31, 2016Revenue 329.11 337.34Profitfortheyear 57.38 70.16Othercomprehensiveincome (0.17) - Totalcomprehensiveincome 57.20 70.16Dividendsreceived 19.60 -

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

321


Reconciliation to carrying amounts

(ìnCrores)

Allergan India Private LimitedParticulars March 31, 2017 March 31, 2016Opening net assets 150.98 126.04Profitfortheyear 57.38 70.16Othercomprehensiveincome (0.17) - Shareoptionsoutstanding (0.27) 2.92Dividendandtaxthereon - (48.14)Closing net assets 207.92 150.98Group'ssharein% 49% 49%ProportionoftheGroup’sownershipinterest 101.88 73.98Dividendsreceivedsubsequently - 23.59Others 4.11 - Carrying Amount 106.00 97.57

Contingent liabilities

(ìnCrores)

Allergan India Private LimitedParticulars March 31, 2017 March 31, 2016 April 1, 2015Shareofassociate'scontingentliabilities-Claimsagainstthecompanynotacknowledgedasdebt 1.43 1.43 - -Disputeddemandsforincometax,salestaxandservicetaxmatters 11.15 12.29 10.31

TOTAL CONTINGENT LIABILITIES 12.58 13.72 10.31

(d) Individually immaterial associates Thegrouphasinterestsinthefollowingindividuallyimmaterialassociatesthatareaccountedforusingtheequitymethod:

Sr. No. Name of the Company Principal place of business

% of ownership interest

1 PiramalPhytocareLimited(PPL) India 17.53%2 BluebirdAeroSystemsLimited Israel 27.83%3 ContextMattersInc(w.e.fSeptember22,2016) U.S.A 22.73%

(ìnCrores)Particulars March 31, 2017 March 31, 2016Aggregatecarryingamountofindividuallyimmaterialassociates 54.37 45.17Aggregateamountsofthegroup’sshareof:Profit/(loss)fromcontinuingoperations (3.89) 5.48Othercomprehensiveincome - - Total comprehensive income (3.89) 5.48




Significant judgement: classification of associate Thegrouphas17.53%shareholdinginPPL.ThegrouphastheabilitytoappointdirectorsontheBoardofPPLgivingitthepowertoparticipateinthefinancialandoperatingpolicydecisions.ThusthegrouphassignificantinfluenceoverPPLmakingitanassociate.

(e) Share of profits from Associates and Joint Venture

(`inCrores)Particulars March 31 2017 March 31 2016ShareofprofitsfromJointVentures 16.68 (0.34)ShareofprofitsfromAssociates 153.22 194.55Total share of profits from Associates and Joint Venture 169.90 194.21

40 BUSINESS COMBINATIONSA. Summary of acquisitions during the current year(i) Acquisition of Ash Stevens OnAugust31,2016,theGroupthroughitssubsidiary,PELPharmaInc.acquired100%ofissuedandoutstandingmembershipinterestsinAsh

StevensLLC,formerlyknownasAshStevensInc.AshStevensisafull-servicepharmaceuticalcontractmanufacturer(CMO)withoverfivedecadesofexperiencedevelopingdrugsubstancesandmanufacturingactivepharmaceuticalingredients(APIs).Italsoprovidesresearchanddevelopmentservicestovariousdrugmanufacturersincludinggovernmentagencies. TheacquisitionisexpectedtobesynergeticwiththeGroup’santibodydrugconjugatesandinjectiblebusinessandexpanditspresenceinNorthAmerica.

(a) Detailsofpurchaseconsideration

Ash StevensParticulars USD in Million ` In CroresCash paid 44.8 300.34Total Purchase Consideration 44.8 300.34

(b) Theassetsandliabilitiesrecognisedasaresultoftheacquisitionareasfollows:

Particulars USD in Million ` In CroresAssetsAccountsreceivable,net 2.1 14.12 Cashandcashequivalents 1.1 7.33Inventories 1.2 7.87Contractsinprocess 1.6 10.50Prepaidexpenses 0.9 6.10PropertyPlantandEquipment 18.6 124.74ComputerSoftware 0.1 0.49Customerrelationship 6.8 45.46 Tradename 4.5 30.19

TOTAL ASSETS 36.9 246.80Liabilities Tradepayable 0.5 3.51 Advancefromcustomers 1.9 12.51 Accruedexpenses 0.3 2.13 Securitydeposit 0.1 0.34

TOTAL LIABILITIES 2.8 18.49Net identificable assets acquired 34.1 228.31

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

323


Theinitialaccountingforbusinesscombinationisincompleteforthefairvaluationofproperty,plantandequipmentandhencetheamountreportedisprovisional.

(c) Calculationofgoodwill

Particulars USD in Million ` In CroresConsiderationtransferred 44.8 300.34Less:Netidentifiableassetsacquired 34.1 228.31Goodwill 10.7 72.03

Thegoodwillisattributabletotheworkforceandtheexpectedhighprofitabilityoftheacquiredbusiness.

Goodwillisfullydeductiblefortaxpurposesoveraperiodof15years.

(d) AcquiredReceivables

Particulars USD in Million ` In CroresFairvalueofacquiredtradereceivables 2.1 14.12 Grosscontractualamountfortradereceivables 2.1 14.22 Contractualcashflowsnotexpectedtobecollected * 0.10

*belowroundingoffnormsadoptedbytheGroup

(e) Revenueandprofitcontribution TheAshStevensbusinesscontributedrevenuesandprofitstothegroupfortheperiodMarch312017asfollows:

Particulars USD in Million ` In CroresRevenue 11.7 78.66Profit/(loss)beforetax (0.4) (2.42)

(f) AcquisitioncostschargedtoP&L Acquisitioncostsof` 5.50Crores(USD0.8million)werechargedtoconsolidatedstatementofprofitandlossundertheheadOtherExpenses.

(g) Purchaseconsideration-cashoutflow

Particulars USD in Million ` In CroresOutflowofcashtoacquiresubsidiary,netofcashacquiredCashconsideration 44.8 300.34Less:BalancesacquiredCashandcashequivalents 1.1 7.33Net outflow of cash - investing activities 43.7 293.01

(ii) Purchase of intrathecal spasticity and pain management business from Mallinckrodt LLC TheGroupthroughitssubsidiary,PiramalCriticalCareLimited,hasenteredintoanagreementtoacquireaportfolioofintrathecalspasticityand

painmanagementdrugsfromMallinckrodtLLCinanallcashdealonJanuary30,2017foraconsiderationof` 1,164.17crores(USD171Million).ThistransactionwasconsummatedonMarch20,2017.Thistransactionisastepfurthertoexpandthegroup’spresenceinglobalgenerichospitaldrugmarket.Oftheaboveconsideration,`114.02crores(USD17million)waspaidupfrontandthebalance`998.72crores(USD154Million)ispayableinFebruary2018.Apartfromtheaboveconsideration,`4.49crores(USD0.67Million)waspaidforfinalinventoryadjustments.




ThetransactionisaccountedforasabusinesscombinationasperIndAS103,Businesscombinations.Theinitialaccountingforbusinesscombinationisincompleteasthetransactionwasconsummatedneartotheyearendandthemeasurementperiodofoneyearisnotover.Outofthetotalamountof`118.51crores(USD17.67Million)paid,`19.85crores(USD2.95Million)isaccountedforunderinventoriesandthebalanceamountpaidisaccountedunderintangibleassetsprovisionally.Thiswillbeallocatedtotheidentifiableintangiblesoverthemeasurementperiod.

Theagreementalsoprovidesforanadditional`207.53crores(USD32Million)payabledependingonachievementofcertainfinancialmilestonesbytheacquiredbusinessoverthenext3years.

Thefairvalueofcontingentconsiderationof`103.76crores(USD16Million)wasestimatedbyallocatingprobabilitytotheachievementofthefinancialmilestones.Theestimatesarebasedondiscountrateof10.31%.

Acquisitioncostsof`22.02crores(USD3.3Million)werechargedtoconsolidatedstatementofprofitandlossundertheheadOtherExpenses.

(iii) Acquisition of majority stake in Searchlight Health Private Limited Duringthepreviousyear,pursuanttoInvestmentAgreement,theCompanyhadinvested` 1.07lakhsforaminoritystakeinSearchlightHealth

Private Limited, a healthcare analytics company. The company had committed to invest an additional amount of ` 44.20 crores subject toachievementofcertainmilestonesbySearchlightHealthPrivateLimited.

Duringthecurrentyear,uponthesecondtrancheofinvestment,theCompanyhaswaivedoffcertainclosingconditionsandconditionsprecedentundertheInvestmentAgreementbywhichithasraisedthestakeinSearchlightHealthPrivateLimitedto51%onafullydilutedbasis.


Particulars ` In CroresCashpaidinthepreviousyear 1.07Cashpaidinthecurrentyear 31.40

TOTAL PURCHASE CONSIDERATION 32.47

(b) TheassetsandliabilitiesasatDecember23,2016recognisedasaresultoftheacquisitionareasfollows:

Particulars ` In CroresAssetsTradereceivables 0.51Cashandcashequivalents 31.45PropertyPlantandEquipment 0.14OtherNoncurrentfinancialassets 0.19OtherNoncurrentassets 0.32Othercurrentassets 0.15

TOTAL ASSETS 32.76Liabilities Noncurrentprovisions 0.02CurrentBorrowings 3.20TradePayables 1.39Othercurrentliabilities 0.60

TOTAL LIABILITIES 5.21 Net identificable assets acquired 27.55Company’s stake 14.05

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

325


(c) Calculationofgoodwill

Particulars ` In CroresConsiderationtransferred 32.47Less:Netidentifiableassetsacquired 14.05Goodwill 18.42

Goodwillisnotdeductibleforincometaxpurposes.

FairvalueofNon-controllinginterestsasontheacquisitiondateis`13.50crores.Thisismeasuredatthenoncontrollinginterest’sproportionateshareoftheSearchlightHealthPrivateLimited’snetidentifiableassets.

Theinitialaccountingforbusinesscombinationisincompleteasthetransactionwasconsummatedneartotheyearendandthemeasurementperiodofoneyearisnotover.Postacquisition,thisbusinesscontributed`1.19croresinrevenueandalossof`0.60crorestothegroup. Thepro-formaeffectsoftheaboveacquisitionontheGroup’sresultswerenotmaterial.

(d) Purchaseconsideration-cashoutflow

Particulars ` In CroresOutflowofcashtoacquiresubsidiary,netofcashacquiredCashconsideration 32.47Less:BalancesacquiredCashandcashequivalents 31.45 Net outflow of cash - investing activities 1.02

B. Summary of acquisitions during the previous year Healthcare Business Insights Inc. (HBI) OnMay14,2015,theGroupthroughitssubsidiary,DecisionResourcesInc.acquired100%ofissuedandoutstandingmembershipinterestsinHBI,

trustedproviderofbestpracticeresearch,trainingandservicestomorethan1,400hospitalsacrosstheU.S.ThisacquisitionwillenablethegrouptoenterintotheproviderspaceintheUnitedStatesofAmerica.

Adaptive Software, LLC and AdaptiveRX LLC (Adaptive) OnFebruary19,2016,theGroupthrough itssubsidiary,DR/DecisionResourcesLLCacquiredtheassetsofAdaptiveSoftwareLLCandentire

controlandownershipof itswhollyownedsubsidiary,AdaptiveRxLLC.AdaptiveSoftwareLLCisengagedinthebusinessofprovidingbusinessprocessmanagementsolutionstothepharmacybenefitmanagementandhealthinsuranceindustry.ThisacquisitionenablestheGroupadirectentryintothehealthcarepayerecosystem.


Particulars HBI AdaptiveUSD in Million ` In Crores USD in Million ` In Crores

Cash paid 30.0 191.87 7.3 50.03Deferredconsideration - - 11.1 75.92ContingentConsideration 2.1 13.54 5.4 37.14Total Purchase Consideration 32.1 205.41 23.8 163.09




(b) Theassetsandliabilitiesrecognisedasaresultoftheacquisitionareasfollows:

Particulars HBI AdaptiveUSD in Million ` In Crores USD in Million ` In CroresFairvalue Fairvalue Fairvalue Fairvalue

AssetsBuilding 0.1 0.67 - - Plant&Equipment 0.1 0.92 - - Furniture&fixtures 0.0 0.13 0.0 0.08Intangibleassets-CustomerRelations 7.5 47.84 6.4 44.00Intangible assets - Developed Technology - - 0.4 2.76Intangibleassets-Trademarks 3.4 21.70 0.3 2.20Intangibleassets-ComputerSoftware 0.1 0.40 - - Intangibleassets-FavorableLease 0.2 1.30 - - Tradereceivables 2.3 14.77 0.4 2.75Cashandcashequivalents 0.2 1.53 - - Othercurrentfinancialassets - - 0.0 0.02Othercurrentassets 0.1 0.32 - -

TOTAL ASSETS 14.0 89.58 7.5 51.81Liabilities Tradepayable 0.3 1.73 - - Deferredrevenue 3.4 22.00 1.1 7.33Accruedliabilties 0.3 1.84 - -

TOTAL LIABILITIES 4.0 25.57 1.1 7.33Net identifiable assets acquired 10.0 64.01 6.4 44.48

(c) Calculationofgoodwill:


Considerationtransferred 32.1 205.41 23.8 163.09Less:Netidentifiableassetsacquired 10.0 64.01 6.4 44.48Goodwill 22.1 141.40 17.4 118.61

Thegoodwillisattributabletotheworkforceandthehighprofitabilityoftheacquiredbusiness.

Goodwillisfullydeductiblefortaxpurposesoveraperiodof15years.

(d) Significantestimate:contingentconsideration (i) HBI In theevent that certainpre-determinedAcademyRevenueandCompanyRevenue targets are achievedbyHBI for the calendar yearended

December31,2015,additionalconsiderationofupto`130.91crores(USD20Million)maybepayableincashbyNovember16,2016.

Thefairvalueofthecontingentconsiderationof`13.75crores(USD2.1Million)wasestimatedbycalculatingthepresentvalueofprobabilityweighedearnoutpaymentsbasedonadiscountrateof15.78%incaseofHBI.Asthetargetswerenotmet,thecontingentconsiderationwaswrittenbacktoconsolidatedstatementofprofitandlossfortheyearendedMarch31,2016undertheheadOtherexpenses.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

327


(ii) Adaptive Contingentconsiderationupto`39.76crores(USD6Million)ispayableiftheeligiblesalesrevenuetargetsaremetincaseofAdaptiveovera

periodoftwoyears.Thefairvalueofthecontingentconsiderationof`35.98crores(USD5.4Million)wasestimatedbycalculatingtheweightageaverageprobableearnings.

AsatMarch31,2017,lossonremeasurementofcontingentconsiderationof`2.05croreshasbeenchargedofftotheconsolidatedstatementofprofitandlossundertheheadOtherExpenses.

(e) AcquiredReceivables


Fairvalueofacquiredtradereceivables 2.3 14.77 0.4 2.75Grosscontractualamountfortradereceivables 2.4 15.14 0.4 2.75Contractualcashflowsnotexpectedtobecollected 0.1 0.36 - -

(f) RevenueandprofitcontributionTheHBIbusinesscontributedrevenuesandprofitstothegroupfortheperiodMarch312016asfollows:

Particulars USD in Million ` In CroresRevenue 9.1 59.55Profitbeforetax 2.7 17.40

SincetheacquisitionofAdaptiveoccurredonFebruary29,2016,theimpactonGroup’srevenueandprofitisnotmaterial.

Thepro-formaeffectsofbothoftheaboveacquisitionsontheGroup’sresultswerenotmaterial.

(g) AcquisitioncostschargedtoP&L Acquisitioncostsof`2.28Crores(USD0.3million)and`2.25Crores(USD0.3million)werechargedtoconsolidatedstatementofprofitandloss

fortheyearendedMarch31,2016inrelationtotheacquisitionofHBIandAdaptiverespectivelyundertheheadOtherexpenses.

(h) Purchaseconsideration-cashoutflow


Outflowofcashtoacquiresubsidiaries,netofcashacquiredCashconsideration 30.0 191.87 7.3 50.03Less:BalancesacquiredCashandcashequivalents 0.2 1.53 - - Net outflow of cash - investing activities 29.8 190.34 7.3 50.03




41 GOODWILL MovementinGoodwillonConsolidationduringtheyear:

`incroresParticulars As at

March 31, 2017As at

March 31, 2016

Opening balance 5,485.38 4,943.69Add:Additionsduringtheyear 90.45 261.30Add:Currencytranslationdifferences (148.64) 280.39Closing balance 5,427.19 5,485.38

Asegmentlevelsummaryofthegoodwillallocationispresentedbelow: :

`incroresParticulars As at

March 31, 2017As at

March 31, 2016As at

April 1, 2015

InformationManagement 4,541.09 4,646.08 4,145.32Pharmaceuticalsmanufacturingandservices 645.49 595.53 563.01FinancialServices 240.61 243.77 235.36

TOTAL 5,427.19 5,485.38 4,943.69

GoodwillistestedforimpairmentatleastannuallyinaccordancewiththeGroup’sprocedurefordeterminingtherecoverablevalueofsuchassets.

TherecoverableamountoftheInformationmanagementsegmentisdeterminedonthebasisofFairValueLessCostToSell(FVLCTS).TheFVLCTSisdeterminedbasedonthemarketcapitalizationapproach,usingtheenterprisevaluetoearningsbeforeinterest,tax,depreciationandamortisationmultiplesderivedfromobservablemarketdata.Thefairvaluemeasurementiscategorizedasalevel2fairvaluebasedontheinputsinthevaluationtechniquesused.

The carrying value of goodwill for the pharmaceutical manufacturing and services (arising from various acquisitions across the globe) andfinancial services are not relatively significant. The recoverable value of these segments were determined using value-in-use (VIU). TheVIU is based on internal forecasts, considering the current economic conditions, growth rates and anticipated future economic conditions. Appropriategrowthratesareusedtoextrapolatecashflowsbeyondthebudgetperiod.Theratesareconsistentwithforecastsincludedinindustryreports. Discountratesusedare in therangeof7%to16%whichreflectspecificrisksrelatingtotherelevantsegmentsandthecountries inwhichtheyoperate.

Basedontheabove,noimpairmentwasidentifiedasofMarch31,2017,March31,2016andApril1,2015astherecoverablevalueofthesegmentsexceededthecarryingvalues.

Themanagementbelievesthatanypossiblechangesinthekeyassumptionswouldnotcausethecarryingamounttoexceedtherecoverableamountofcashgeneratingunit.

42 EMPLOYEE BENEFITS : Brief description of the Plans: Other Long Term Employee Benefit Obligations Leave Encashment, which are expected to be availed or encashed beyond 12 months from the end of the year are treated as

other long term employee benefits. The Group’s liability is actuarially determined (using the Projected Unit Credit method) atthe end of each year. Actuarial losses/ gains are recognised in the Statement of Profit and Loss in the year in which they arise. LongTermServiceAwardsarerecognisedasaliabilityatthepresentvalueofthedefinedbenefitobligationasatthebalancesheetdate.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

329


Defined Contribution plans TheGroup’sdefinedcontributionplansareProvidentFund (incaseof certainemployees),Superannuation,OverseasSocial SecurityPlans,

EmployeesStateInsuranceFundandEmployees’PensionScheme(undertheprovisionsoftheEmployees’ProvidentFundsandMiscellaneousProvisions Act, 1952) and 401(k) plan contribution (in case of US subsidiaries). The Group has no further obligation beyondmaking thecontributionstosuchplans.

Post-employment benefit plans: GratuityforemployeesinIndiaispaidasperthePaymentofGratuityAct,1972.Employeeswhoareincontinuousserviceforaperiodof5

yearsareeligibleforgratuity.Theamountofgratuitypayableonretirement/terminationistheemployeeslastdrawnbasicsalarypermonthcomputedproportionatelyforthenumberofyearsofservice.TheGrouphasbothfundedandnonfundedplansandmakescontributionstorecognisedfundsinIndiaincaseoffundedplans.TheGroup’sGratuityPlanisadministeredbyaninsurerandtheInvestmentsaremadeinvariousschemesofthetrust.TheGroupfundstheplanonaperiodicalbasis.

Incaseofcertainemployees,theProvidentfundisadministeredthroughanin-housetrust.Periodiccontributionstothetrustareinvestedinvariousinstrumentsconsideringthereturn,maturity,safety,etc.,withintheoverallambitoftheProvidentFundTrustRulesandinvestmentpatternnotifiedthroughtheMinistryofLabourinvestmentguidelinesforexemptedprovidentfunds.

In case of a foreign subsidiary, the subsidiary sponsors a defined benefit retirement plan. The benefits are based on employees’ years ofexperienceandfinalremuneration.Theplanisfundedthroughaseparatetrustee-administeredfund.Thepensioncostforthemaindefinedplansisestablishedinaccordancewiththeadviceofindependentqualifiedactuary.

TheseplanstypicallyexposetheGrouptoactuarialriskssuchas:investmentrisk,interestraterisk,longevityriskandsalaryrisk.

Investment risk Thepresentvalueofthedefinedbenefitplanliability iscalculatedusingadiscountratewhichisdeterminedbyreferencetomarketyields

attheendofthereportingperiodongovernmentbonds.Planinvestmentisamixofinvestmentsingovernmentsecurities,andotherdebtinstruments.

Interest risk Adecreaseinthebondinterestratewillincreasetheplanliability;however,thiswillbepartiallyoffsetbyanincreaseinthereturnontheplan’s

debt investments.

Longevity risk Thepresentvalueofthedefinedbenefitplanliabilityiscalculatedbyreferencetothebestestimateofthemortalityofplanparticipantsboth

duringandaftertheiremployment.Anincreaseinthelifeexpectancyoftheplanparticipantswillincreasetheplan’sliability.

Salary risk Thepresentvalueofthedefinedbenefitplanliabilityiscalculatedbyreferencetothefuturesalariesofplanparticipants.Assuch,anincrease

inthesalaryoftheplanparticipantswillincreasetheplan’sliability.

TheGrouphasbothfundedandnonfundedplansandmakescontributionstorecognisedfundsinIndiaincaseoffundedplans.TheGroupdoesnotfullyfundtheliabilityandmaintainsatargetleveloffundingtobemaintainedoveraperiodoftimebasedonestimationsofexpectedgratuitypayments.Inrespectofcertainemployees,ProvidentFundcontributionsaremadetoaTrustadministeredbytheGroup.Thecontributionsmadetothetrustarerecognisedasplanassets.PlanassetsintheProvidentfundtrustaregovernedbylocalregulations,includinglimitsoncontributionsineachclassofinvestments.

TheGroupactivelymonitorshowthedurationandtheexpectedyieldoftheinvestmentsarematchingtheexpectedcashoutflowsarisingfromtheemployeebenefitobligations,withtheobjectivethatassetsofthegratuity/providentfundobligationsmatchthebenefitpaymentsastheyfalldue.Investmentsarewelldiversified,suchthatthefailureofanysingleinvestmentwouldnothaveamaterialimpactontheoveralllevelofassets.




A largeportionofassetsconsistsofgovernmentandcorporatebonds,althoughtheGroupalso invests inequities,cashandmutual funds.TheplanassetmixisincompliancewiththerequirementsoftheregulationsincaseofProvidentfund.Incaseofanoverseassubsidiary,thepensionplansarefundedthroughaseparatetrustee-administeredfund.Thesubsidiaryemploysabuildingblockapproachindeterminingthelongtermrateofreturnonpensionplanassets.Historicalmarketsarestudiedandassetswithhighervolatilityareassumedtogeneratehigherreturnsconsistentwithwidelyacceptedcapitalmarketprinciples.

I. Charge to the Statement of Profit and Loss based on Defined Contribution Plans:

` in CroresParticulars Year Ended

March 31, 2017 Year Ended

March 31, 2016

Employer’scontributiontoRegionalProvidentFundOffice 4.02 2.28Employer’scontributiontoSuperannuationFund 0.41 0.49Employer’scontributiontoEmployees’StateInsurance 0.61 0.35Employer’scontributiontoEmployees’PensionScheme1995 4.28 3.85ContributiontoPensionFund 38.05 43.72401(k)Plancontribution 30.26 14.36

IncludedinContributiontoProvidentandOtherFundsandR&DExpensesdisclosedunderOtherExpenses(ReferNote34and36)

II. Disclosures for defined benefit plans based on actuarial valuation reports as on March 31, 2017.A. ChangeinDefinedBenefitObligation

(`inCrores)(Funded) (Non-Funded)

Particulars Gratuity Pension Provident Fund GratuityYear Ended March 31, Year Ended March 31, Year Ended March 31, Year Ended March 31,

2017 2016 2017 2016 2017 2016 2017 2016Present Value of Defined Benefit Obligation as atbeginningoftheyear

39.30 35.08 501.07 511.50 151.69 133.56 3.62 2.62

InterestCost 3.09 2.79 13.83 19.40 12.92 10.61 0.28 0.20CurrentServiceCost 3.92 3.29 0.95 1.42 9.68 8.56 0.47 0.31PastServiceCost - - - - - - 0.08 -Contributionsfromplanparticipants - - - - 15.31 13.49 - - LiabilityTransferredInforemployeesjoined - - - - 5.56 7.07 - - LiabilityTransferredOutforemployeesleft - - - - (4.96) (7.72) - - Liabilityacquiredonacquisitionofasubsidiary 0.02 - - - - - - - BenefitsPaid (2.53) (3.78) (11.19) (17.49) (8.81) (13.88) (0.05) - Actuarial(Gains)/loss-duetochangeinDemographicAssumptions

- (0.92) - (31.29) - - 0.17 (0.01)

Actuarial (Gains)/loss - due to change in FinancialAssumptions

1.58 0.32 53.76 - - - 0.10 (0.01)

Actuarial(Gains)/loss-duetoexperienceadjustments 1.07 2.52 31.60 - - - 1.73 0.51ExchangeDifferencesonForeignPlans - - (82.56) 17.53 - - - - Present Value of Defined Benefit Obligation as at the end of the year

46.45 39.30 507.46 501.07 181.39 151.69 6.40 3.62

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

331


B. ChangesintheFairValueofPlanAssets



2017 2016 2017 2016 2017 2016 2017 2016FairValueofPlanAssetsasatbeginningoftheyear 28.30 25.58 627.59 610.85 151.69 133.56 - - InterestIncome 2.23 2.04 13.97 21.29 12.92 10.61 - - Contributionsfromemployer 0.96 5.00 1.24 7.17 9.68 8.56 - - Contributionsfromplanparticipants - - - 15.31 13.49 - - AssetsTransferredInforemployeesjoined 0.04 - - - 5.56 7.07 - - AssetsTransferredoutforemployeesleft - - - - (4.96) (7.72) - - Assetacquiredonacquisitionofasubsidiary 0.05 - - - - - - - BenefitsPaidfromthefund (2.53) (3.78) (11.19) (17.49) (8.81) (13.88) - - ReturnonPlanAssets,ExcludingInterestIncome 0.71 (0.54) 95.04 (14.15) - - ExchangeDifferencesonForeignPlans - - (102.41) 19.92 - - - - Fair Value of Plan Asset as at the end of the year 29.76 28.30 624.24 627.59 181.39 151.69 - -

C. AmountrecognisedintheBalanceSheet

(`inCrores)

(Funded) (Non-Funded)

Particulars Gratuity Pension Provident Fund Gratuity

Year Ended March 31, As at April 1, Year Ended March 31, As at April 1, Year Ended March 31, As at April 1, Year Ended March 31, As at April 1,

2017 2016 2015 2017 2016 2015 2017 2016 2015 2017 2016 2015

PresentValueofDefinedBenefit Obligation as attheendoftheyear

46.45 39.30 35.08 507.46 501.07 511.50 181.39 151.69 133.56 6.40 3.62 2.62

FairValueofPlanAssetsAsatendoftheyear

29.76 28.30 25.58 624.24 627.59 610.85 181.39 151.69 133.56 - - -

Funded Status - - - (116.78) (126.52) (99.35) - - - - -

Asset Ceiling - - - 110.87 118.87 95.51 - - - - -

Effect of currencytransalations

- - - 0.02 2.32 - - - - - -

Net Liability/(Asset) recognised in the Balance Sheet (Refer Notes 8, 20 and 26)

16.69 11.00 9.50 (5.89) (5.33) (3.84) - - - 6.40 3.62 2.62

Recognised under:

Non Current provision (Refer Note 20)

6.38 1.89 1.74 - - - - - - 5.71 2.99 2.26

Current provision (Refer Note 26)

10.31 9.11 7.76 - - - - - - 0.69 0.63 0.36

Other Non-current assets (Refer Note 8)

- - - (5.89) (5.33) (3.84) - - - - - -

TheProvidentFundhasasurplusthat isnotrecognisedonthebasisthatfutureeconomicbenefitsarenotavailabletotheGroupintheformofareductioninfuturecontributionsoracashrefundduetolocalregulations.

Surplusinpensionfundincaseofanoverseassubsidiaryisrecognisedtotheextent,futureeconomicbenefitsareavailabletotheGroupintheformofareductioninfuturecontibutions.

TheGrouphasnolegalobligationtosettlethedeficitinthefundedplan(Gratuity)withanimmediatecontributionoradditionaloneoffcontributions.TheGroupintendstocontinuetocontributethedefinedbenefitplansinlinewiththeactuary’slatestrecommendations.




D. ExpensesrecognisedinConsolidatedStatementofProfitandLoss



2017 2016 2017 2016 2017 2016 2017 2016CurrentServiceCost 3.92 3.29 0.95 1.42 9.68 8.56 0.47 0.31PastServiceCost - - - - - - 0.08 - NetinterestCost 0.86 0.75 (0.15) (1.89) - - 0.28 0.20Total Expenses / (Income) recognised in the Statement of Profit And Loss*

4.78 4.04 0.80 (0.47) 9.68 8.56 0.83 0.51

*Included in Salaries and Wages, Contribution to Provident and Other Funds, Gratuity Fund and Research and Development Expenses (ReferNote34and36)

E. ExpensesRecognizedintheOtherComprehensiveIncome(OCI)



2017 2016 2017 2016 2017 2016 2017 2016Actuarial(Gains)/LossesonObligationForthePeriod-Duetochangesindemographicassumptions

- (0.92) - - - - 0.17 (0.01)

Actuarial(Gains)/LossesonObligationForthePeriod-Duetochangesinfinancialassumptions

1.58 0.32 53.76 (31.29) - - 0.10 (0.01)

Actuarial(Gains)/LossesonObligationForthePeriod-Duetoexperienceadjustment

1.07 2.52 31.60 - - - 1.73 0.51

ReturnonPlanAssets,ExcludingInterestIncome (0.71) 0.54 (95.04) 14.15 - - - - Change in Asset Ceiling - - 8.64 23.36 - - - - Net (Income)/Expense For the Period Recognized in OCI 1.94 2.46 (1.04) 6.22 - - 2.00 0.49

F. SignificantActuarialAssumptions:

(Figuresin%)

(Funded) (Non-Funded)

Particulars Gratuity Pension Provident Fund Gratuity

As at March 31, As at March 31, As at March 31, As at March 31,

2017 2016 2015 2017 2016 2015 2017 2016 2015 2017 2016 2015

Discount Rate (perannum)

6.85-8.00 7.80 7.96 2.20 3.00 3.55 7.09 7.56 7.96 7.22 7.72 7.89

Salaryescalationrate 7.00-11.00 7.00 7.00 1.20 1.20 1.20 7.00 7.00 7.00 9.00 9.00 9.00

ExpectedRateofreturnon Plan Assets (perannum)

6.85-8.00 7.80 7.96 2.20 3.00 3.55 7.09 7.56 7.96 - - -

Theexpectedrateofreturnonplanassetsisbasedonmarketexpectationsatthebeginningoftheyear.Therateofreturnonlong-termgovernmentbondsistakenasreferenceforthispurpose.

Incaseofcertainemployees,theProvidentFundcontributionismadetoaTrustadministeredbytheGroup.IntermsoftheGuidancenoteissuedbytheInstituteofActuariesofIndia,theactuaryhasprovidedavaluationofProvidentfundliabilitybasedontheassumptionslistedaboveanddeterminedthatthereisnoshortfallattheendofeachreportingperiod.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

333


G. Movementsinthepresentvalueofnetdefinedbenefitobligationareasfollows:


Particulars Gratuity Pension GratuityAs at March 31, As at March 31, As at March 31,

2017 2016 2017 2016 2017 2016OpeningNetLiability/(asset) 11.00 9.50 (5.33) (3.84) 3.62 2.62 ExpensesRecognizedinStatementofProfitorLoss 4.78 4.04 0.80 (0.47) 0.83 0.51ExpensesRecognizedinOCI 1.94 2.46 (1.04) 6.22 2.00 0.49ExchangeFluctuation - - 0.92 (0.07) - - NetLiability/(Asset)TransferIn (0.04) - - - - - Net(Liability)/AssetTransferOut - - - - - - Netassetaddedonacquisitionofsubsidiary (0.03) - - - - -BenefitPaidDirectlybytheEmployer - - - - (0.05) - Employer'sContribution (0.96) (5.00) (1.24) (7.17) - - Net Liability/(Asset) Recognized in the Balance Sheet 16.69 11.00 (5.89) (5.33) 6.40 3.62

H. CategoryofAssets

(`inCrores)(Funded)

Particulars Gratuity Pension Provident FundAs at March 31, As at March 31, As at March 31,

2017 2016 2015 2017 2016 2015 2017 2016 2015GovernmentofIndiaAssets (Central&State)

12.97 15.32 11.43 - - - 73.84 56.75 48.27

PublicSectorUnitBonds - - - - - - 41.75 49.10 46.87DebtInstruments - - - 474.42 478.22 466.08 - - - CorporateBonds 11.19 10.26 11.41 - - - 33.90 15.88 9.50Fixed Deposits under Special DepositSchemesofCentralGovernment*

1.34 - - - - - 27.05 28.75 28.92

Insurancefund 0.63 - - - - - - - - Asset-BackedSecurities - - - - - - - - - StructuredDebt - - - - - - - - - EquitySharesofListedEntities 3.58 2.73 2.74 - - - 4.75 1.21 - GlobalEquities - - - 149.82 149.37 144.77 - - - Others 0.04 - - - - - 0.10 - -

TOTAL 29.76 28.30 25.58 624.24 627.59 610.85 181.39 151.69 133.56

*Exceptthis,alltheotherinvestmentsarequoted.




I. OtherDetails: Funded Gratuity

Particulars As at March 31, 2017


NoofActiveMembers 4,100 3,783PerMonthSalaryForActiveMembers 9.46 9.11AverageExpectedFutureService(Years) 7-9 years 8ProjectedBenefitObligation(PBO)(Ìncrores) 46.45 39.30Prescribed Contribution For Next Year (12 Months) (` In crores) 11.12 9.11

J. CashFlowProjection:FromtheFund:

(ìnCrores)Projected Benefits Payable in Future Years From the Date of Reporting Estimated for the year

ended March 31, 2018Estimated for the year ended March 31, 2017

1stFollowingYear 14.52 12.96 2ndFollowingYear 2.42 2.44 3rdFollowingYear 2.94 2.69 4thFollowingYear 3.11 3.39 5thFollowingYear 3.23 3.82 Sum of Years 6 To 10 17.66 27.22

TheGroup’sGratuityPlanisadministeredbyaninsurerandtheInvestmentsaremadeinvariousschemesofthetrust.TheGroupfundstheplanonaperiodicalbasis.

Incaseofcertainemployees,theProvidentfundisadministeredthroughanin-housetrust.Periodiccontributionstothetrustareinvestedinvariousinstrumentsconsideringthereturn,maturity,safety,etc.,withintheoverallambitoftheProvidentFundTrustRulesandinvestmentpatternnotifiedthroughtheMinistryofLabourinvestmentguidelinesforexemptedprovidentfunds.

Weightedaveragedurationofthedefinedbenefitobligationisintherangeof7-9years(Previousyear6years)

K. SensitivityAnalysis

(ìnCrores)Projected Benefits Payable in Future Years From the Date of Reporting

Gratuity - Funded Pension - Funded Gratuity - Non Funded As at

March 31, 2017As at

March 31, 2016As at

March 31, 2017As at

March 31, 2016As at

March 31, 2017As at

March 31, 2016

Impactof+1%ChangeinRateofDiscounting (2.34) (1.89) (39.43) (36.30) 6.39 (0.15)Impactof-1%ChangeinRateofDiscounting 2.65 2.13 51.05 46.51 (0.41) 0.16Impactof+1%ChangeinRateofSalaryIncrease 2.61 2.12 14.30 13.01 0.45 0.15Impactof-1%ChangeinRateofSalaryIncrease (2.35) (2.05) (11.04) (10.17) (0.40) (0.14)

Theabovesensitivityanalysesarebasedonchangeinanassumptionwhileholdingallotherassumptionsconstant.Inpractice,thisisunlikelytooccur,andchangesinsomeoftheassumptionsmaybecorrelated.Whencalculatingthesensitivityofthedefinedbenefitobligationtosignificantactuarialassumptions thesamemethod (presentvalueof thedefinedbenefitobligationcalculatedwith theprojectedunitcreditmethodat theendof thereportingperiod)hasbeenappliedaswhencalculatingthedefinedbenefitliabilityrecognisedinthebalancesheet.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

335


Theestimatesoffuturesalaryincreases,consideredinactuarialvaluation,takeaccountofinflation,seniority,promotionandotherrelevantfactors,suchassupplyanddemandintheemploymentmarket.

TheliabilityforLongtermServiceAwards(Non–Funded)asatyearendis 2.09crores(AsatMarch31,2016- 1.97crores,AsatApril1,2015-Previousyear`0.88Crores)

TheliabilityforLeaveEncashment(Non–Funded)asatyearendis`38.67Crores(Previousyear`30.03Crores,AsatApril1,2015-`25.28Crores)

43 Information in accordance with the requirements of Indian Accounting Standard 24 on Related Party Disclosures.1. List of related partiesA. Controlling Entities TheAjayG.PiramalFoundation@ PiramalLifeSciencesLimited-SeniorEmployeesStockOptionTrustthroughitsTrustee,Mr.AjayGPiramal@ The Sri Krishna Trust through its Trustees, Mr.Ajay Piramal and Dr.(Mrs.) Swati A. Piramal (Previously held through its CorporateTrustees,PiramalManagementServicesPrivateLimited)@ AasanInfoSolutions(India)PrivateLimited@ PiramalWelfareTrust(FormerlyknownasThePiramalEnterpriseExecutivesTrust)throughitsTrustee, PiramalCorporateServicesLimited@ PRLRealtorsLLP@

B. Subsidiaries - Refer Note 39 (a) for list of subsidiaries.

C. Other related parties EntitiescontrolledbyKeyManagementPersonnel AasanCorporateSolutionsPrivateLimited(FormerlyknownasAasanDevelopersand ConstructionsPrivateLimited)(DemergedfromPiramalEstates)(AasanDevelopers) GopikrishnaPiramalMemorialHospital(GPMH) PiramalCorporateServicesLimited(PCSL) PiramalEstatesPrivateLimited(PiramalEstates) PiramalGlassLimited(PGL) PiramalGlassUSAInc. PiramalRealtyPrivateLimited@ PiramalWaterPrivateLimited IndiaVentureAdvisorsPrivateLimited(IndiaVenture) PiramalForgingPrivateLimited(PiramalForging)@ PiramalSecurityPrivateLimited(PiramalSecurity)@ PiramalHospitalityPrivateLimited(PiramalHospitality)@ TopzoneMercantileCompanyLLP(Topzone)@ PRLDevelopersPrivateLimited(PRL) PRLAgastyaPrivateLimited TheSriHariTrust EmployeeBenefitTrusts

StaffProvidentFundofPiramalHealthcareLimited(PPFT) PiramalHealthcareLimitedEmployeesGroupGratuityAssuranceScheme @Therearenotransactionsduringtheyear.




D. Associates and its intermediatesShriramCapitalLimited ShriramTransportFinanceCompanyLimited(ShriramTransport)(w.e.f.July21,2015) ShriramCityUnionFinanceLimited(ShriramCityUnion)(w.e.f.July21,2015) ShriramLifeInsuranceCompanyLimited(ShriramLife)(w.e.f.July21,2015) ShriramGeneralInsuranceCompanyLimited(w.e.f.July21,2015)@ShriramCreditCompanyLimited(w.e.f.July21,2015)@BharatRe-insuranceBrokersPrivateLimited(w.e.f.July21,2015)@ShriramOverseasInvestmentPrivateLimited(w.e.f.July21,2015)@ShriramInvestmentsHoldingsLimited(w.e.f.July21,2015)@BluebirdAeroSystemsLimited@PiramalPhytocareLimited(PPL)AllerganIndiaPrivateLimited(Allergan)ContextMattersInc.(w.e.fSeptember22,2016)

E. Jointly controlled entities ConvergenceChemicalsPrivateLimited(Convergence) ShrilekhaFinancialServices(partnershipfirm)(uptoJanuary8,2017) ShrilekhaBusinessConsultancyPrivateLimited(w.e.f.January9,2017)@ NovusCloudSolutionsPrivateLimited(uptoApril1,2015)@ ZebraManagementServicesPrivateLimited(w.e.fApril1,2015)@

F. Key Management Personnel and their relatives Mr.AjayG.Piramal Dr.(Mrs.)SwatiA.Piramal Ms.NandiniPiramal Mr.VijayShah Mr.PeterDeYoung[husbandofMs.NandiniPiramal]

G. Non Executive/Independent Directors Dr.R.A.Mashelkar Mr.GautamBanerjee Mr.GoverdhanMehta Mr.N.Vaghul Mr.S.Ramadorai Mr.DeepakSatwalekar Mr.KekiDadiseth Mr.SiddharthNMehta @Therearenotransactionsduringtheyearwiththeabovecompanies

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

337


2. Details of transactions with related parties. (`inCrores)

Details of Transactions Jointly Controlled Entities

Associates & Intermediates

Other Related Parties

Total

2017 2016 2017 2016 2017 2016 2017 2016Purchase of Goods-PGL - - - - 4.70 4.12 4.70 4.12-PiramalGlassUSAInc. - - - - 4.91 8.54 4.91 8.54

TOTAL - - - - 9.61 12.66 9.61 12.66Sale of Goods-PiramalGlassUSAInc. - - - - 1.09 - 1.09 --Allergan - - 65.69 59.24 - - 65.69 59.24

TOTAL - - 65.69 59.24 1.09 - 66.78 59.24Amenities Charges-PiramalEstates - - - - - 1.52 - 1.52-AasanDevelopers - - - - 1.47 0.28 1.47 0.28

TOTAL - - - - 1.47 1.80 1.47 1.80Rendering of Services-Allergan - - 0.53 0.94 - - 0.53 0.94-Others - - - - - 0.01 - 0.01

TOTAL - - 0.53 0.94 - 0.01 0.53 0.95Royalty Expense- PCSL - - - - 21.75 30.00 21.75 30.00

TOTAL - - - - 21.75 30.00 21.75 30.00Rent Expense-GPMH - - - - 0.01 - 0.01 --PiramalEstates - - - - - 10.54 - 10.54-AasanDevelopers - - - - 15.80 2.00 15.80 2.00-Others - - - - 1.16 0.54 1.16 0.54

TOTAL - - - - 16.97 13.08 16.97 13.08Reimbursements of expenses recovered-PGL - - - - 1.65 - 1.65 --PiramalEstates - - - - - 0.36 - 0.36- PPL - - 0.05 0.12 - - 0.05 0.12-ConvergenceChemicalsPrivateLimited 0.19 - - - - - 0.19 -- PRL - - - - 0.22 - 0.22 --Others - - - - - 0.27 - 0.27

TOTAL 0.19 - 0.05 0.12 1.87 0.63 2.11 0.75Reimbursements of expenses paid-PiramalGlassUSAInc - - - - 0.18 1.06 0.18 1.06-GPMH - - - - - 1.52 - 1.52-AasanDevelopers - - - - 0.55 - 0.55 -

TOTAL - - - - 0.73 2.58 0.73 2.58Donation Paid-PiramalWaterPrivateLimited - - - - 0.02 - 0.02 -

TOTAL - - - - 0.02 - 0.02 -Purchase of Fixed Assets-PRLAgastyaPrivateLimited - - - - 408.03 - 408.03 -

TOTAL - - - - 408.03 - 408.03 -Security deposit placed - --AasanDevelopers - - - - 0.73 - 0.73 -

TOTAL - - - - 0.73 - 0.73 -




(`inCrores)Details of Transactions Jointly Controlled

EntitiesAssociates &

Intermediates Other Related

Parties Total

2017 2016 2017 2016 2017 2016 2017 2016Refund of Security Deposit-PiramalEstates - - - - - 0.22 - 0.22

TOTAL - - - - - 0.22 - 0.22Sale of Assets-Topzone - - - - - 70.00 - 70.00

TOTAL - - - - - 70.00 - 70.00Purchase of Securities-PiramalForging - - - - - 0.01 - 0.01-PiramalSecurity - - - - - * - *-PiramalHospitality - - - - - * - *

TOTAL - - - - - 0.01 - 0.01Dividend Income-ShriramCapital - - 8.30 36.06 - - 8.30 36.06-ShriramTransport - - 22.60 22.60 - - 22.60 22.60-ShriramCityUnion - - 9.87 10.20 - - 9.87 10.20-Allergan - - 19.60 - - - 19.60 -

TOTAL - - 60.37 68.86 - - 60.37 68.86*-BelowtheroundingoffthresholdappliedbytheGroup

Finance granted/(repayments)-Convergence 16.91 12.29 - - - - 16.91 12.29

TOTAL 16.91 12.29 - - - - 16.91 12.29

Loan Taken /(repayments) - Net-ShriramLife - - (5.00) 5.00 - - (5.00) 5.00

TOTAL - - (5.00) 5.00 - - (5.00) 5.00Interest received on loans/investments-Convergence 3.74 - - - - - 3.74 --Others - 0.02 - - - - - 0.02

TOTAL 3.74 0.02 - - - - 3.74 0.02Interest paid on loans-ShriramLife - - 0.21 0.02 - - 0.21 0.02

TOTAL - - 0.21 0.02 - - 0.21 0.02Sale of Investments-TheSriHariTrust - - - - 55.59 - 55.59 -

TOTAL - - - - 55.59 - 55.59 -Contribution to Funds- PPFT - - - - 24.98 29.06 24.98 29.06-PiramalHealthcareLimitedEmployeesGroup GratuityAssuranceScheme

- - - - - 5.00 - 5.00

TOTAL - - - - 24.98 34.06 24.98 34.06

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

339


Apart from the above, the Group has transacted with the following subsidiaries which have not been consolidated (Refer note 39 (a)):

(ìnCrores)Particulars 2017 2016Expenditure towards Corporate Social Responsibility activities- PFEL 20.89 18.76- PSMRI 9.14 12.71- Udgam 0.21 0.57

TOTAL 30.24 32.04Donation Paid- PFEL 1.50 - - PSMRI 7.49 0.52

TOTAL 8.99 0.52 Finance granted /(repayments) - Net (including loans and Equity contribution in cash or in kind) - PSMRI 1.50 -

TOTAL 1.50 - Interest Received on Loans/Investments - PSMRI 0.32 -

TOTAL 0.32 -

Allthetransactionsweremadeonnormalcommercialtermsandconditionsandatmarketrates.

Compensation of key managerial personnel Theremunerationofdirectorsandothermembersofkeymanagerialpersonnelduringtheyearwasasfollows:

(ìnCrores)Particulars 2017 2016Short-termemployeebenefits 19.93 17.41Post-employmentbenefits 3.26 2.78Otherlong-termbenefits 0.85 0.74Commissionandotherbenefitstonon-executive/independentdirectors 2.76 2.67

TOTAL 26.80 23.60

PaymentsmadetothedirectorsandothermembersofkeymanagerialpersonnelareapprovedbytheNomination&RemunerationCommittee

3. Balances of related parties.

(ìnCrores)Account Balances Jointly Controlled Entities Associates &

Intermediates Other Related Parties Total

2017 2016 2015 2017 2016 2015 2017 2016 2015 2017 2016 2015Trade Receivables-PGL - - - - - - - - 0.81 - - 0.81-PiramalGlassUSAInc - - - - - - 0.08 0.17 - 0.08 0.17 - -PiramalEstates - - - - - - 0.83 0.83 - 0.83 0.83 - -AasanDevelopers - - - - - - 1.30 0.56 - 1.30 0.56 - -Others - - - - - - - 0.05 0.01 - 0.05 0.01

TOTAL - - - - - - 2.21 1.61 0.82 2.21 1.61 0.82Advance from Customer-Allergan - - - - 2.87 - - - - - 2.87 -

TOTAL - - - - 2.87 - - - - - 2.87 - Consideration Receivable-Topzone - - - - - - - 70.00 - - 70.00 -

TOTAL - - - - - - - 70.00 - - 70.00 -




(`inCrores)Account Balances Jointly Controlled Entities Associates &

Intermediates Other Related Parties Total

2017 2016 2015 2017 2016 2015 2017 2016 2015 2017 2016 2015Loans from Related Parties-ShriramLife - - - - 5.00 - - - - - 5.00 -

TOTAL - - - - 5.00 - - - - - 5.00 - Long-Term Financial Assets-AasanDevelopers - - - - - - 7.28 7.28 - 7.28 7.28 - -PiramalEstates - - - - - - - - 7.78 - - 7.78-ConvergenceChemicalsPrivateLimited 24.10 7.19 - - - - - - - 24.10 7.19 -

TOTAL 24.10 7.19 - - - - 7.28 7.28 7.78 31.38 14.47 7.78Trade Payables-PiramalGlassUSAInc - - - - - - 0.38 0.21 0.09 0.38 0.21 0.09-PiramalEstates - - - - - - - - 0.56 - - 0.56-PGL - - - - - - 0.15 0.65 - 0.15 0.65 - - PCSL - - - - - - 3.71 11.45 12.65 3.71 11.45 12.65 -AasanDevelopers - - - - - - 0.30 - - 0.30 - - -Others - - - - - - - 0.07 0.01 - 0.07 0.01

TOTAL - - - - - - 4.54 12.38 13.31 4.54 12.38 13.31 Payable for Purchase of Assets-PRLAgastyaPrivateLimited - - - - - - 36.38 - - 36.38 - -

TOTAL - - - - - - 36.38 - - 36.38 - - Current Account balances with related parties- PCSL - - - - - - 0.03 - - 0.03 - - -PGL - - - - - - 1.71 - - 1.71 - - - PPL - - - 0.01 - - - - - 0.01 - - -Convergence 2.20 - - - - - - - - 2.20 - - - PRL - - - - - - 0.22 - - 0.22 - -

TOTAL 2.20 - - 0.01 - - 1.96 - - 4.17 - -

Apart from the above, the Group has balances outstanding with the following subsidiaries which have not been consolidated (Refer note 39 (a)):

`incroresLoans to related parties - Unsecured (at amortised cost) 2017 2016 2015- PSMRI 1.50 - -

TOTAL 1.50 - -

Alloutstandingbalancesareunsecuredandarerepayableincash

44 Property,Plant&Equipment,CapitalWorkInProgress,NonConvertibleDebentures,Loans,BrandsandTrademarks,InterCorporateDepositsandOtherFinancialAssetsamountingto` 13,693.18Crores(Ason31stMarch2016` 3,596.51Croresandason1stApril20151,694.22Crores)aremortgaged/hypothecatedasasecurityagainstlongtermsecuredborrowingsasatMarch31,2017.

InventoriesandTradereceivablesamounting`231.34Crores(Ason31stMarch2016` 332.83Croresandason1stApril2015211.53Crores)arehypothecatedasasecurityagainstshorttermsecuredborrowingsasatMarch31,2017.

45 The Group’s significant operating lease arrangements are mainly in respect of residential / office premises, computers, motor vehicles andvaporizers.Theaggregateleaserentalspayableontheseleasingarrangementsarechargedasrentunder“OtherExpenses”inNote36.

Theseleasearrangementsareforaperiodrangingfromoneyeartofifteenyearsandareinmostcasesrenewablebymutualconsent,onmutuallyagreeableterms.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

341


ìncroresPayable As at

March 31, 2017As at

March 31, 2016As at

April 1, 2015

NotLaterthanoneyear 68.35 72.25 77.35Laterthanoneyearbutnotlaterthanfiveyears 180.87 213.85 157.63Laterthanfiveyears 43.80 37.30 30.20

Rentexpenses,recognisedunderOtherExpenses(ReferNote36)pertainstominimumleasepaymentonly.

46 EarningsPerShare(EPS)-EPSiscalculatedbydividingtheprofitattributabletotheequityshareholdersbytheweightedaveragenumberofequitysharesoutstandingduringtheyear.Numbersusedforcalculatingbasicanddilutedearningsperequityshareareasstatedbelow:

ìncrores

For the Year Ended March 31, 2017

For the Year Ended March 31, 2016Particulars

1.ProfitattributabletoownersofPiramalEnterprisesLimited(ìnCrores) 1,252.33 904.742.WeightedNumberofShares(Nos.) 172,563,100 172,563,1003.Earnings/(Loss)pershare-BasicandDiluted(`) 72.6 52.4

4.Facevaluepershare(`) 2.00 2.00

47 (a) The Company conducts research and development to find new sustainable chemical routes for pharmaceutical& herbal products. ThecompanyisundertakingdevelopmentactivitiesforOralSolidsandSterileInjectables,apartfromotherActivePharmaceuticalIngredients. TheCompanyhasresearchanddevelopmentcentresinMumbai,EnnoreandAhmedabad.

DetailsofadditionstoPropertyPlant&Equipments&IntangiblesunderDevelopmentandqualifyingRevenueExpenditureforDepartmentofScientific&IndustrialResearch(DSIR)approvedresearchanddevelopmentfacilities/divisionoftheCompanyatMumbai,EnnoreandAhmedabad(witheffectfromSeptember23,2016)fortheyearareasfollows;

ìncrores

For the Year Ended March 31, 2017

For the Year Ended March 31, 2016Description

Revenue Expenditure 43.39 35.36 Capital Expenditure, NetAdditionstoPropertyPlant&Equipments 7.11 30.28AdditionstoIntangiblesunderDevelopment 11.55 - Less:SaleproceedsoftheassetsandTransferoftheAssets - 3.75Less:CreditfortransferofR&DassetsoutofR&Dcenter - 6.74

TOTAL 18.66 19.79

During the yearendedMarch31, 2015, theCompanyhaddecided to curtail investments inNewChemical Entity research.Accordingly,Costs andwrite-downsassociatedwiththescale-downincurredduringthepreviousyear,disclosedunderExceptionalIncome/(Expenses)(ReferNote37),arementionedbelow:

ìncrores

For the Year Ended March 31, 2016Description

(Gain)/LossonsaleofPropertyPlant&Equipment (2.56)TOTAL (2.56)




(b) TheGroup through its subsidiary Piramal Imaging SAhas invested in the followingmolecules: - FSPG - targeting ametabolic pathwaywhichbalancesoxidativestressincancerandprovidesanadditionalgrowthadvantageforavarietyoftumors.

-Bombesin-targetingaccurateandearlierdetectionofprostatecancerandimprovedstagingofthedisease -GP1-a18F-labeledPETtracerthatbindsspecificallytothekeyreceptorinvolvedinplateletaggregationandthrombiformation.

48 TheConsolidated results for theyearendedMarch31,2017 includes the results forPiramalCriticalCare ItaliaS.P.A,PiramalHoldings (Suisse)SA,PiramalTechnologiesSAandPiramalCriticalCareDeutschlandGmbHbasedonauditedaccountsuptotheirrespectivefinancialyearendingDecember31,2016andmanagementestimatespreparedbyrespectiveCompany’sManagementfortheinterimperiodendingMarch31,2017.TheresultsofPiramalDutchHoldingsN.V.,BluebirdAeroSystemsLimited,PiramalCriticalCareSouthAfrica(Pty)LtdandPiramalHealthcarePensionTrusteesLimitedarebasedonmanagementestimatesfortheyearendedMarch31,2017asauditedresultswereunavailable.ThepercentageofcombinedRevenuesfromoperationsfortheyearendedMarch31,2017foralltheabovecompaniestotheConsolidatedRevenueis0.34%.Thepercentageofcombinedprofit/(loss)fortheyearendedMarch31,2017foralltheabovecompaniestotheConsolidatedProfitandLossis(1.44)%.

49 CAPITAL MANAGEMENT TheGroupmanagesitscapitaltoensurethatitwillbeabletocontinueasgoingconcernwhilemaximisingthereturntostakeholdersthroughthe

optimisationofthedebtandequitybalance.ThecapitalstructureoftheGroupconsistsofnetdebt(borrowingsasdetailedinnotes18,23and24offsetbycashandbankbalances)andtotalequityoftheGroup.

TheGroupdeterminestheamountofcapitalrequiredonthebasisofannualaswellaslongtermoperatingplansandotherstrategicinvestmentplans.Thefundingrequirementsaremetthroughnonconvertibledebtsecuritiesorotherlong-term/short-termborrowings.TheGroupmonitorsthecapitalstructureonthebasisoftotaldebttoequityratioandmaturityprofileoftheoveralldebtportfoliooftheGroup.

ThecapitalcomponentsoftheGroupareasgivenbelow:

`incrores

As at March 31, 2017 March 31, 2016 April 1, 2015

Total Equity 14,895.78 12,948.47 13,425.60Borrowings-Current 12,079.48 6,828.93 2,796.54Borrowings-NonCurrent 14,495.69 7,474.00 3,687.27CurrentMaturitiesofLongTermDebt 3,875.81 1,975.86 702.53Total Debt 30,450.98 16,278.79 7,186.34Cash&Cashequivalents (1,490.44) (297.98) (278.71)Net Debt 28,960.54 15,980.81 6,907.63Debt/Equity Ratio 1.94 1.23 0.51

ThetermsoftheSecuredandunsecuredloansandborrowingscontaincertainfinancialcovenantsprimarilyrequiringtheCompanyandit’ssubsidiariestomaintaincertainfinancialratioslikeTotalDebttoTotalNetWorth,InterestCoverageRatio,FixedAssetCoverratio,Minimumnetworthconditions,etc.TheCompanyandit’ssubsidiariesarebroadlyincompliancewiththesaidcovenantsandbankshavegenerallywaived/condonedsuchcovenants.

50 RISK MANAGEMENT TheGroup’sactivitiesexposeittomarketrisk,liquidityriskandcreditrisk. The Group has an independent and dedicated Enterprise Risk Management (ERM) system to identify, manage and mitigate business risks.

BoardhasapprovedtheAssetLiabilityManagementPolicyandtheformationofAssetLiabilityManagementCommittee(ALCO).TheALCOincludestheGroup’s seniormanagement and an external industry expert. It defines the strategy formanaging liquidity and interest rate risks in thebusiness.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

343


Thisnoteexplainsthesourcesofriskwhichthegroupisexposedtoandhowthegroupmanagestheriskandtheimpactofhedgeaccountinginthefinancialstatements.

Risk Exposure arising from ManagementLiquidityrisk Borrowingsandotherliabilities ALCOdeliberatesonthestaticliquiditygapstatement,futureassetgrowthplans,tenorofassets,

marketliquidityandpricingofvarioussourcesoffunds.Itdecidesontheoptimalfundingmixtakingintoconsiderationtheassetstrategyandafocusondiversifyingsourcesoffunds.

Marketrisk-Interestrate Long-term borrowings atvariablerates

ALCO reviews the interest rate gap statement and themix of floating and fixed rate assets andliabilities.TheRiskManagementGrouphasalsoinitiatedascenarioanalysistoassesstheshort-termimpactofinterestratesonnetinterestincome(NII).

Market risk - Securities pricerisks

Sensitivityanalysis TheGroupcontinuetoeffectivelyevaluatevariousrisksinvolvedinunderlyingassets,beforeandaftermakinganysuchstrategicinvestments.

Marketrisk-Foreignexchange Sensitivityanalysis The centralised treasury function aggregates the foreign exchange exposure and takes prudentmeasurestohedgetheexposurebasedonprevalentmacroeconomicconditions.

Creditrisk Cashandcashequivalents,tradereceivables, derivative financialinstruments, financial assetsmeasuredatamortisedcost.

Diversificationofbankdeposits,creditlimitsandlettersofcredit.Each investment in financial services is assessed by the investment team as well as independentrisk team on the risk-return framework. The combined analysis of these teams is presented tothe Investment Committee for investment decision. The risk is being partly mitigated by settingup a concentration risk framework, which incentivises business units to diversify portfolio acrosscounterparties,sectorsandgeographies.

a. Liquidity Risk Management LiquidityRiskreferstoinsufficiencyoffundstomeetthefinancialobligations.LiquidityRiskManagementimpliesmaintenanceofsufficientcash

andmarketablesecuritiesandtheavailabilityoffundingthroughanadequateamountofcommittedcreditlinestomeetobligationswhendue.

The Group has formulated an Asset Liability Management Policy. The Asset Liability Management Committee (ALCO) is responsible for themanagement of the Group’s short-term,medium-term and long-term funding and liquiditymanagement requirements. The Groupmanagesliquidityriskbymaintainingadequatereserves,bankingfacilitiesandbycontinuouslymonitoringforecastandactualcashflows,andbyassessingthematurityprofilesoffinancialassetsandliabilities.TheGrouphasaccesstoundrawnborrowingfacilitiesattheendofeachreportingperiod,asdetailedbelow:

TheGrouphasthefollowingundrawncreditlinesavailableasattheendofthereportingperiod.

`incrores

As at Particulars March 31, 2017 March 31, 2016 April 1, 2015-Expiringwithinoneyear 9,324.28 3,544.15 3,887.95-Expiringbeyondoneyear - - -

9,324.28 3,544.15 3,887.95

ThefollowingtablesdetailtheGroup’sremainingcontractualmaturityforitsnon-derivativefinancialliabilitieswithagreedrepaymentperiods.ThetableshavebeendrawnupbasedontheundiscountedcashflowsoffinancialliabilitiesbasedontheearliestdateonwhichtheGroupcanberequiredtopay.Thetablesincludebothinterestandprincipalcashflows.Totheextentthatinterestflowsarefloatingrate,therateapplicableasofreportingperiodendsrespectivelyhasbeenconsidered.ThecontractualmaturityisbasedontheearliestdateonwhichtheGroupmayberequiredtopay.




ìncrores

March 31, 2017Maturities of Financial Liabilities Upto 1 year 1 to 3 years 3 to 5 years 5 years & above Borrowings 16,209.51 15,915.83 2,419.56 1,056.29 TradePayables 764.29 - - - DerivativeFinancialLiabilities 30.73 - - - OtherFinancialLiabilities 1,206.07 149.74 0.74 -

18,210.60 16,065.57 2,420.30 1,056.29

ìncrores

March 31, 2016Maturities of Financial Liabilities Upto 1 year 1 to 3 years 3 to 5 years 5 years & above Borrowings 9,350.60 7,119.92 1,290.64 -TradePayables 702.56 - - -DerivativeFinancialLiabilities - 4.03 - -OtherFinancialLiabilities 271.36 39.57 3.56 -

10,324.52 7,163.52 1,294.20 -

ìncrores

April 1, 2015Maturities of Financial Liabilities Upto 1 year 1 to 3 years 3 to 5 years 5 years & above Borrowings 3,718.75 3,139.05 1,031.42 21.03TradePayables 668.04 - - - OtherFinancialLiabilities 112.78 2.53 - -

4,499.57 3,141.58 1,031.42 21.03

ThefollowingtabledetailstheGroup’sexpectedmaturityfor itsnon-derivativefinancialassets.Thetablehasbeendrawnupbasedontheundiscountedcontractualmaturitiesofthefinancialassetsincludinginterestthatwillbeearnedonthoseassets.Theinclusionofinformationonnon-derivativefinancialassetsisnecessaryinordertounderstandtheGroup’sliquidityriskmanagementastheliquidityismanagedonanetassetandliabilitybasis.Hence,maturitiesoftherelevantassetshavebeenconsideredbelow.

ìncrores

March 31, 2017Maturities of Financial Assets Upto 1 year 1 to 3 years 3 to 5 years 5 years & above Investments&Loans 5,573.46 13,930.32 6,792.19 2,102.99 TradeReceivables 1,147.86 - - -

6,721.32 13,930.32 6,792.19 2,102.99

ìncrores

March 31, 2016Maturities of Financial Assets Upto 1 year 1 to 3 years 3 to 5 years 5 years & above Investments&Loans 3,882.11 10,820.71 5,103.84 837.46TradeReceivables 1,004.90 - - -

4,887.01 10,820.71 5,103.84 837.46

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

345


ìncrores

April 1, 2015Maturities of Financial Assets Upto 1 year 1 to 3 years 3 to 5 years 5 years & above Investments&Loans 3,307.33 4,360.28 1,015.95 92.52TradeReceivables 845.59 - - -

4,152.92 4,360.28 1,015.95 92.52

Thebalancesdisclosedinthetableabovearethecontractualundiscountedcashflows.Balancesduewithin12monthsequaltheircarryingbalancesastheimpactofdiscountingisnotsignificant

Incaseofloancommitments,theexpectedmaturitiesareasunder:

ìncrores

March 31, 2017 March 31, 2016 April 1, 2015Within 1 year Within 1 year Within 1 year

Commitmenttoinvestinnon-convertibledebentures 106.45 1,257.45 798.94CommitmenttoinvestinInterCompanyDeposits/Loans 230.40 555.45 170.00CommitmenttoinvestinOptionallyConvertibleDebentures - - 100.00

TOTAL 336.85 1,812.90 1,068.94

ìncrores

March 31, 2017 March 31, 2016 April 1, 20151 to 3 years 1 to 3 years 1 to 3 years

Commitment to invest in AIF 75.00 85.00 -TOTAL 75.00 85.00 -

b. Interest Rate Risk Management TheGroupisexposedtointerestrateriskasithasassetsandliabilitiesbasedonfloatinginterestratesaswell.TheGrouphasanapprovedAssetand

LiabilityManagementPolicywhichempowerstheAssetandLiabilityManagementCommittee(ALCO)toassesstheinterestrateriskrunbyitandprovideappropriateguidelinestotheTreasurytomanagetherisk.TheALCOreviewstheinterestrateriskonperiodicbasisanddecidesontheassetprofileandtheappropriatefundingmix.TheALCOreviewstheinterestrategapstatementandtheinterestratesensitivityanalysis.

TheexposureoftheCompany’sborrowingstotheinterestrateriskattheendofthereportingperiodismentionedbelow:

ìncrores

As at Particulars March 31, 2017 March 31, 2016 April 1, 2015Variablerateborrowings 11,541.91 5,536.55 3,623.55Fixedrateborrowings 18,712.80 10,668.76 3,686.27

30,254.71 16,205.31 7,309.82

Thesensitivityanalysisbelowhavebeendeterminedbasedontheexposuretointerestratesforassetsandliabilitiesattheendofthereportingperiod.Forfloatingrateassetsandliabilities,theanalysisispreparedassumingtheamountoftheliabilities/assetsoutstandingattheendofthereportingperiodwasoutstandingforthewholeyearandtheratesareresetaspertheapplicableresetdates.Thebasisriskbetweenvariousbenchmarksusedtoresetthefloatingrateassetsandliabilitieshasbeenconsideredtobeinsignificant.




Ifinterestratesrelatedtoborrowingshadbeen100basispointshigher/lowerandallothervariableswereheldconstantfortheCompanyanditssubsidiariesinIndia,theGroup’s

-Profitbeforetaxfortheyearended/OtherEquity(pretax)asonMarch31,2017woulddecrease/increaseby 78.68Crores(Previousyear 28.95Crores).ThisismainlyattributabletotheGroup’sexposuretoborrowingsatfloatinginterestrates.

Ifinterestratesrelatedtoborrowingshadbeen25basispointshigher/lowerandallothervariableswereheldconstantfortheCompany’ssubsidiarieslocatedoutsideIndia,theGroup’s

-Profitbeforetaxfortheyearended/OtherEquity(pretax)asonMarch31,2017woulddecrease/increaseby` 9.19Crores(Previousyear` 6.60Crores).ThisismainlyattributabletotheGroup’sexposuretoborrowingsatfloatinginterestrates.

Ifinterestratesrelatedtoloansgiven/debenturesinvestedhadbeen100basispointshigher/lowerandallothervariableswereheldconstant,theGroup’s

-Profitbeforetaxfortheyearended/OtherEquity(pretax)asonMarch31,2017woulddecrease/increaseby`68.38Crores(Previousyear` 7.76Crores).ThisismainlyattributabletotheGroup’sexposuretolendingsatfloatinginterestrates.

c. Other price risks TheGroupisexposedtoequitypricerisksarisingfromequityinvestmentsandclassifiedinthebalancessheetatfairvaluethroughOtherComprehensive

Income.

Equity price sensitivity analysis: Thetablebelowsummarisestheimpactofincreases/decreasesontheGroup’sEquityandOCIfortheperiod.Analysisisbasedontheassumptionthat

equityindexhadincreased/decreasedby5%withalltheothervariablesheldconstant,andtheseinvestmentsmovedinthelinewiththeindex.

`incrores

Impact on OCIParticulars March 31, 2017 March 31, 2016NSENifty100,Increaseby5% 199.46 157.13NSENifty100,Decreaseby5% (199.46) (157.13)

TheGrouphasdesignatedthefollowingsecuritiesasFVTOCIInvestments: ShriramCityUnionFinanceLimited ShriramTransportFinanceCompanyLimited

TheGroupchosethispresentationalternativebecausetheinvestmentweremadeforstrategicpurposesratherthanwithaviewtoprofitonsubsequentsale,andtherearenoplanstodisposeoftheseinvestments.

50 (d) FOREIGN CURRENCY RISK MANAGEMENT The Group is exposed to Currency Risk arising from its trade exposures and Capital receipt / payments denominated, in other than the

FunctionalCurrency.TheGrouphasadetailedpolicywhichincludessettingoftherecognitionparameters,benchmarktargets,theboundarieswithinwhich the treasury has to perform and also lays down the checks and controls to ensure the effectiveness of the treasury function. TheGrouphasdefinedstrategiesforaddressingtherisksforeachcategoryofexposures(e.g.forexports,forimports,forloans,etc.).Thecentralisedtreasuryfunctionaggregatestheforeignexchangeexposureandtakesprudentmeasurestohedgetheexposurebasedonprevalentmacro-economicconditions.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

347


i) Derivatives outstanding as at the reporting datei. Firm commitment and highly probable forecast transaction

As at March 31, 2017 As at March 31, 2016 As at April 1, 2015FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In Crores

ForwardcontractstosellUSD/INR 5.38 351.54 3.90 267.17 7.28 473.92ForwardcontractstosellEUR/USD 0.50 37.51 1.20 91.38 - - ForwardcontractstosellGBP/USD 0.19 19.02 1.20 114.57 0.95 87.28

ii. Receivable of Loan to related parties


ForwardcontractstosellUSD 4.18 271.70 4.33 296.94 3.07 194.36

iii. Loans payable to banks


CrosscurrencyinterestrateswapUSD/INR 3.77 244.18 6.02 398.93 - -

ii) Particulars of foreign currency exposures as at the reporting dateCurrencies March 31, 2017 March 31, 2016 As at April 1, 2015

Advances from customers Trade receivables Advances from customers Trade receivables Advances from customers Trade receivables

FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In Crores

EUR 0.04 2.96 1.92 133.05 0.04 2.73 0.57 42.97 0.01 0.91 1.01 67.36

USD 0.62 39.96 4.80 311.33 0.46 30.56 3.72 246.70 0.28 17.53 3.41 213.40

GBP 0.12 9.45 1.51 122.54 * 0.14 0.73 69.31 0.01 0.65 0.76 70.61

AUD - - 0.01 0.35 - - - - * 0.09 0.01 0.64

CHF - - - - - - * 0.17 - - - -

CAD - - - - - - 0.02 0.78 - - - -

SGD - - 0.01 0.35 - - * 0.16 - - * -

Currencies March 31, 2017 March 31, 2016 As at April 1, 2015Advances to vendors Trade payables Advances to vendors Trade payables Advances to vendors Trade payables


CHF * 0.25 0.06 3.81 0.10 7.12 0.03 2.04 * 0.31 0.05 2.94EUR 0.06 4.13 1.13 78.48 1.16 86.71 0.35 26.07 1.22 82.22 0.25 16.64 GBP 0.01 0.58 0.10 7.93 0.04 3.43 0.03 3.16 0.02 1.96 0.06 5.87JPY 0.15 5.34 0.13 7.49 0.03 0.02 0.07 0.04 0.05 0.03 0.13 0.08SEK 0.13 1.01 0.04 0.27 0.13 1.03 0.04 0.28 0.13 0.97 0.04 0.26USD 0.19 12.34 1.19 76.86 0.44 29.00 2.26 149.27 0.22 13.89 1.75 109.41INR - - 0.17 0.17 - - - - - - 0.12 0.12HKD - - - - - - - - - - * 0.03THB 0.04 0.07 - - 0.04 0.07 - - 0.04 0.04 - - AUD - - - - - - * 0.08 - - - - CAD - - - - - - * 0.05 * * * 0.02SGD - - - - * * - - - - - - NZD - - - - - - * * - - * *

*-BelowtheroundingoffthresholdappliedbytheGroup




Currencies March 31, 2017 March 31, 2016 As at April 1, 2015Loan from Banks Loan from Banks Loan from Banks

FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In CroresUSD 7.53 488.37 1.12 73.94 0.85 52.94EUR 1.71 118.74 - - - -GBP 0.25 20.44 - - - -

Currencies March 31, 2017 March 31, 2016 As at April 1, 2015

Loans and interest receivable

Current Account Balances






USD 44.00 2,853.94 0.07 4.39 33.74 2,236.05 (0.02) (0.13) 19.68 1,207.79 0.07 4.47

GBP 5.32 430.33 0.02 1.47 1.06 101.14 0.17 16.15 0.64 59.71 0.13 12.05

EUR 11.87 822.80 (0.13) (9.23) 0.33 24.96 (0.32) (24.40) 0.22 14.69 0.06 3.91

CHF 0.25 16.39 - - 0.32 22.08 - - 0.28 18.22 * 0.06

Currencies March 31, 2017 March 31, 2016 As at April 1, 2015Loans taken and interest payable Loans taken and interest payable Loans taken and interest payable

FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In CroresEUR 7.84 543.25 2.93 220.59 3.13 209.89USD 6.44 417.78 1.67 110.85 4.67 292.03GBP 4.77 385.73 1.96 186.61 1.26 116.07CHF - - 10.38 716.72 - - CAD - - * 0.07 - -

Currencies March 31, 2017 March 31, 2016 As at April 1, 2015Other Current liabilities Other Current liabilities Other Current liabilities

FC in Crores ` In Crores FC in Crores ` In Crores FC in Crores ` In CroresUSD - - 0.15 10.00 - -

*-BelowtheroundingoffthresholdappliedbytheGroup

Oftheabove,theGroupismainlyexposedtoUSD,GBP,EUR&CHF.HencethefollowingtableanalysestheGroup’sSensitivitytoa5%increaseanda5%decreaseintheexchangeratesofthesecurrenciesagainstINR.

For the year ended March 31, 2017 For the year ended March 31, 2016 Currencies Increase/

DecreaseTotal Assets

in FCTotal

Liabilities in FC

Change in exchange rate

Impact on Profit or Loss/Other

Equity for the year

Total Assets in FC

Total Liabilities

in FC

Change in exchange rate

Impact on Profit or Loss/Other Equity

for the yearUSD Increase by 5%# 49.07 15.78 3.24 107.86 37.87 5.52 3.31 107.08USD Decrease by 5%# 49.07 15.78 (3.24) (107.86) 37.87 5.52 (3.31) (107.08)GBP Increase by 5%# 6.85 5.24 4.05 6.52 1.99 1.99 4.77 (0.00)GBP Decrease by 5%# 6.85 5.24 (4.05) (6.52) 1.99 1.99 (4.77) 0.00EUR Increase by 5%# 13.85 10.86 3.46 10.35 2.05 3.31 3.77 (4.75)EUR Decrease by 5%# 13.85 10.86 (3.46) (10.35) 2.05 3.31 (3.77) 4.75CHF Increase by 5%# 0.25 0.06 3.24 0.62 0.42 0.03 3.45 1.35 CHF Decrease by 5%# 0.25 0.06 (3.24) (0.62) 0.42 0.03 (3.45) (1.35)

#Holdingalltheothervariablesconstant

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

349


iii) During the year, the functional currencies of the following subsidiaries were reassessed and changed: A. PiramalCriticalCareLimitedhadGreatBritainpoundsasitsfunctionalcurrency.HoweverafterOctober2016,theentityhadmajorityassets

andliabilitiesdenominatedinUSDandduetooverseasacquisitionwhereinmajorityofrevenuewouldbedenominatedinUSD,thefunctionalcurrencywaschangedtoUSD.

B. PiramalDutchHoldingsN.V.hadEUROasitsfunctionalcurrency.SinceOctober2016,theentityhadmajorityassetsandliabilitiesdenominatedinUSDandhencethefunctionalcurrencywaschangedtoUSD.

50 (e) ACCOUNTING FOR CASH FLOW HEDGE TheGrouphastakenforeigncurrencyfloatingrateborrowingswhicharelinkedtoLIBOR.Formanagingtheforeigncurrencyriskandinterestrate

riskarisingfromchangesinLIBORonsuchborrowings,theGrouphasenteredintocross-currencyinterestrateswap(CCIRS)fortheentireloanliability.TheGrouphasdesignatedtheCCIRS(hedginginstrument)andtheborrowing(hedgeditem)intoahedgingrelationshipandapplieshedgeaccounting.

UnderthetermsoftheCCIRS,theGrouppaysinterestatthefixedratetotheswapcounterpartyinINRandreceivesthefloatinginterestpaymentsbasedonLIBORinforeigncurrency.Asthecriticaltermsofthehedgeditemandthehedginginstrument(notional,interestperiods,underlyingandfixedrates)arematchingandtheinterestcashflowsareoff-setting,aneconomicrelationshipexistsbetweenthetwo.Thisensuresthatthehedginginstrumentandhedgeditemhavevaluesthatgenerallymoveintheoppositedirection.

HedgeEffectiveness Testing is assessed at designationdateof thehedging relationship, andon anongoingbasis. Theongoing assessment isperformedataminimumateachreportingdateoruponasignificantchangeincircumstancesaffectingthehedgeeffectivenessrequirements,whichevercomesfirst.

ThedateonwhichCCIRSandtheborrowingsweredesignatedintohedgingrelationshipislaterthanthedateonwhichtherespectivecontractswereenteredinto.Thistimingdifferencehascausedhedgeineffectivenesstoacertainextent,theeffectofwhichhasbeenrecognisedinprofitorlossundertheheadExchangegain/losses.

FollowingtableprovidesquantitativeinformationregardingthehedginginstrumentasonMarch31,2017:

`incroresType of hedge and risks

Nominal value Carrying amount of hedging instruments

(included under “other current and non-current

financial liabilities”)

Maturity date

Hedge ratio Average contracted

fixed interest rate

Changes in fair value of hedging instrument

used as the basis for recognising hedge

effectiveness

Changes in the value of hedged item

used as the basis for recognising hedge

effectiveness(Liabilities) (Liabilities)

Cash Flow HedgeForeign currency andInterestraterisk

900.00

37.71 June2017toJune2018

1:1 9.46% (51.23) 51.23

FollowingtableprovidestheeffectsofhedgeaccountingonfinancialperformancefortheyearendedMarch31,2017:

`incroresType of hedge Changes in the value

of hedging instruments recognised in Other

comprehensive income

Hedge ineffectiveness recognised in profit or loss

Amount reclassified from cash flow hedge reserve to

profit or loss

Line-item affected in statement of profit or loss because of reclassification

Cash flow hedgeInterestRateriskandForeignExchangeRisk 51.23 - 28.27 Finance Cost

(27.66) ForeignExchange(gain)/loss




Movementincashflowhedgingreserve: `incrores

Particulars AmountAsonMarch31,2016 - ChangesinfairvalueofCCIRS (51.23)Amountsreclassifiedtoprofitorloss 55.93Deferredtaxesrelatedtoabove (1.63)AsonMarch31,2017 3.07

50 (f) CREDIT RISK Typically,thereceivablesoftheGroupcanbeclassifiedin2categories: 1.PharmaandInformationManagementTradeReceivables 2.FinancialServicesbusinessLoanBookprimarilycomprisingofRealestatedevelopers,InfrastructureCompaniesandOthers.PleasereferNote10

forriskmitigationtechniquesfollowedforPharmaandInformationManagementTradeReceivables.RiskmitigationmeasuresforFinancialServicesbusinessprimarilycomprisingofRealEstateDevelopersandStrategicInvestmentGroupsareexplainedinthenotebelow.

CreditriskreferstotheriskthatcounterpartywilldefaultonitscontractualobligationsresultinginfinanciallosstotheGroup.TheGrouphasadoptedapolicyofdealingwithcreditworthycounterpartiesandobtainingsufficientcollateral,whereappropriate,asameansofmitigatingtheriskoffinanciallossfromdefaults.TheRiskmanagementteamhasdevelopedproprietaryinternalratingmodelstoevaluateriskreturntrade-offforthe loansand investmentsdonebytheGroup.Theoutputoftraditionalcreditratingmodel isanestimateofprobabilityofdefault.Thesemodelsaredifferent fromthe traditionalcredit ratingmodelsas they integratebothprobabilityofdefaultand lossgivendefaultintoasinglemodel.

Thelendingexposureincludeslendingtothebelowsectors

Exposure as atSectors March 31, 2017 March 31, 2016 April 1, 2015Real Estate 87.58% 85.96% 83.24%Infrastructure 3.59% 6.71% 8.97%Others 8.83% 7.33% 7.79%

Credit Risk Management Creditriskmanagementisachievedbyconsideringvariousfactorslike: • Cashflowatrisk–Thisisanassessmentofthestandaloneprojectorbusinessfromwhichinterestservicingandprincipalrepaymentisexpectedtobe

done. • Securitycover–Thisisanassessmentofthevalueofthesecurityunderstressscenariowhichisfurtheradjustedforfactorslikeliquidity,enforceability,

transparencyinvaluationetc.ofthecollateral. • Promoterstrength–Thisisanassessmentofthepromoterfromfinancial,managementandperformanceperspective. • Exit–Thisisanassessmentoftheliquidityoftheloanorinvestment. Theoutputfromeachoftheanalysisisconvertedtoariskweightequivalent.Eachofthefourcomponentsoftheriskanalysisareassignedaspecificweight

whichdifferbasedontypeofinvestment.Theriskweightisthenconvertedintocapitalrequirement.Therequiredcapitalandthereturniscombinedtocreateametricwhichisusedfordealassessment.

BasedontheaboveassessmenttheriskteamcategorisesthedealsintothebelowRiskGrades

-Good Dealswithveryhighriskadjustedreturns-InvestmentGrade Dealswithhighriskadjustedreturns-ManagementReviewGrade Dealswithriskadjustedreturnsrequiredasperlendingpolicy-NotAdvisableGrade Dealswithlowerthanrequiredriskadjustedreturns

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

351


Further,aperiodicreviewoftheperformanceoftheportfolioisalsocarriedoutbytheRiskGroup.TheRiskGroupadjuststhestresscaseconsideredduring the initial approval based on actual performanceof the deal, developments in the sector, regulatory changes etc. The deal level output iscombinedtoformaportfoliosnapshot.Thetrendsfromportfolioareusedtoprovidestrategicinputstothemanagement.

Thecreditriskonliquidfundsandotherfinancialinstrumentsislimitedbecausethecounterpartiesarebankswithhighcredit-ratingsassignedcredit-ratingagenciesormutualfunds.

Provision for Expected Credit Loss TheGroupconsiderstheprobabilityofdefaultuponinitialrecognitionofassetandwhethertherehasbeenasignificantincreaseincreditriskonanongoingbasisthroughouteachreportingperiod.ToassesswhetherthereisasignificantincreaseincreditrisktheGroupcomparestheriskofadefaultoccurringontheassetasatthereportingdatewiththeriskofdefaultasatthedateofinitialrecognition.Itconsidersavailablereasonableandsupportiveforward-lookingparameters,whicharebothqualitativeandquantitative.TheseparametershavebeendetailedinNoteno.viiofSignificantAccountingPolicies.BasedontheresultyieldedbytheaboveassessmenttheFinancialassetsareclassifiedinto(1)Standard(Performing)Asset,(2)SignificantCreditDeteriorated(Under-Performing)Asset(3)Default(Non-Performing)Asset(CreditImpaired).Macroeconomicinformation(suchasregulatorychanges,marketinterestrateorgrowthrates)isincorporatedaspartoftheinternalratingmodel.Ingeneral,itispresumedthatcreditriskhassignificantlyincreasedsinceinitialrecognitionifthepaymentsaremorethan30dayspastdue.ForthepurposeofexpectedcreditlossanalysistheGroupdefinesdefaultasanyassetwithmorethan90daysoverdues.Thisisalsoaspertherebuttablepresumptionprovidedbythestandard.

TheGroupprovidesforexpectedcreditlossbasedonthefollowing:

Category - Description Basis for Recognition of Expected Credit LossStage1-Standard(Performing)Assets 12 month ECLStage2-SignificantCreditDeterioratedAssets LifetimeECLStage3-Default(Non-Performing)Assets(CreditImpaired) LifetimeECL

AsatApril1,2015,acombinationofbothinternalandexternalProbabilityofDefault(PD)hasbeenusedbytheGroupsincetheassetportfoliowasataverynascentstage.TheinternalPDhasbeencomputedbydividingthedefaultobservedduringtheyearwiththenumberofinvestmentspresentonthebookatthestartoftheyear.ForExternalPDtheGrouphasrelieduponthe10yearPDdatafromexternalratingagency.ForLossgivendefault(LGD),theGrouphasreliedoninternalandexternalinformation.

FortheyearendedMarch31,2017andMarch31,2016theGrouphasdevelopedaPDMatrixafterconsideringsomeparametersasstatedbelow:

(1)BorrowerGrade(2)PastOverdueHistory(3)RepeatDealwithBorrower(4)StatusfrommonthlyAssetMonitoringreport(5)DealIRR(6)DealTenureremaining.BasedontheseparameterstheGrouphascomputedthePD.TheGrouphasalsobuilt inmodelscorecardstodeterminethe internalLGD.However,sincetherehasbeennodefaulthistorytosubstantiatetheinternalLGD,theGrouphasmadeuseofacombinationofbothinternalaswellasexternalLGD.

Expected Credit Loss as at the Reporting period:

`inCrores

As at March 31, 2017Particulars Asset Group Gross Carrying

Amount at DefaultExpected

Credit LossCarrying Amount net of impairment provision

VeryHighqualityliquidassets Other Financial Assets and Loans 1,143.68 - 1,143.68 Assets for which credit risk has not significantlyincreasedfrominitialrecognition

Investments at amortised cost 17,172.72 327.40 16,845.32Loans 6,440.17 119.97 6,320.20

Assets forwhich credit riskhas increased significantlybutnotcreditimpaired

Investments at amortised cost 163.61 5.68 157.93Loans 44.64 2.33 42.31

Assets forwhich credit riskhas increased significantlyandcreditimpaired

Investments at amortised cost 64.66 26.30 38.36Loans 115.85 50.78 65.07

TOTAL 25,145.33 532.46 24,612.87




ìnCrores

As at March 31, 2016Particulars Asset Group Gross Carrying



VeryHighqualityliquidassets OtherFinancialAssetsandLoans 1,102.72 - 1,102.72Assets for which credit risk has not significantlyincreasedfrominitialrecognition

Investmentsatamortisedcost 9,775.59 220.44 9,555.15Loans 2,632.02 58.92 2,573.10

Assets forwhich credit riskhas increased significantlybutnotcreditimpaired

Loans 53.41 4.02 49.39


Investmentsatamortisedcost 23.93 10.51 13.42

Loans 103.57 50.02 53.55

TOTAL 13,691.24 343.91 13,347.33

ìnCrores

As at April 1, 2015Particulars Asset Group Gross Carrying



VeryHighqualityliquidassets OtherFinancialAssetsandLoans 1,369.47 - 1,369.47Assets for which credit risk has not significantlyincreasedfrominitialrecognition

Investmentsatamortisedcost 3,430.62 74.58 3,356.04Loans 1,350.49 38.81 1,311.68


Investmentsatamortisedcost 22.31 11.11 11.20Loans 124.21 66.26 57.95

TOTAL 6,297.10 190.76 6,106.34

a) Reconciliation of Loss Allowance

ìnCrores

For the year ended March 31, 2017 Investments and Loans Loss allowance

measured at 12 month expected losses

Loss allowance measured at life-time expected losses Financial assets for which credit

risk has increased significantly and not credit-impaired

Financial assets for which credit risk has increased significantly and

credit-impaired Balanceatthebeginningoftheyear 279.35 4.02 60.54 Transferredto12-monthECL - - - TransferredtoLifetimeECLnotcreditimpaired - - - TransferredtoLifetimeECLcreditimpaired-collectiveprovision - - - TransferredtoLifetimeECLcreditimpaired-specificprovision (2.90) - 2.90 Charge to Statement of Profit and Loss OnAccountofRateChange (51.68) - (2.86) OnAccountofDisbursements 306.07 5.68 39.59 OnAccountofRepayments (83.47) (1.69) (23.09)

Balance at the end of the year 447.37 8.01 77.08

Thereasonforincreaseinprovisionisduetoincreaseintheloans&investmentswhichispartiallyoffsetbyareductioninrateofECL.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

353


`inCrores

For the year ended March 31, 2016 Investments and Loans Loss allowance

measured at 12 month expected losses

Loss allowance measured at life-time expected losses Financial assets for which credit

risk has increased significantly and not credit-impaired

Financial assets for which credit risk has increased significantly and

credit-impaired

Balanceatthebeginningoftheyear 113.38 - 77.38Transferredto12-monthECL - - - TransferredtoLifetimeECLnotcreditimpaired (1.36) 1.36 - TransferredtoLifetimeECLcreditimpaired-collectiveprovision (1.00) - 1.00Charge to Statement of Profit and Loss OnAccountofRateChange (3.46) 2.66 3.61 OnAccountofDisbursements 234.50 - - OnAccountofRepayments (62.71) - (21.45)

Balance at the end of the year 279.35 4.02 60.54

Thereasonforincreaseinprovisionisduetoincreaseintheloans&investmentswhichispartiallyoffsetbyareductioninrateofECL.

b) Movement in Expected Credit Loss on undrawn loan commitments:

`incrores

Expected Credit Loss on Loan CommitmentsParticulars March 31, 2017 March 31, 2016Balancesasatthebeginningoftheyear 39.93 25.34 Additions 5.96 16.54 Rate change (0.33) (0.14)Amount used (39.20) (1.81)Balances as at the end of the year 6.36 39.93ClassifiedasNon-current(Refernote20) - - ClassifiedasCurrent(Refernote26) 6.36 39.93

TOTAL 6.36 39.93

c) TheamountsofFinancialAssetsoutstandingintheBalanceSheetalongwiththeundrawnloancommitments(refernote28)asattheendofthereportingperiodrepresentthemaximumexposuretocreditrisk.

DescriptionofCollateralheldassecurityandothercreditenhancements Thecredit riskmanagementpolicyof theGroupprescribesa security coverof200%of theproposed facilityamount.TheGroupperiodically

monitorsthequalityaswellasthevalueofthesecuritytomeettheprescribedlimits.ThecollateralheldbytheGroupvariesoncasetocasebasisandincludes:

i) First/SubservientchargeontheLandand/orBuildingoftheprojectorotherprojects ii) First/Subservientchargeonthefixedandcurrentassetsoftheborrower iii) Hypothecationoverreceivablesfromfundedprojectorotherprojectsoftheborrower iv) PledgeonSharesoftheborrowerortheirrelatedparties v) GuaranteesofPromoters/PromoterUndertakings vi) Postdated/Undatedcheques

Asatthereportingdate,theratioofvalueofthecollateralheldassecurityforthecreditimpairedfinancialassetstotheexposureatdefaultfortheseassetsishigherthan1.




d) Thecreditimpairedassetsasatthereportingdatesweresecuredbychargeonlandandbuildingandprojectreceivablesamountingto:

ìncroresSectors March 31, 2017 March 31, 2016 April 1, 2015ValueofSecurity 105.36 66.97 69.15

Collateral taken over by the Group against recovery on credit impaired asset: TheGrouphastakenpossessionofaresidentialpropertywhichwasmortgagedascollateraltorecoverduesonacreditimpairedasset.Thecarrying

valueofthecollateralis`15.91croresandaccountedforasassetheldforsale.

51 MOVEMENT IN PROVISIONS :

ìncroresParticulars Litigations / Disputes Provisions for Grants -

CommittedOnerous Contracts Incentive

As at As at As at As atMarch 31,

2017March 31,

2016March 31,

2017March 31,

2016March 31,

2017March 31,

2016March 31,

2017March 31,

2016

Balancesasatthebeginningoftheyear 13.39 26.42 28.83 24.29 17.19 36.55 22.60 - Additions - - - - - 17.59 7.62 22.60UnwindingofDiscount - - 2.72 3.05 - - - - Amount used - - (13.25) - (6.12) (35.94) - - Revaluationofclosingbalances - - (0.42) 1.49 (0.65) (1.01) (0.74) - Unusedamountsreversed (9.89) (13.03) - - (1.06) - - - Balances as at the end of the year 3.50 13.39 17.88 28.83 9.36 17.19 29.48 22.60ClassifiedasNon-current(Refernote20) - - 4.91 15.58 4.25 10.08 29.48 22.60ClassifiedasCurrent(Refernote26) 3.50 13.39 12.97 13.25 5.11 7.11 - -

TOTAL 3.50 13.39 17.88 28.83 9.36 17.19 29.48 22.60

Provisionforlitigation/disputesrepresentsclaimsagainsttheGroupnotacknowledgedasdebtsthatareexpectedtomaterialiseinrespectofmattersunderlitigation.Futurecashoutflowsaredeterminableonlyonreceiptofjudgments/decisionspendingwithvariousforums/authorities.

ProvisionforOnerouscontractsrepresentstheamountsprovidedforcontractswheretheunavoidablecostsofmeetingtheobligationsunderthecontractexceedtheeconomicbenefitsexpectedtobereceivedunderit.

ProvisionforgrantsrepresentexpectedcontributionstobepaidinFY2017-18and2018-19.

Provisionforincentiverepresentstock-basedcompensationforcertainemployeesinasubsidiary.

52 ThedetailsofSpecifiedBankNotes(asdefinedintheMCAnotificationGSR308(E)datedMarch31,2017)heldandtransactedduringtheperiodfromNovember8,2016toDecember30,2016areasfollows:

(ìncrores)Particulars Specified Bank

Notes (SBN)Other Denomination

NotesTotal

Closingcashinhandason08.11.2016 0.06 0.04 0.10 (+)Permittedreceipts@ 0.03 0.27 0.30 (-)Permittedpayments - 0.23 0.23 (-)AmountdepositedinBanks 0.09 - 0.09 Closing cash in hand as on 30.12.2016 - 0.08 0.08

@ForSBN,itrepresentsunspentadvancelyingwithemployeesubsequentlyreturnedtoemployer.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

355


53 TheChiefOperatingDecisionmakeroftheCompanyexaminestheGroup’sperformancebothfromaproductandfromageographicperspective.Fromaproductperspective,themanagementhasidentifiedthefollowingreportablesegments:

1.PharmaceuticalsManufacturingandServices 2.FinancialServices 3.InformationManagement

1.PharmaceuticalsManufacturingandServices:Inthissegment,theGrouphasastrongpresenceinPharmaSolutions,CriticalCare,ConsumerProductsServicesandImaging.TheCompanyandcertainsubsidairiesactasaContractDevelopmentandmanufacturingorganizationofferingbothAPIsandformulations.TheGroup’scriticalcarebusinessdealsintheinhalationanesthesiamarket.Thegroup’sconsumerproductsbusinessisprimarilyan India-centricconsumerhealthcarebusinesswithstrongbrandsportfolio.TheGroupalsohasapresence in Imagingbusiness;asubsidiaryhasUSFDAandEuropeanCommissionapprovalforthecommercialsaleofitsdiagnosticimagingagent.

2.FinancialServices:Company’sfinancialservicessegmentoffersacompletesuiteoffinancialproductstomeetthediverseneedsofitscustomers.TheCompanylendstovariousrealestatedevelopersandunderspecialsituationopportunitiesinvarioussectorsandhasinvestmentsinShriramGroup,throughwhichtheCompanyhasexposuretoretailfinancingsegments.

3. InformationManagement: PEL’s InformationManagementbusiness,DecisionResourcesGroup (DRG), is amarket-leadingdecision-supportplatform in the healthcare information services space. DRG provides indispensable insights to life sciences companies as well as healthcareprovidersandpayersthroughavarietyofhighvalue-addeddataandanalytics,researchreports,andknowledge-basedservices.Theseofferingsenablecustomerstomakeinformedinvestment,costcontainmentandstrategicbusinessdecisionsintheirchosenmarkets.

`incroresParticulars Pharmaceuticals

manufacturing and services

Financial services Information Management

Eliminations Total

March 2017

March 2016

March 2017

March 2016

March 2017

March 2016

March 2017

March 2016

March 2017

March 2016

Revenue from operations 3,972.87 3,485.92 3,351.50 1,739.72 1,222.38 1,155.92 - 0.08 8,546.75 6,381.48Segment Results 333.41 170.04 1,421.55 815.91 104.03 176.89 - - 1,858.99 1,162.84Add:ExchangeGain,Net 45.46 101.26Add:UnallocatedIncome/(Netofunallocated cost)

(157.69) (130.72)

Less:FinanceCost 436.50 373.34Profit before share of net profits of investments accounted for using equity method and tax

1,310.26 760.04

Add:Shareofnetprofitofassociatesandjointventuresaccountedforusingtheequitymethod

169.90 194.21

Less:TaxExpenses 228.12 49.51

Net Profit before Non controlling interest

1,252.04 904.74




Included in the above Segment results, are the Exceptional Items as mentioned below:


manufacturing and servicesInformation Management Total

March 2017 March 2016 March 2017 March 2016 March 2017 March 2016Gainonsaleofproperties - 70.23 - - - 70.23Costs/(Income)associatedwithR&Dscaledown - 2.56 - - - 2.56 LossonSaleofPiramalClinicalResearchBusiness - (2.60) - - - (2.60)Lossonimpairmentofassets - (15.09) - - - (15.09)LossonsaleofBST-Cargel - (0.16) - - - (0.16)SeverancePay (9.95) - - (9.28) (9.95) (9.28)

TOTAL (9.95) 54.94 - (9.28) (9.95) 45.66

Other Information


manufacturing and servicesFinancial services Information

Management Eliminations Total

March 2017

March 2016

March 2017

March 2016

March 2017

March 2016

March 2017

March 2016

March 2017

March 2016

Segment Assets 7,086.32 4,729.00 33,003.70 19,248.18 5,846.02 5,466.75 - - 45,936.04 29,443.93UnallocableCorporateAssets 2,303.32 1,535.78Total Assets 48,239.36 30,979.71SegmentLiabilities 1,565.22 881.73 22,478.04 10,718.35 1,086.20 607.95 - - 25,129.46 12,208.03UnallocableCorporateLiabilities 8,227.33 5,823.33Total Liabilities 33,356.79 18,031.36CapitalExpenditure 3,104.05 578.75 31.26 8.18 114.59 499.02 - - 3,249.90 1,085.95UnallocableCapitalExpenditure 408.80 - Depreciationandamortisation 290.41 211.51 2.38 2.55 88.90 41.39 - - 381.70 255.45 NonCashexpenditureotherthandepreciationandamortisation

6.76 15.35 155.01 167.96 1.11 4.23 - - 162.88 187.54

The above segment assets and unallocatedassetsinclude:Investmentinassociatesandjointventuresaccountedforbytheequitymethod

2,752.54 2,597.18

Summary of Segment Assets and Liabilities as at April 1, 2015

(`incrores)

Assets Liabilities Pharmaceuticalsmanufacturingandservices 4,227.99 828.35Financialservices 11,495.90 211.50Informationmanagement 4,585.43 407.36Unallocated 1,693.25 7,129.88

TOTAL 22,002.57 8,577.09

Geographical Segments

`incroresDetails Within India Outside India Eliminations Total

March 2017 March 2016 March 2017 March 2016 March 2017 March 2016 March 2017 March 2016Revenuefromoperations 4,234.18 2,473.76 4,585.12 4,220.38 (272.55) (312.66) 8,546.75 6,381.48CarryingamountofNoncurrentAssets* 2,138.08 1,536.14 9,113.11 6,899.29 0.27 (130.30) 11,251.46 8,305.13

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

357


Geographical Segments as on April 1, 2015

ìncroresDetails Within India Outside India Eliminations TotalCarryingamountofNoncurrentAssets* 1,236.03 5,811.60 69.16 7,116.78

*OtherthanFinancialinstruments,deferredtaxassetsandpost-employmentbenefitassetsNocustomercontributedmorethan10%ofthetotalrevenueoftheGroup

54) INCOME TAXES RELATING TO OPERATIONS

a) Income tax recognised in profit or loss

(ìnCrores)



Current taxInrespectofthecurrentyear 440.52 298.48Inrespectofprioryears 44.94 (0.06)

485.46 298.42Deferred taxInrespectofthecurrentyear (257.34) (248.91)Total income tax expense recognised 228.12 49.51

b) Income tax recognised in other comprehensive income

(ìnCrores)



Current tax - -Deferred taxArisingonincomeandexpensesrecognisedinothercomprehensiveincome:ExchangelossonlongtermloanstransferredtoOCI (51.57) - Fairvalueremeasurementofhedginginstrumentsenteredintoforcashflowhedges 1.63 - Remeasurementofdefinedbenefitobligation (1.41) (1.02)Total income tax recognised in other comprehensive income (51.35) (1.02)

c) Deferred tax balances

Thefollowingistheanalysisofdeferredtaxassets/(liabilities)presentedintheconsolidatedstatementoffinancialposition:

(ìnCrores)

March 31, 2017 March 31, 2016 April 1, 2015Deferredtaxassets(net) 625.21 317.93 91.84Deferredtaxliabilities(net) (30.75) (30.26) (33.81)

594.46 287.67 58.03

Deferredtaxassetsandliabilitiesarerecognizedforthefuturetaxconsequencesoftemporarydifferencesbetweenthecarryingvaluesofassetsandliabilitiesandtheirrespectivetaxbases,andunutilizedbusinesslossanddepreciationcarry-forwardsandtaxcredits.Deferredtaxassetsarerecognizedtotheextentthat it isprobablethatfuturetaxable incomewillbeavailableagainstwhichthedeductibletemporarydifferences,unusedtax losses,depreciationcarry-forwardsandunusedtaxcreditscouldbeutilized.




Movement of Deferred Tax during the year ended March 31, 2017

(`incrores)Particulars Opening

balanceRecognised in

profit or lossUtilized during

the yearRecognised in other


Closing balance

Deferred tax (liabilities)/assets in relation to: Measurementoffinancialassetsatamortisedcost/fairvalue 53.07 29.39 - - 82.46Provision for expected credit loss on financial assets (includingcommitments)

129.96 47.95 - - 177.91

OtherProvisions 4.77 2.64 - - 7.41Amortisationofexpenseswhichareallowedincurrentyear 3.67 (1.11) - - 2.56 Disallowancesforitemsallowedonpaymentbasis 38.39 1.81 - 1.41 41.61 Effectofrecognitionofleaserentexpenseonstraightlinebasis 2.74 (0.24) - - 2.50Unrealisedprofitmarginoninventory - 40.32 - - 40.32Property,PlantandEquipmentandIntangibleassets (139.46) (26.99) - - (166.45)Measurementoffinancialliabilitiesatamortisedcost (4.29) (14.36) - - (18.65)Fairvaluemeasurementofderivativecontracts (3.07) 0.66 - - (2.41)FairValuationofInvestment (8.21) (7.22) - - (15.43)UnamortisedDistributionExpenses (9.54) 2.84 - - (6.70)Shareofundistributedearningsofassociates (10.75) (0.85) - - (11.60)Othertemporarydifferences (5.90) 10.90 - (1.90) 3.10Cashflowhedges - - - (1.63) (1.63)Deferred tax on exchange differences on long term loansdesignatedasnetinvestmentstransferredtoOCI

- (51.57) - 51.57 -

Broughtforwardlosses - 76.35 - - 76.35Unusedtaxcredit(MATcreditentitlement) 236.29 146.82 - - 383.11

TOTAL 287.67 257.34 - 49.45 594.46

Movement of Deferred Tax during the year ended March 31, 2016

(`incrores)Particulars Opening

balanceRecognised in

profit or lossUtilized during

the yearRecognised in other


Closing balance

Deferred tax (liabilities)/assets in relation to: Measurementoffinancialassetsatamortisedcost/fairvalue 51.78 1.29 - - 53.07Provision for expected credit loss on financial assets (includingcommitments)

26.34 103.62 - - 129.96

OtherProvisions 15.15 (10.38) - - 4.77Amortisationofexpenseswhichareallowedincurrentyear 5.12 (1.45) - - 3.67Disallowancesforitemsallowedonpaymentbasis 27.61 9.76 - 1.02 38.39Effectofrecognitionofleaserentexpenseonstraightlinebasis - 2.74 - - 2.74Property,PlantandEquipmentandIntangibleassets (131.78) (7.68) - - (139.46)Measurementoffinancialliabilitiesatamortisedcost (1.47) (2.82) - - (4.29)Fairvaluemeasurementofderivativecontracts (2.99) (0.08) - - (3.07)FairValuationofInvestment (7.28) (0.93) - - (8.21)UnamortisedDistributionExpenses (12.83) 3.29 - - (9.54)Shareofundistributedearningsofassociates (6.70) (4.05) - - (10.75)Othertemporarydifferences (8.72) 2.07 - 0.75 (5.90)Broughtforwardlosses 76.69 (76.69) - - 0.00Unusedtaxcredit(MATcreditentitlement) 27.11 230.22 (21.04) - 236.29

TOTAL 58.03 248.91 (21.04) 1.77 287.67

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

359


Theincometaxexpensefortheyearcanbereconciledtotheaccountingprofitasfollows:

(`inCrores)Particulars For the year ended

March 31, 2017For the year ended

March 31, 2016

Consolidated Profit before tax 1,310.26 760.04Income tax expense calculated at 34.608% (2015-16: 34.608%) 453.45 263.03Effectofexpensesthatarenotdeductibleindeterminingtaxableprofit 77.50 48.84Utilisationofpreviouslyunrecognisedtaxlosses (323.79) (392.10)Effectofincomeswhicharetaxedatdifferentrates (11.09) 50.69Profitonsaleofproperty,plant,andequipment - (3.70)Effectofincomeswhichareexemptfromtax (24.73) (19.48)Effectofexpensesforwhichweighteddeductionundertaxlawsisallowed (18.18) (21.57)Effectofpreviouslyunrecognisedtaxlossesusedtoreducedeferedtaxexpense (76.35) - Taxprovisionforearlieryears 44.94 (0.06)Taxlossesforwhichnodeferredincometaxisrecognised 83.34 75.45Temporarydifferencesforwhichnodeferredincometaxwasrecognised 8.14 2.25 Chargeforpreviouslyrecogniseddeferredtaxassets - 20.09Unrealisedprofitmarginoninventory (40.32) - Dividendreceivedfromoverseassubsidiary - 16.37DeferredtaxonexchangedifferencesonlongtermloansdesignatedasnetinvestmentstransferredtoOCI 51.57 - Shareofundistributedearningsofassociates 0.85 4.05Others 2.79 5.63 Income tax expense recognised in consolidated statement of profit or loss 228.12 49.51

Thetaxrateusedforthereconciliationsaboveisthecorporatetaxrateof34.608%(fortheyear2016-17and2015-16)payablebycorporateentitiesinIndiaontaxableprofitsundertaxlawinIndianjurisdiction.

Inassessingtherealizabilityofdeferredtaxassets,theGroupconsiderstheextenttowhichitisprobablethatthedeferredtaxassetwillberealized.Theultimaterealizationofdeferredtaxassets isdependentuponthegenerationoffuturetaxableprofitsduringtheperiodsinwhichthosetemporarydifferencesandtaxlosscarry-forwardsbecomedeductible. TheGroup considers theexpected reversal ofdeferred tax liabilities, projected future taxable incomeand taxplanning strategies inmaking thisassessment.

Based on this, the Group believes that it is probable that the Groupwill realize the benefits of these deductible differences. The amount of deferred tax assetconsidered realizable, however, could be reduced in the near term if the estimates of future taxable income during the carry-forward period are reduced.

AsatMarch31,2017,theGrouphasrecognizedDeferredTaxAssetof` 76.35Croresonunusedtax losses,consideringprofits inthepast2yearsandreasonablecertaintyofrealisationofsuchdeferredtaxassetinthefutureyears.

Deferredtaxassetamountingto` 677.08crores,` 927croresand`1,158.42crores(excludingtheamountalreadyrecognisedtotheextentofDeferredTaxLiabiltiesamountingto` 57.49Crores)asatMarch31,2017,March31,2016andApril1,2015,respectivelyinrespectofunusedtaxlosseswasnotrecognizedbytheGroup,considering that theCompanyand its subsidiarieshadahistoryof tax losses for recentyears.UnrecognizedDeferred taxof`198.41crores,`206.91croresand`176.14croresasatMarch31,2017,March31,2016andApril1,2015areattributabletocarryforwardtaxlosseswhicharenotsubjecttoexpirationdates.Theremainingunrecognizeddeferredtaxof`478.67crores,`720.09croresand`982.28croresasatMarch31,2017,March31,2016andApril1,2015,respectivelyareattributabletocarryforwardtaxlosseswhichexpiresinvariousyearsthroughfiscal2037.

TheCompanyhascalculateditstaxliabilityforcurrentdomestictaxesafterconsideringMAT.TheexcesstaxpaidunderMATprovisionsoverandabovenormaltaxliabilitycanbecarriedforwardandset-offagainstfuturetax liabilitiescomputedundernormaltaxprovisions.TheCompanywasrequiredtopayMATduringthecurrentandpreviousyearandaccordingly,adeferredtaxassetof` 236.29croresand`146.82croreshasbeenrecognizedinthestatementoffinancialpositionasatMarch31,2016and2017respectively,whichcanbecarriedforwardforaperiodof10years(15yearsw.e.f.currentyear)fromtheyearofrecognition.




55 (A) DISCLOSURES MANDATED BY SCHEDULE III BY WAY OF ADDITIONAL INFORMATION

Name of the entity Net Assets (total assets minus total liabilities)

Share in Profit or (loss) Share in Other Comprehensive Income

Share in Total Comprehensive Income

As a % of Consolidated

net assets

Amount (` Crores)

As a % of Consolidated profit or loss

Amount (` Crores)


Other Comprehensive

Income

Amount (` Crores)


Total Comprehensive

Income

Amount (` Crores)

ParentPiramalEnterprisesLimited 22.41% 3,331.89 46.44% 581.55 107.34% 731.90 67.92% 1,313.44SubsidiariesIndianPHLFininvestPrivateLimited 0.32% 47.11 1.71% 21.47 0.00% - 1.11% 21.47SearchlightHealthPrivateLimited 0.30% 45.35 (0.18)% (2.20) 0.00% - (0.11)% (2.20)PiramalCapitalLimited 0.01% 2.00 0.00% - 0.00% - 0.00% - PiramalFundManagementPrivateLimited 2.02% 300.74 4.21% 52.67 (0.72)% (4.88) 2.47% 47.79INDIAREIT Investment Management Co. 1.13% 167.53 0.56% 6.96 0.00% - 0.36% 6.96PiramalAssetManagementPrivateLimited 0.00% 0.08 (0.03)% (0.32) 0.00% - (0.02)% (0.32)PiramalFinanceLimited 22.79% 3,391.24 21.71% 271.85 0.31% 2.08 14.16% 273.94PELFinholdPrivateLimited 0.00% 0.01 0.00% - 0.00% - 0.00% - Piramal Investment Advisory Services PrivateLimited

0.00% 0.66 0.00% 0.02 0.00% - 0.00% 0.02

PiramalConsumerProductsPrivateLimited 0.00% 0.01 (0.00)% (0.00) 0.00% - (0.00)% (0.00)PiramalSystems&TechnologiesPrivateLimited 0.26% 38.52 (0.12)% (1.53) 0.00% - (0.08)% (1.53)PiramalTechnologiesSA 0.00% 0.02 (0.00)% (0.04) (0.09)% (0.63) (0.03)% (0.67)PiramalInvestmentOpportunitiesFund 0.12% 18.30 0.14% 1.70 0.00% - 0.09% 1.70PiramalAssetReconstructionPrivateLimited 0.01% 2.02 (0.00)% (0.01) 0.00% - (0.00)% (0.01)PELAssetResurgenceAdvisoryPrivateLimited 0.04% 6.39 (0.16)% (2.01) 0.00% - (0.10)% (2.01)ForeignPiramalInternational 0.00% - 0.00% - 0.00% - 0.00% - PiramalHoldings(Suisse)SA (0.78)% (116.76) (0.33)% (4.18) (1.26)% (8.57) (0.66)% (12.75)PiramalImagingSA 4.34% 646.35 (3.17)% (39.70) 6.74% 45.99 0.33% 6.29PiramalImagingGmbH 0.00% 0.27 0.83% 10.36 (0.09)% (0.63) 0.50% 9.74PiramalImagingLimited (1.53)% (228.25) (1.49)% (18.62) 0.99% 6.73 (0.62)% (11.89)PiramalDutchHoldingsN.V. 4.20% 625.03 (1.61)% (20.18) 2.16% 14.72 (0.28)% (5.46)PiramalHealthcareInc. 2.51% 373.07 (3.65)% (45.68) (4.49)% (30.65) (3.95)% (76.34)PiramalCriticalCare,Inc. 3.19% 474.92 23.51% 294.38 0.00% - 15.22% 294.38PiramalPharmaInc. 0.12% 17.73 (4.21)% (52.68) 0.00% - (2.72)% (52.68)PELPharmaInc. (4.89)% (727.13) (1.12)% (14.06) 0.08% 0.57 (0.70)% (13.49)Ash Stevens LLC 1.94% 288.18 (0.14)% (1.80) 0.00% - (0.09)% (1.80)PiramalPharmaSolutionsInc. 1.82% 271.12 0.23% 2.93 0.00% - 0.15% 2.93PiramalCriticalCareItalia,S.P.A 0.13% 19.34 0.95% 11.90 (0.13)% (0.86) 0.57% 11.04PiramalCriticalCareDeutschlandGmbH 0.05% 7.02 (0.20)% (2.56) (0.10)% (0.68) (0.17)% (3.24)PiramalHealthcare(UK)Limited 2.44% 363.88 5.16% 64.57 (5.08)% (34.62) 1.55% 29.95PiramalHealthcarePensionTrusteesLimited 0.00% - 0.00% - 0.00% - 0.00% - PiramalCriticalCareLimited 0.18% 27.41 (8.85)% (110.79) (3.53)% (24.10) (6.97)% (134.89)PiramalHealthcare(Canada)Limited 0.78% 115.65 4.83% 60.45 (0.89)% (6.04) 2.81% 54.41 PiramalCriticalCareSouthAfrica(Pty)Ltd (0.00)% (0.11) (0.01)% (0.11) 0.00% - (0.01)% (0.11)PiramalDutchIMHoldcoB.V. 0.45% 67.33 0.27% 3.42 (1.23)% (8.36) (0.26)% (4.94)PEL-DRGDutchHoldcoB.V.(andSubsidaries) 17.24% 2,566.33 1.17% 14.67 0.00% - 0.76% 14.67

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

361



Share in Profit or (loss) Share in Other Comprehensive Income



net assets

Amount (` Crores)


Amount (` Crores)


Other Comprehensive

Income

Amount (` Crores)


Total Comprehensive

Income

Amount (` Crores)

Non-controlling Interests in all subsidiaries (0.09)% (13.21) (0.02)% (0.29) 0.00% - (0.01)% (0.29)Associates (Investment as per the equity method)IndianAllerganIndiaPrivateLimited 0.71% 106.00 2.25% 28.11 (0.01)% (0.08) 1.45% 28.03PiramalPhytocareLimited 0.01% 0.88 0.00% 0.01 (0.00)% (0.00) 0.00% 0.01ShriramCapitalLimited(ReferNote4(a)) 0.00% - 10.30% 129.00 (0.00)% (0.00) 6.67% 129.00Foreign BluebirdAeroSystemsLimited 0.26% 38.38 (0.22)% (2.80) 0.00% - (0.14)% (2.80)ContextMattersInc 0.10% 15.11 (0.09)% (1.10) 0.00% - (0.06)% (1.10)Joint venture (Investment as per the equity method)IndianConvergenceChemicalsPrivateLimited 0.23% 34.74 (0.03)% (0.32) 0.00% - (0.02)% (0.32)Shrilekha Business Consultancy Private Limited(ReferNote4(a))

17.18% 2,557.42 1.36% 17.00 0.00% - 0.88% 17.00

TOTAL 100.00% 14,882.57 100.00% 1,252.04 100.00% 681.89 100.00% 1,933.93

55 (B) DISCLOSURES MANDATED BY SCHEDULE III BY WAY OF ADDITIONAL INFORMATION FOR THE YEAR ENDED MARCH 31, 2016


Share in profit or (loss) Share in Other Comprehensive Income



net assets

Amount (` In

Crores)


Amount (` In

Crores)


Other Comprehensive

Income

Amount (` In

Crores)


Total Comprehensive

Income

Amount (` In

Crores)

ParentPiramalEnterprisesLimited 37.22% 4,819.97 73.12% 661.55 115.66% (697.43) (11.87)% (35.88)SubsidiariesIndianPHLFininvestPrivateLimited 0.27% 35.43 (0.01)% (0.10) 0.00% - (0.03)% (0.10)PiramalFundManagementPrivateLimited 2.45% 317.13 0.97% 8.78 (1.81)% 10.90 6.52% 19.68PHLFinancePrivateLimited 4.09% 528.99 9.15% 82.81 0.02% (0.13) 27.40% 82.68PiramalInvestmentAdvisoryServicesPrivateLimited 0.02% 3.07 0.00% 0.02 0.00% - 0.01% 0.02PiramalSystems&TechnologiesPrivateLimited (0.01)% (1.16) 0.31% 2.83 (0.12)% 0.73 1.18% 3.56 PELFinholdPrivateLimited 0.00% 0.01 0.00% - 0.00% - 0.00% - PELAssetResurgenceAdvisoryPrivateLimited 0.04% 5.01 (0.01)% (0.05) 0.00% - (0.02)% (0.05)PiramalConsumerProductsPrivateLimited 0.00% 0.02 0.00% - 0.00% - 0.00% - PiramalAssetReconstructionPrivateLimited 0.02% 2.03 (0.00)% (0.04) 0.00% - (0.01)% (0.04)PiramalInvestmentOpportunitiesFund 0.12% 15.00 0.00% - 0.00% - 0.00% - ForeignPiramalInternational 0.00% - 0.00% - 0.00% - 0.00% - PiramalHoldings(Suisse)SA (3.09)% (400.60) (7.40)% (66.97) (2.64)% 15.90 (16.93)% (51.07)PiramalImagingSA 2.78% 359.35 (2.36)% (21.39) 3.30% (19.89) (13.68)% (41.28)PiramalImagingGmbH (0.01)% (1.56) (5.25)% (47.50) 0.00% - (15.74)% (47.50)PiramalCriticalCareItalia,S.P.A 0.17% 22.01 (1.38)% (12.49) (0.29)% 1.73 (3.57)% (10.76)PiramalCriticalCareDeutschlandGmbH 0.02% 2.80 (0.14)% (1.25) (0.20)% 1.18 (0.02)% (0.07)PiramalCriticalCareLimited 1.15% 149.03 (0.01)% (0.10) (0.67)% 4.06 1.31% 3.96





Share in profit or (loss) Share in Other Comprehensive Income



net assets

Amount (` In

Crores)


Amount (` In

Crores)


Other Comprehensive

Income

Amount (` In

Crores)


Total Comprehensive

Income

Amount (` In

Crores)

PiramalImagingLimited 0.43% 55.95 (8.09)% (73.23) 0.00% - (24.27)% (73.23)PiramalHealthcare(Canada)Limited (0.13)% (17.14) 4.31% 39.04 (0.35)% 2.13 13.65% 41.17PiramalHealthcare(UK)Limited 2.41% 312.25 2.61% 23.63 0.01% (0.08) 7.81% 23.55 PiramalHealthcarePensionTrusteesLimited 0.00% - 0.00% - 0.00% - 0.00% - PiramalDutchHoldingsN.V. 0.27% 35.16 1.46% 13.18 0.35% (2.09) 3.68% 11.09PiramalHealthcareInc. (8.15)% (1,054.86) (10.35)% (93.60) (16.41)% 98.97 1.78% 5.37PiramalCriticalCare,Inc. 7.48% 969.02 14.75% 133.48 0.00% - 44.24% 133.48PiramalPharmaInc. (0.00)% (0.19) (5.69)% (51.46) 0.00% - (17.06)% (51.46)ColdstreamLaboratoriesInc. 1.87% 241.64 (0.63)% (5.66) 0.00% - (1.88)% (5.66)DRGHoldcoInc. (14.51)% (1,878.23) (2.47)% (22.33) 0.00% - (7.40)% (22.33)PiramalIPPHoldingsLLC 13.25% 1,716.11 0.00% - 0.00% - 0.00% - DecisionResourcesIncanditssubsidiaries 30.26% 3,918.24 14.98% 135.54 3.15% (18.99) 38.63% 116.55 PiramalDutchIMHoldcoB.V. (0.00)% (0.04) (0.00)% (0.04) 0.00% - (0.01)% (0.04)PEL-DRGDutchHoldcoB.V. (0.00)% (0.04) (0.00)% (0.04) 0.00% - (0.01)% (0.04)INDIAREIT Investment Management Co. 1.52% 197.42 0.82% 7.41 0.00% - 2.46% 7.41PiramalAssetManagementPrivateLimited (0.00)% (0.54) (0.15)% (1.39) 0.00% - (0.46)% (1.39)PiramalTechnologiesSA 0.00% 0.01 (0.01)% (0.10) 0.00% - (0.03)% (0.10)Non-controlling Interests in all subsidiaries (0.00)% (0.12) 0.00% - 0.00% - 0.00% - Associates (Investment as per the equity method)IndianShriramCapitalLimited 18.68% 2,419.38 16.94% 153.26 0.00% - 50.79% 153.26 AllerganIndiaPrivateLimited 0.75% 97.57 3.96% 35.81 0.00% - 11.87% 35.81PiramalPhytocareLimited 0.01% 0.87 (0.06)% (0.58) 0.00% - (0.19)% (0.58)Foreign BluebirdAeroSystemsLimited 0.34% 44.30 0.67% 6.06 0.00% - 2.01% 6.06Joint ventures (Investment as per the equity method)IndianConvergenceChemicalsPrivateLimited 0.27% 35.06 (0.04)% (0.34) 0.00% - (0.11)% (0.34)

TOTAL 100.00% 12,948.35 100.00% 904.74 100.00% (603.01) 100.00% 301.73

56 (A) TRANSITION TO Ind AS Overall principle Theaccountingpoliciessetoutinnote2havebeenappliedinpreparingthefinancialstatementsfortheyearended31March2017,thecomparative

informationpresentedinthesefinancialstatementsfortheyearended31March2016andinthepreparationofanopeningIndASbalancesheetat1April2015(theGroup’sdateof transition). Inpreparing itsopening IndASbalancesheet, theGrouphasadjustedtheamounts reportedpreviouslyinfinancialstatementspreparedinaccordancewiththeaccountingstandardsnotifiedunderCompanies(AccountingStandards)Rules,2006(asamended)andotherrelevantprovisionsoftheAct(previousGAAPorIndianGAAP).AnexplanationofhowthetransitionfrompreviousGAAPtoIndAShasaffectedtheGroup’sfinancialposition,financialperformanceandcashflowsissetoutinthefollowingtablesandnotes.

Exemptions and Exceptions availed: SetoutbelowaretheapplicableIndAS101optionalexemptionsandmandatoryexceptionsappliedinthetransitionfrompreviousGAAPtoIndAS.

Ind AS Optional Exemptions: Deemed cost for property, plant and equipment and other intangible assets IndAS101permitsafirst-timeadoptertoelecttocontinuewiththecarryingvalueforallofitsproperty,plantandequipmentasrecognisedinthe

financialstatementsasatthedateoftransitiontoIndAS,measuredasperthepreviousGAAPandusethatasitsdeemedcostasatthedateoftransitionaftermakingnecessaryadjustmentsforde-commissioningliabilities.ThisexemptioncanalsobeusedforintangibleassetscoveredbyIndAS38IntangibleAssets.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

363


Accordingly,theGrouphaselectedtomeasureallofitsproperty,plantandequipmentandintangibleassetsattheirpreviousGAAPcarryingvalue.

Designation of previously recognized financial instruments IndAS101allowsanentitytodesignateinvestmentsinequityinstrumentsatFVTOCIonthebasisofthefactsandcircumstancesatthedateof

transitiontoIndAS.TheGrouphasdesignatedcertaininvestmentsinequityshareasheldatFVTOCIonthebasisofthefactsandcircumstancesthatexistedatthetransition.

Determining whether an arrangement contains a lease AppendixC to IndAS17 requiresanentity toassesswhetheracontractorarrangementcontainsa lease. Inaccordancewith IndAS17, this

assessment should be carried out at the inception of the contract or arrangement. Ind AS 101 provides an option tomake this assessmenton the basis of facts and circumstances existing at the date of transition to IndAS, exceptwhere the effect is expected to be notmaterial. TheGrouphaselectedtoapplythisexemptionforsuchcontracts/arrangements.

Business Combinations IndAS101providestheoptiontoapplyIndAS103prospectivelyfromthetransitiondateorfromaspecificdatepriortothetransitiondate.This

providesrelieffromfullretrospectiveapplicationthatwouldrequirerestatementofallbusinesscombinationspriortothetransitiondate.

ThegroupelectedtoapplyIndAS103prospectivelytobusinesscombinationsoccurringafteritstransitiondate.Businesscombinationsoccurringpriortothetransitiondatehavenotbeenrestated.Thegrouphasappliedsameexemptionforinvestmentinassociatesandjointventures.

Prospective application of Ind AS 21 to business combinations Ind AS 101 allows a first-time adopter not to apply Ind AS 21 Effects of changes in Foreign Exchange Rates retrospectively for business

combinations thatoccurredbefore thedateof transition to IndAS. In suchcases,where theentitydoesnotapply IndAS21 retrospectivelyto fair value adjustments and goodwill, the entity treats them as assets and liabilities of the acquirer entity and not as the acquiree. Thegrouphaselectedtoapplythisexemption.

Cumulative translation differences IndAS101permitscumulativetranslationgainsandlossestoberesettozeroatthetransitiondate.Thisprovidesrelieffromdeterminingcumulative

currencytranslationdifferencesinaccordancewithIndAS21fromthedateasubsidiaryorequitymethodinvesteewasformedoracquired.

Thegroupelectedtoresetallcumulativetranslationgainsandlossestozerobytransferringittoopeningretainedearningsatitstransitiondate.

Ind AS Mandatory Exceptions: Estimates: Anentity’sestimatesinaccordancewithIndASsatthedateoftransitiontoIndASshallbeconsistentwithestimatesmadeforthesamedatein

accordancewithpreviousGAAP(afteradjustmentstoreflectanydifferenceinaccountingpolicies),unlessthereisobjectiveevidencethatthoseestimateswereinerror.IndASestimatesasat1April2015areconsistentwiththeestimatesasatthesamedatemadeinconformitywithpreviousGAAP.TheGroupmadeestimatesforfollowingitemsinaccordancewithIndASatthedateoftransitionasthesewerenotrequiredunderpreviousGAAP: A.InvestmentindebtinstrumentscarriedatFVTPL;and

B.Impairmentoffinancialassetsbasedonexpectedcreditlossmodel.

Derecognition of financial assets and financial liabilities Ind AS 101 requires a first-time adopter to apply the de-recognition provisions of Ind AS 109 prospectively for transactions occurring on or

afterthedateoftransitionto IndAS.However, IndAS101allowsafirst-timeadoptertoapplythede-recognitionrequirements in IndAS109retrospectivelyfromadateoftheentity’schoosing,providedthattheinformationneededtoapplyIndAS109tofinancialassetsandfinancialliabilitiesderecognisedasaresultofpasttransactionswasobtainedatthetimeofinitiallyaccountingforthosetransactions.Thegrouphaselectedtoapplythede-recognitionprovisionsofIndAS109prospectivelyfromthedateoftransitiontoIndAS.

Classification and measurement of financial assets IndAS101requiresanentitytoassessclassificationandmeasurementoffinancialassets(investmentindebtinstruments)onthebasisofthefactsand

circumstancesthatexistatthedateoftransitiontoIndAS.TheGrouphasdeterminedtheclassificationofFinancialAssetsintermsofwhetherthey




meettheamortizedcostcriteria,FVTPLcriteriaorFVOTCIcriteriabasedonthefactsandcircumstancesthatexistedasoftransitiondate.

Impairment of financial assets: TheGrouphasappliedtheimpairmentrequirementsofIndAS109retrospectively;however,aspermittedbyIndAS101,ithasusedreasonable

andsupportableinformationthatisavailablewithoutunduecostorefforttodeterminethecreditriskatthedatethatfinancialinstrumentswereinitiallyrecognisedinordertocompareitwiththecreditriskatthetransitiondate.

56 (B) RECONCILIATION OF TOTAL EQUITY AS AT MARCH 31, 2016 AND APRIL 1, 2015`incrores

Particulars Notes As at March 31, 2016 (End of last period

presented under previous GAAP)

As at April 1, 2015 (Date of transition)

Total equity (shareholders’ funds) under previous GAAP 12,422.10 11,735.93FairvaluationgainoninvestmentsheldthroughOCI a 705.88 1,398.52Measurementoffinancialassetsatamortisedcost b (175.20) (64.26)MeasurementoffinancialassetsatFVTPL b 38.42 44.18Expectedcreditlossallowanceoninvestments,loansandcommitments c (105.50) (107.19)ReversalofamortisationofgoodwillunderIndAS d 76.07 - Remeasurementofnetpensionassets e (118.88) (95.51)Amortisationofdistributionfees f 27.64 37.54Measurementofforwardexchangecontractsatfairvalue g 8.86 7.73Measurementoffinancialliabilitiesatamortisedcost h 59.78 77.08Recognitionofconstructiveobligation i (28.84) (24.29)Recognitionofleaserentexpenseonstraight-linemethod j (7.94) - DividendsnotrecognisedasliabilityuntildeclaredunderIndAS k - 415.39Impactofequitymethodofaccountingbeingfollowedforassociates/jointventures l 0.62 (3.10)ApplicationofacquisitionmethodofaccountingforBusinessCombinationsunderIndAS103 m 5.98 - Others 0.23 (1.95)Effectofforeigncurrencytranslation n (1.26) - NetDeferredTaximpactonalltheIndASadjustments o 40.39 5.41 Total adjustments to equity 526.25 1,689.55Total Equity Under Ind AS 12,948.35 13,425.48

Reconciliation of total comprehensive income for the year ended March 31, 2016:

`incroresParticulars Notes Year ended March 31, 2016

(latest period presented under previous GAAP)

Profit as per previous GAAP 950.60Adjustments:Measurementoffinancialassetsatamortisedcost b (110.94)MeasurementoffinancialassetsatFVTPL b (5.76)Measurementoflossallowanceoncertainfinancialassetsusingtheexpectedcreditlossmodel c 1.69ReversalofamortisationofgoodwillunderIndAS d 76.07Remeasurementofnetpensionassets e (17.14)Amortisationofdistributionfees f (9.90)Measurementofforwardexchangecontractsatfairvalue g 1.13 Measurementoffinancialliabilitiesatamortisedcost h (17.31)Unwindingofdiscountingofprovisions i (4.55)

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

365


`incroresParticulars Notes Year ended March 31, 2016

(latest period presented under previous GAAP)

Recognitionofleaserentexpenseonstraight-linemethod j (7.94)Impactofequitymethodofaccountingbeingfollowedforassociates/jointventures l 3.72ApplicationofacquisitionmethodofaccountingforbusinesscombinationsunderIndAS103 m 5.98Remeasurementofdefinedbenefitobligationtransferredtoothercomprehensiveincomeand(expense) p 2.02Others 2.10NetDeferredTaximpactonalltheIndASadjustments o 34.97Total effect of transition to Ind AS (45.86)Profit for the year as per Ind AS 904.74Othercomprehensiveincomefortheyear(netoftax) a,e,n,p (603.01)Total comprehensive income under Ind AS 301.73

Notes

a) UnderpreviousGAAP,longterminvestmentsweremeasuredatcostlessdiminutioninvaluewhichisotherthantemporary.UnderIndAS,thesefinancialassetshavebeendesignatedasmeasuredatFVTOCI.OnthedateoftransitiontoIndAS,thesefinancialassetshavebeenmeasuredattheirfairvaluewhichishigherthanthecostasperpreviousGAAP,resultinginanincreaseinthecarryingamountby`705.88croresasatMarch31,2016andby`1,398.52croresasatApril1,2015.FairvaluechangeswithrespecttoinvestmentsinequityinstrumentsdesignatedasatFVTOCIhavebeenrecognisedinFVTOCI–EquityinvestmentsreserveasatthedateoftransitionandsubsequentlyintheothercomprehensiveincomefortheyearendedMarch31,2016.Thisincreasedotherreservesby`705.88croresasatMarch31,2016andby`1,398.52croresasatApril1,2015andOtherComprehensiveIncomefortheyearendedMarch31,2016decreasedby`692.64crores.

b) UnderpreviousGAAP,investments,termloansandinter-corporatedepositswerecarriedatcostwhereasunderIndAS,thesearemeasuredbasedonentity’sbusinessmodelformanagingthefinancialassetsandcontractualcashflowcharacteristicsofthefinancialasset.Theinvestments,termloansandinter-corporatedepositsthatmeetthebusinessmodelandcontractualcashflowtestsaremeasuredatamortisedcostandinterestincomeisrecognisedaspertheeffectiveinterestratemethod.Thosethatdonotmeetthesetestsaremeasuredatfairvalue.Consideringtheabovecriteriatheinvestments,termloansandinter-corporatedepositshavedecreasedby`136.78croresasatMarch31,2016and`20.08croresasatApril1,2015.Thetotalequitydecreasedbyanequivalentamount.TheprofitfortheyearendedMarch31,2016decreasedby 116.70croresonaccountofthesame.

c) UnderpreviousGAAP,provisionfordoubtfulloansandreceivableswascalculatedusingincurredlossmodel.UnderIndAS,theprovisiononfinancialassets and commitments, including trade receivablesneeds tobe calculatedusing theexpected credit lossmodel.Accordingly, an additionalprovisionfor`105.50croreswasrecognizedasatMarch31,2016and`107.19croresasrecognisedatApril1,2015.Thetotalequitydecreasedbyequivalentamount.TheprofitfortheyearendedMarch31,2016increasedby`1.69crores.

d) UnderthepreviousGAAP,goodwillonacquisitioninInformationManagementsegmentwasamortisedoveraperiodof10years.UnderIndAS,goodwillcannotbeamortised,buttestedforimpairment.Accordingly,amortisationof`76.07croreshasbeenwrittenbackinthestatementofprofitandlossfortheyearendedMarch31,2016resultinginanincreaseintheprofitandtotalequityasonthatdate.




e) UnderpreviousGAAP,thesurplusinthedefinedbenefitplaninanoverseassubsidiarywasrecognisedasanasset.UnderIndAS,suchsurplusisrestrictedtotheextentofthepresentvalueofanyeconomicbenefitsavailableintheformofrefundsfromtheplanorreductionsinfuturecontributionstotheplan.OnthedateoftransitiontoIndAS,thegrouphaswrittenoffthesurplusassetsthusresultinginadecreaseinthetotalequityby`118.88croresasatMarch31,2016andby`95.51croresasatApril1,2015.Thechangesintheeffectoflimitinganetdefinedbenefitassettotheassetceilinghasbeenchargedtoothercomprehensiveincomeresultinginadecreaseof`6.23croresfortheyearendedMarch31,2016.TheprofitfortheyearendedMarch31,2016hasdecreasedby`17.14crores.

f) UnderpreviousGAAP,expensesfordistributionfeeswererecognisedasexpenseasandwhenincurred.AsperIndAS,theseexpensesarerecognisedasassetandamortizedonasystematicbasisthatisconsistentwiththetransferofinvestmentmanagementservicestothecustomer.ThishasresultedintherecognitionofassetasatMarch31,2016of`27.64croresandasatApril1,2015of`37.54croreswithanequivalentincreaseinthetotalequity.TheprofitfortheyearendedMarch31,2016hasdecreasedby`9.90crores.

g) UnderpreviousGAAP,premiumpaidforderivativecontractswasamortizedoverthetermofthederivativecontractswhereasunderIndASthederivativecontractsaremeasuredatFVTPL.Thus,theunamortizedpremiumasonApril1,2015andasonMarch31,2016hasbeenchargedofftoretainedearningsandtotheStatementofProfitandLossrespectivelyandderivativecontractshavebeenrecognisedatfairvalue.ThishasresultedintonetincreaseintotalequityasonMarch31,2016by`8.86CroresandasonApril1,2015by`7.73crores.TheprofitfortheyearendedMarch31,2016increasedby`1.13croresonaccountofthesame.

h) UnderpreviousGAAP,borrowingswererecordedatcostandtransactioncostswerechargedtoStatementofProfitandLossasandwhenincurred.UnderIndAS,transactioncostincurredtowardsoriginationofborrowingsisrequiredtobedeductedfromthecarryingamountofborrowingsoninitialrecognition.ThesecostsarerecognisedintheStatementofProfitandLossoverthetenureoftheborrowingaspartofinterestexpensebyapplyingeffectiveinterestratemethod.Accordingly,borrowingsasatMarch31,2016havebeenreducedby`59.78croresand`77.08croresasatApril1,2015.ThetotalequityincreasedbyanequivalentamountandtheprofitfortheyearendedMarch31,2016decreasedby`17.31crores.

i) UnderpreviousGAAP,noprovisionwasaccountedforConstructiveobligations.UnderIndAS,provisionsneedtoberecognised(atdiscountedvalue)forthetheseobligations.Accordingly,anadditionalprovisionwasrecognisedat`28.84croresasatMarch31,2016and`24.29croresasatApril1,2015.Thetotalequitydecreasedbyequivalentamount.Theunwindingofdiscountsinthiscaseamounted`4.55croresduringtheyearendedMarch31,2016resultingindecreaseinprofittothatextent.

j) UnderpreviousGAAP,therewasnoclearguidanceontreatmentofleaseincentives.UnderIndAS,intheeventthatleaseincentivesarereceivedtoenterintooperatingleases,suchincentivesarerecognisedasaliability.Paymentsmadeunderoperatingleases(netofanyincentivesreceivedfromthelessor)arechargedtoprofitorlossonastraight-linebasisovertheperiodoftheleaseunlessthepaymentsarestructuredtoincreaseinlinewithexpectedgeneralinflationtocompensateforthelessor’sexpectedinflationarycostincreases.Accordingly,thetotalequityasonMarch31,2016andtheprofitfortheyearendedMarch31,2016decreasedby`7.94crores.

k) UnderpreviousGAAP,dividendsonequitysharesrecommendedbytheBoardofDirectorsaftertheendofthereportingperiodbutbeforethefinancialstatementwereapprovedforissuewererecognisedinthefinancialstatementasaliability.UnderIndAS,suchdividendsarerecognisedwhenapprovedbythemembersinageneralmeeting.TheeffectofthischangeisanincreaseintotalequityasatMarch31,2016of` Nil and `415.39croresasatApril1,2015butdoesnotaffecttheprofitfortheyearendedMarch31,2016.

l) UnderpreviousGAAP,PiramalPhytocareLimited (PPL)wasconsideredas longterm investmentandmeasuredatcost.Thegrouphas17.53%shareholding inPPL.Thegrouphas theability toappointdirectorsontheBoardofPPLgiving it thepowertoparticipate in thefinancialandoperatingpolicydecisions.ThusthegrouphassignificantinfluenceoverPPLmakingitanassociate.Accordingly,underIndAS,theinvestmentinPPLhasbeenaccountedusingtheequitymethodresultingintoadecreaseinthetotalequityby`3.68croreasonMarch31,2016andby `3.10croresasonApril1,2015.Profitfortheyearhasreducedby`0.58crores.Apartfromthis,reversalofdividenddistributiontaxandotherconsolidationadjustmentsinanassociatehasincreasedtheprofitfortheyearendedMarch31,2016by`4.30crores.

m) TheGrouphaselectednottoapplyIndAS103BusinessCombinationsretrospectivelytopastbusinesscombinationsthatoccurredbeforethetransitiondateofApril1,2015,thusnothavinganyimpactontotalequityasonthatdate.TheapplicationofIndAS103foracquisitionsafterApril1,2015hasresultedinaincreaseinthetotalequityandtheprofitfortheyearendedMarch31,2016by`5.98crores.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

367


n) Impactsof the changes in the foreign currency translationson theadjustmentsmadeon transition to IndAShavebeen recognised inothercomprehensiveincome.

o) DeferredtaxeshavebeenrecognisedonadjustmentsmadeontransitiontoIndAS.

p) UnderIndAS,remeasurementsi.e.actuarialgainsandlossesandthereturnonplanassets,excludingamountsincludedinthenetinterestexpenseonthenetdefinedbenefitliabilityarerecognisedinothercomprehensiveincomeinsteadofprofitorlossasunderthepreviousGAAP.Asaresultofthischange,theprofitfortheyearendedMarch31,2016increasedby`2.02crores.ThereisnoimpactonthetotalequityasatMarch31,2016.

q) ThegrouphaselectedtoresetthebalanceappearingintheforeigncurrencytranslationreservetozeroasatApril1,2015.Accordingly,translationreservebalanceunderpreviousGAAPof`266.15croreshasbeentransferredtoretainedearnings.Thereisnoimpactontotalequityasaresultofthisadjustment.

r) UnderIndAS,allitemsofincomeandexpenserecognisedinaperiodshouldbeincludedinprofitorlossfortheperiod,unlessastandardrequiresorpermitsotherwise.Itemsofincomeandexpensethatarenotrecognisedinprofitorlossbutareshowninthestatementofprofitandlossas‘othercomprehensiveincome’includesremeasurementsofdefinedbenefitplans,fairvaluegainsor(losses)onFVTOCIequityinstruments,deferredgainsandlossesoncashflowhedgeandeffectofcurrencytranslationofforeignoperations.TheconceptofothercomprehensiveincomedidnotexistunderpreviousGAAP.

s) Associate Allergan India Private Limited AllerganIndiaPrivateLimitedwasaccountedforusingtheproportionateconsolidationmethodunderpreviousGAAPwhereasitbeinganassociate

needstobeaccountedusingtheequitymethodunderIndAS.Therefore: Onthetransitiondate,theGrouphasrecognisedinvestmentinAllerganIndiaPrivateLimitedbymeasuringitattheaggregateofthecarrying

amountoftheassetsandliabilitiesthattheGrouphadproportionatelyconsolidatedunderpreviousGAAPasofthetransitiondate; Thisinvestmentamounthasbeendeemedtobethecostofinvestmentatinitialrecognition; TheGrouphastestedtheinvestmentinAllerganIndiaPrivateLimitedforimpairmentasofthetransitiondate; After initial recognition at the transition date, the Group has accounted for Allergan India Private Limited using the equitymethod in

accordancewithIndAS28;and Thebreak-downoftheassetsandliabilitiesofAllerganIndiaPrivateLimitedthatwerepreviouslyaggregatedintothesinglelineinvestment

balanceatthetransitiondateisbelow:`incrores

Particulars April 1, 2015Non-current assetsProperty,plantandequipment 1.71Otherintangibleassets 0.55Financial assets 3.68DeferredTaxAssets(Net) 1.72Othernoncurrentassets 1.91Current assets Cashandcashequivalents 37.00Inventories 18.91Otherfinancialassets 11.94Othercurrentassets 4.17Current liabilities Currentfinancialliabilities (14.85)Provisions (2.42)Othercurrentliabilities (2.56)Net assets derecognised 61.76Share of net assets recognised under equity method 61.76




t) Joint Venture Convergence Chemicals Private Limited ConvergenceChemicalsPrivateLimitedwasaccountedforasasubsidiaryusingthefullconsolidationmethodunderpreviousGAAPwhereasit

needstobeaccountedforasajointventureusingtheequitymethodunderIndAS.Therefore: Theinvestmentamounthasbeendeemedtobethecostofinvestmentatinitialrecognition; TheGrouphastestedtheinvestmentinConvergenceChemicalsPrivateLimitedforimpairmentasofthetransitiondate; Afterinitialrecognitionatthetransitiondate,theGrouphasaccountedforConvergenceChemicalsPrivateLimitedusingtheequitymethod

inaccordancewithIndAS28;and Thebreak-downoftheassetsandliabilitiesofConvergenceChemicalsPrivateLimitedthatwillhavetobedisaggregatedfromthesingleline

investmentbalanceatthetransitiondateisbelow.

`incroresParticulars April 1, 2015 (Date of

transition) (amounts as reported in previous GAAP)

Non-current assetsProperty,plantandequipment -CapitalWorkinprogress 4.11 Othernoncurrentassets 88.82Current assets Cashandcashequivalents 0.72Non-current Liabilities Borrowings (32.00)CurrentliabilitiesPayables (2.24)Net assets derecognised 59.41Share of net assets recognised under equity method 30.30

u) Impact of Ind AS adoption on the Statement of Cash Flow for the year ended March 31, 2016:

` inCroresParticulars Previous GAAP Adjustments Ind ASNetCashflowfromOperatingActivities (6,777.33) (178.86) (6,956.19)NetCashflowfromInvestingActivities (876.78) 272.74 (604.04)NetCashflowfromFinancingActivities 7,619.87 (75.97) 7,543.90Net Increase/(decrease) in cash and cash equivalents (34.24) 17.91 (16.33)

TheadjustmentsareprimarilyonaccountofBankoverdraftnowconsideredasCashandCashEquivalents,deconsolidationofConverganceChemicalsPrivateLimited,discontinuanceofproportionateconsolidationofAllerganIndiaPrivateLimited,consolidationofPiramalInvestmentOppotunitiesFundandotherIndASreclassifications.

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

369


57 FAIR VALUE MEASUREMENT Financial Instruments by category:a) Categories of Financial Instruments:

`inCroresMarch 31, 2017 March 31, 2016 April 1, 2015

Particulars FVTPL FVTOCI Amortised Cost

FVTPL FVTOCI Amortised Cost

FVTPL FVTOCI Amortised Cost

Financial AssetsInvestments 1,397.54 3,988.92 17,041.61 1,008.39 3,142.57 9,568.56 291.55 3,835.21 3,367.22Loans - - 7,335.73 - - 3,533.23 - - 2,644.62Cash&BankBalances - - 1,540.90 - - 365.94 - - 423.69TradeReceivables - - 1,107.74 - - 970.81 - - 819.29OtherFinancialAssets 14.69 - 220.83 11.47 - 234.06 12.77 - 81.70

1,412.23 3,988.92 27,246.81 1,019.86 3,142.57 14,672.60 304.32 3,835.21 7,336.52Financial liabilities

Borrowings (including CurrentMaturitiesofLongTermDebt)

- - 30,450.98 - - 16,278.79 - - 7,186.34

TradePayables - - 764.29 - - 702.56 - - 668.04OtherFinancialLiabilities 172.52 - 1,214.76 40.01 - 278.51 - - 115.31

172.52 - 32,430.03 40.01 - 17,259.86 - - 7,969.69

b) Fair Value Hierarchy and Method of Valuation Thissectionexplainsthejudgementsandestimatesmadeindeterminingthefairvaluesofthefinancialinstrumentsthatare(a)recognisedand

measuredat fair valueand (b)measuredatamortisedcostand forwhich fair valuesaredisclosed in thefinancial statements. Toprovideanindicationaboutthereliabilityoftheinputsusedindeterminingfairvalue,thegrouphasclassifieditsfinancialinstrumentsintothethreelevelsprescribedundertheaccountingstandard.Anexplanationofeachlevelfollowsunderneaththetable.

`InCroresFinancial Assets March 31, 2017

Notes Carrying Value

Level 1 Level 2 Level 3 Total

Measured at FVTPL - Recurring Fair Value MeasurementsInvestments

InvestmentsinPreferenceShares 1.70 1.70 1.70 Investmentsindebenturesorbonds

RedeemableNon-ConvertibleDebentures i. 987.86 987.86 987.86 Investments in Mutual Funds ii. 191.56 191.56 191.56 InvestmentinAlternativeInvestmentFund/VentureCapitalFunds vi. 216.42 216.42 216.42

Other Financial AssetsDerivativeFinancialAssets iii. 14.69 14.69 14.69

Measured at FVTOCIInvestmentsinEquityInstruments ii. 3,988.92 3,988.92 3,988.92 Measured at Amortised Cost for which fair values are disclosedInvestmentsInvestmentsindebenturesorbonds(GrossofExpectedCreditLoss) iv. 17,401.00 17,317.67 17,317.67 LoansTermLoans(GrossofExpectedCreditLoss) iv. 6,548.59 7,039.98 7,039.98 IntercorporateDeposits(GrossofExpectedCreditLoss) iv. 43.78 41.39 41.39 Financial LiabilitiesMeasured at FVTPL - Recurring Fair Value MeasurementsContingentConsideration vii. 141.79 141.79 141.79 DerivativeFinancialLiabilities iii. 30.73 30.73 30.73 Measured at Amortised Cost for which fair values are disclosed

Borrowings(includingCurrentMaturitiesofLongTermDebt) v. 30,450.98 30,720.32 30,720.32




`InCroresFinancial Assets March 31, 2016




InvestmentsinEquityInstruments 29.43 29.43 29.43InvestmentsinPreferenceShares 0.66 0.66 0.66Investmentsindebenturesorbonds

RedeemableNon-ConvertibleDebentures i. 758.44 758.44 758.44Investments in Mutual Funds ii. 6.23 6.23 6.23 InvestmentinAlternativeInvestmentFund/VentureCapitalFund vi. 213.63 213.63 213.63


Measured at FVTOCIInvestmentsinEquityInstruments ii. 3,142.57 3,142.57 3,142.57

Measured at Amortised Cost for which fair values are disclosedInvestmentsInvestmentsindebenturesorbonds(GrossofExpectedCreditLoss) iv. 9,799.51 10,148.72 10,148.72LoansTermLoans(GrossofExpectedCreditLoss) iv. 916.08 896.76 896.76IntercorporateDeposits(GrossofExpectedCreditLoss) iv. 1,864.63 1,856.52 1,856.52Financial LiabilitiesMeasured at FVTPL - Recurring Fair Value MeasurementsContingentConsideration vii. 35.98 35.98 35.98DerivativeFinancialLiabilities iii. 4.03 4.03 4.03Measured at Amortised Cost for which fair values are disclosed


`InCroresFinancial Assets April 1, 2015




InvestmentsinEquityInstruments 28.36 28.36 28.36InvestmentsinPreferenceShares 0.63 0.63 0.63Investmentsindebenturesorbonds

RedeemableNon-ConvertibleDebentures i. - - - Investments in Mutual Funds ii. 127.44 127.44 127.44InvestmentinAlternativeInvestmentFund vi. 135.12 135.12 135.12


Measured at FVTOCIInvestmentsinEquityInstruments ii. 3,835.21 3,835.21 3,835.21

Measured at Amortised Cost for which fair values are disclosedInvestmentsInvestmentsindebenturesorbonds(GrossofExpectedCreditLoss) iv. 3,452.91 3,595.56 3,595.56LoansTermLoans(GrossofExpectedCreditLoss) iv. 829.69 789.82 789.82IntercorporateDeposits(GrossofExpectedCreditLoss) iv. 636.71 789.52 789.52Financial LiabilitiesMeasuredatAmortisedCostforwhichfairvaluesaredisclosed


STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

371


Except for thosefinancial instruments forwhich thecarryingamountsarementioned in theabove table, theCompanyconsiders that thecarryingamountsrecognisedinthefinancialstatementsapproximatetheirfairvalues.

Forfinancialassetsthataremeasuredatfairvalue,thecarryingamountsareequaltothefairvalues.

Level1:Level1hierarchyincludesfinancialinstrumentsmeasuredusingquotedprices.Thisincludeslistedequityinstruments,tradedbondsandmutualfundsthathavequotedprice.Thefairvalueofallequityinstruments(includingbonds)whicharetradedinthestockexchangesisvaluedusingtheclosingpriceasatthereportingperiod.ThemutualfundsarevaluedusingtheclosingNAV.

Level2:The fairvalueoffinancial instruments thatarenot traded inanactivemarket (forexample, tradedbonds,over-thecounterderivatives) isdeterminedusingvaluationtechniqueswhichmaximisetheuseofobservablemarketdataandrelyaslittleaspossibleonentity-specificestimates.Ifallsignificantinputsrequiredtofairvalueaninstrumentareobservable,theinstrumentisincludedinlevel2.

Level3:Ifoneormoreofthesignificantinputsisnotbasedonobservablemarketdata,theinstrumentisincludedinlevel3.Thisisthecaseforunlistedequitysecurities,contingentconsideration,Debentures,TermLoansandICDsincludedinlevel3.

Valuation techniques used to determine the fair values:i. Discountedcashflowmethodhasbeenusedtodeterminethefairvalue.Theyieldusedfordiscountinghasbeendeterminedbasedontrades,

marketpolls,levelsforsimilarissuerwithsamematurity,spreadovermatrices,etc.ForinstrumentswherethereturnsarelinkedtothesharepriceoftheinvesteecompanytheequitypricehasbeenderivedusingMonteCarlosimulationandlocalvolatilitymodelusingtheinputslikespotrate,volatilitysurface,termstructuresandriskfreeratesfromgloballyaccepted3rdpartyvendorforthesedata.

ii. ThisincludeslistedequityinstrumentsandmutualfundswhicharefairvaluedusingquotedpricesandclosingNAVinthemarket.

iii. Thisincludesforwardexchangecontractsandcrosscurrencyinterestrateswap.Thefairvalueoftheforwardexchangecontractisdeterminedusingforwardexchangerateatthebalancesheetdate.Thefairvalueofcrosscurrencyinterestrateswapiscalculatedasthepresentvalueoffuturecashflowbasedonobservableyieldcurvesandforwardexchangerates.

iv. Discountedcashflowmethodhasbeenusedtodeterminethefairvalue.ThediscountingfactorusedhasbeenarrivedatafteradjustingtherateofinterestforthefinancialassetsbythedifferenceintheGovernmentSecuritiesratesfromdateofinitialrecognitiontothereportingdates.

v. Fairvaluesofborrowingsarebasedondiscountedcashflowusingacurrentborrowingrate.TheyareclassifiedasLevel3valueshierarchyduetotheuseofunobservableinputs,includingowncreditrisk.

vi. Discountedcashflowmethodhasbeenusedtodeterminethefairvalue.Thediscountingfactorhasbeencomputedusingamixofpasttrendsaswellaslikelyrateofreturnoftheunderlyingprojects.

vii. Discountedcashflowmethodhasbeenusedtodeterminethefairvalueofcontingentconsideration.




c) Fair Value measurements use significant unobservable inputs (level 3) Thefollowingtablepresentsthechangesinlevel3itemsfortheperiodendedMarch31,2017andMarch31,2016

Debentures Alternative Investment

Fund/Venture Capital Fund

Equity Instruments

Preference Shares

Contingent Consideration

Total

As at April 1, 2015 - 135.12 28.36 0.63 - 164.11Acquisitions/Additions 675.00 88.98 1.07 - 35.98 801.03Gains/(Losses)recognisedinprofitorloss 83.65 2.67 - - - 86.32Gains/(Losses)recognisedinothercomprehensiveincome - - - 0.03 - 0.03Realisations (0.22) (13.14) - - - (13.36)As at March 31, 2016 758.43 213.63 29.43 0.66 35.98 1,038.13Acquisitions 304.55 17.73 - 1.04 103.76 427.08Lossesrecognisedinprofitorloss - - - - 2.05 2.05Gains/(Losses)recognisedinprofitorloss 160.48 20.88 27.29 - - 208.65Gains/(Losses)recognisedinothercomprehensiveincome - - - - - - Transferoutduringtheyear - - - - - - Realisations (235.60) (35.82) (56.72) - - (328.14)As at March 31, 2017 987.86 216.42 - 1.70 141.79 1,347.77

d) Valuation Process TheCompanyengagesexternalvaluationconsultantstofairvaluefinancialinstrumentsmeasuredatFVTPLandFVTOCI.Themainlevel3inputsused

forunlistedequitysecurities,preferenceshares,investmentinAIF/Venturecapitalfund,contingentconsiderationanddebenturesareasfollows:

1)ForNonConvertibleDebentures,WaterfallapproachhasbeenusedtoarriveattheyieldsforsecuritiesheldbytheCompany.FordeterminingtheequitypricesMonteCarlosimulationsandlocalvolatilitymodelusingtheinputslikespotrate,volatilitysurface,termstructuresandriskfreeratesfromgloballyacceptedthirdpartyvendorforthesedatahavebeenused.

2)ForAlternativeInvestmentFund/VentureCapitalFund,Discountedcashflowmethodhasbeenusedtodeterminethefairvalue.Thediscountingfactorhasbeencomputedusingamixofpasttrendsaswellaslikelyrateofreturnoftheunderlyingprojects.

3)ForContingentconsideration,fairvaluehasbeenestimatedbyallocatingprobabilitytoachievementoffinancialmilestones.DiscountrateisdeterminedusingCapitalAssetPricingModel.

e) Sensitivity for instruments:

`inCroresNature of the instrument Fair value As

on March 31, 2017

Fair value As on March 31, 2016

Fair value As on April 1, 2015

Significant unobservable inputs*

Increase / Decrease in the

unobservable input

Sensitivity Impact for the year ended March 31, 2017

Sensitivity Impact for the year ended March 31, 2016

FV Increase/(Decrease)

FV Increase/(Decrease)

FVIncrease/(Decrease)

FVIncrease/(Decrease)

NonConvertibleDebentures 987.86 758.45 - Discountrate 1% (24.23) 25.05 (27.98) 29.22Equitycomponent(projections)

5% - - - -

Alternative Investment Fund/VentureCapitalFund

216.42 213.63 135.12 Discountrate 1% (1.03) 1.01 (1.57) 1.53 CashFlow 5% (6.71) 6.71 (6.67) 6.67

ContingentConsideration 141.79 35.98 - Discountrate 1% 2.59 (2.59) 0.54 (0.54)

ExpectedCashOutflow

10% 9.79 (9.79) 3.60 (3.60)

*Therewerenosignificantinter-relationshipsbetweenunobservableinputsthatmateriallyaffectfairvalues.

f) Management uses its best judgment in estimating the fair value of its financial instruments. However, there are inherent limitations in anyestimationtechnique.Therefore,forsubstantiallyallfinancialinstruments,thefairvalueestimatespresentedabovearenotnecessarilyindicative

STRATEGIC O

VERVIEWM

ANAG

EMEN

T DISCU

SSION

& AN

ALYSIS BO

ARD &

MAN

AGEM

ENT PRO

FILESFIN

ANCIAL STATEM

ENTS

STATUTO

RY REPORTS

373


ofalltheamountsthattheCompanycouldhaverealizedorpaidinsaletransactionsasofrespectivedates.Assuch,thefairvalueofthefinancialinstrumentssubsequenttotherespectivereportingdatesmaybedifferentfromtheamountsreportedateachyearend.

58 (a) TheGroupoperatesanincentiveplanarrangementforcertainemployeesofcertainsubsidiaries.TheschemeprovidesacashpaymenttotheemployeesbasedonaspecificnumberofphantomsharesatgrantandsharepriceofPiramalEnterprisesLimited,theultimateparentcompanyatthevestingdate.TheCashpaymentisdependentontheperformanceoftheunderlyingsharesofPiramalEnterprisesLimitedandcontinuedemploymentonvestingdate.ThefairvaluesoftheawardiscalculatedusingtheBlackScholesmodelatthegrantdate.Thefairvalueisupdatedateachreportingdateastheawardsareaccountedascashsettledplan.TheinputstothemodelsarebasedonthePiramalEnterprisesLimitedhistoricdata,theriskfreerateandtheweightedaveragefairvalueofsharesintheschemeatthereportingdate.Theamountexpensedinthecurrentyearrelatingtotheplanis` 2.43Crores.TheGroupconsiderstheseamountasnotmaterialandaccordinglyhasnotprovidedfurtherdisclosuresasrequiredbyIndAS102“ShareBasedPayments”.

58 (b) AsubsidiaryhasissuedcertainoptionsundertheSchemetitled“HealthSuperhiwayEmployeesStockOptionPlan-2011”(ESOPPlan)toitsemployees.Eachoptioncomprisesoneunderlyingequityshareofthesubsidiary.Theexercisepriceofeachoptionshallbe`54.10.TheoptionsgrantedvestsoveraperiodoffouryearsfromthedateofgrantinproportionsspecifiedintheScheme.Optionsmaybeexercisedwithinthreeyearsofvesting.Sincetheexercisepriceofthesharesismuchhigherthanthebookvalueoftheshareofthesubsidiary,thereisnoimpactontheearnings.

59 Duringthepreviousyear,theCompanyidentifiedafraudcommittedbyanemployeeinoneofitsdivisions.TheCompanyinitiatedaninternalinvestigationinthematter.Basedontheresultsoftheinvestigation,itwasconcludedthattheemployeehadmisrepresentedtovariouscustomersandraisedforgedinvoicesandcreditnotestotheextentof` 3.18croresduringthepreviousyear.TheCompanyhadfiledacriminalcomplaintwithappropriateauthoritiesand ispursuing thematter further.TheCompanyhadtakenappropriatemeasuresandhad furtherstrengthenedinternalprocessesandcontrolstopreventsuchcases.Duringthecurrentyear,theCompanyhasrecoveredanamountof` 1.80croresfromsuchcustomers.

60 ThefinancialstatementsfortheyearendedMarch31,2017includetheresultsandfinancialpositionofassociatestowhomIndASdoesnotapplycurrentlyandhence,theresultsareaccountedbasedoncurrentlyapplicableIndianGAAP.

61 Subsequenttotheyearend,onApril6,2017,theGroupthroughitssubsidiary,SigmaticLimited,acquiredUKbasedSharpInsightLimitedforUSD1.45millionequivalentto` 9.42Crores.

62 TheBoardofDirectorsattheirmeetingheldonMay12,2017haveapprovedtheissuanceofequitysharesand/orconvertiblesecuritiesforanaggregateamountnotexceeding` 5000croresoranequivalentamountthereofinoneormoreforeigncurrencies,includingapprovalofthepostalballotnoticeforobtainingshareholders’approval.

63 ThefinancialstatementswereapprovedbyboardofdirectorsonMay12,2017.

Signaturetonote1to63offinancialstatements.

ForPrice Waterhouse ForandonbehalfoftheBoardofDirectorsFirmRegistrationNumber:301112ECharteredAccountants

Ajay G. Piramal Chairman

Jeetendra Mirchandani Rajesh Laddha Leonard D’Souza Partner ChiefFinancialOfficer CompanySecretaryMembershipNumber:048125

Mumbai,May12,2017 Mumbai,May12,2017

notes to the consolidated financial · pdf filethe consolidated financial statements have been...

Documents